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Background: Although person-centred care (PCC) has been identified as necessary to achieve 
the 90-90-90 HIV treatment targets, limited research has considered the meaning and practice of 
PCC in low- and middle-income settings. 
Aim: To develop a community-based enhanced care intervention to improve person-centred 
outcomes for people living with HIV/AIDS, and to test the feasibility of a cluster randomised 
controlled trial in terms of participant recruitment and retention, and intervention delivery.  
Methods: The Medical Research Councils’ (MRC) guidance for developing and evaluating 
complex interventions was used to conduct a sequential mixed methods design. This comprised 
an initial systematic review to identify and appraise the evidence for models of person-centred 
HIV care delivered in community care settings; systematic review findings then informed a topic 
guide for qualitative interviews. People living with HIV/AIDS (PLWHA) and healthcare 
professionals (HCP) were interviewed regarding HIV care, what PCC means in the African 
(Ghanaian) context and what person-centred outcomes matter to PLWHA. Interview findings were 
mapped onto a PCC theory in an expert intervention development workshop. A “community-
based enhanced care intervention” (CECI) was developed and tested in a parallel mixed-methods 
feasibility cluster (2 clusters) randomised controlled trial (cRCT). Qualitative and quantitative data 
were analysed using NVivo version 12 and the SPSS version 25 respectively. Primary outcome 
was trial recruitment and retention.   
Results: The systematic review revealed limited research on person-centred models of care in 
community settings, as the 5 studies retained in the final analysis only 2 delivered all four PCC 
components (physical, psychological, social and spiritual wellbeing). N= 24 PLWHA and 15 HCP 
were interviewed about HIV care delivery and their perspectives on PCC. The qualitative 
interviews revealed that PLWHA are not involved in their care and care does not address what 
mattered to them. HCP also lack skills to undertake holistic assessment and to practice PCC. 
These findings were integrated to form the key components of the CECI intervention. Of the 83 
PLWHA screened for the feasibility cRCT, 60 were enrolled (30 participants assigned to each 
cluster). Recruitment and retention rates were 87% and 97% respectively. Potential effect size 
estimated at final timepoint for all measures using Partial Eta Squared statistics as a measure for 
3 
effect size and 95% confidence interval were: APCA POS [0.7 (95% CI 0.17 to 1.23) p<0.001]; 
MOS-HIV [0.7 (95% CI 0.17 to 1.23) p<0.001]; Picker Patient Experience Questionnaire (PPE-
15) [0.8 (95% CI 0.27 to 1.31) p<0.001; CARE Measure [1.0 (95% CI 0.45 to 1.55) p<0.001],
POSITIVE OUTCOMES [0.7 (95% CI 0.17 to 1.23) p<0.001]. Post-trial interviews revealed a 
general acceptability of the intervention including PLWHA feeling satisfied about their involvement 
in making decisions about their own care and their symptoms and concerns being assessed and 
addressed holistically using PCC. Training on the CECI was well received by HCP who felt 
equipped with skills to carry out holistic assessment and to practice PCC.  
Conclusion: These findings indicate that PCC care is context-specific and contextual meaning 
of PCC should guide PCC intervention development to address what matters to PLWHA. The 
CECI was successfully implemented, it was feasible to recruit and retain participants in the trial 
and CECI was acceptable for both PLWHA and HCP. Results confirm the feasibility and justify a 
definitive cRCT of CECI to improve person-centred outcomes for PLWHA.  
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Chapter 1 Introduction and background 
1.1 Introduction 
There are approximately 37.9 million people living with HIV/AIDS (PLWHA) globally [1]. PLWHA 
experience diverse problems throughout the disease trajectory, including physical pain [2] and 
other symptoms [3, 4]. Evidence suggests that pain experienced by PLWHA impacts on retention 
in care, adherence, and consequently viral load suppression, and physical function [5-8]. Also, 
PLWHA experience psychological and physical symptoms even after commencement of 
antiretroviral therapy (ART) [9-15]. PLWHA also experience social isolation [16], spiritual distress 
[17], and their significant others also endure emotional [18] and financial [19] hardships. It has 
been revealed that disclosing HIV/AIDS status can result in adverse personal outcomes such as 
loss of relationships and social rejection [20].  
 
Currently, PLWHA on ART have higher prevalence of depression, anxiety and worse health-
related quality of life than the general population [14, 15, 21]. Evidence from Africa suggests that, 
44-58% of PLWHA irrespective of their treatment status, experience depression and other 
psychological problems [22]. Research has recognised a negative correlation between 
depression and adherence which, could pose a real threat to global successes of reducing the 
AIDS epidemic [23, 24]. Therefore, failure to manage these psychosocial and other problems 
experienced by PLWHA could result in serious clinical implications, including increased treatment 
failure and viral replication [25].  
 
The WHO’s “Global strategy on integrated people-centred health services 2016-2026”, has called 
for the reorientation of care models to prioritise primary and community care services, and delivers 
holistic and comprehensive care that is sensitive to the needs of each individual [26]. Person-
centred care has been recognised as one fast-track action to achieve the 90/90/90 targets set by 
the World Health Organisation (WHO) [27], and can be defined as care that focuses on the whole 
person, incorporating high quality care that addresses what matters to that individual [28-34]. 
Although person-centred care is a global goal, there is no agreed international definition [35-38], 




Person-centredness must underpin interventions for PLWHA to remain in care and achieve 
optimal health [40]. This study is conceptually underpinned by the theory of person-centred care. 
Person-centred care is a central pillar to recent moves to enhance global HIV care and support 
[41-43], as it enables healthcare professionals to holistically assess the needs of PLWHA, and to 
initiate management strategies that reflect the interaction between physical, psychological, social 
and spiritual wellbeing. Retention in HIV/AIDS care, adherence and satisfaction with HIV/AIDS 
care could be informed by a better understanding of these four dimensions of wellbeing in relation 
to these outcomes.  
 
1.2 Thesis structure 
Chapter one of this thesis comprises the introduction and background of the study, which 
provides the reader with a justification for conducting the study including the overview of the thesis 
and the contextual background of HIV/AIDS. It describes the global, HIV/AIDS epidemiology 
including that of the sub-Saharan region and Ghana. This chapter includes a description of the 
healthcare delivery system in Ghana and challenges faced in delivering care to PLWHA. HIV 
symptom burden, models of HIV care delivery, rationale for focusing on community models of 
care, holistic care and the need for person-centred care for PLWHA is also outlined in this chapter.  
 
Chapter two presents the aim and objectives of the thesis.  
 
Chapter three details the study methods including a discussion of the design rationale for the 
study design. This chapter is organised by thesis objective and the corresponding methods. The 
first section of chapter three describes the study phases, complex intervention, the MRC guidance 
and the use of theory of change. It then describes the setting where the study was conducted 
including ethical considerations made in relation to the design and implementation of the study 
contents. The methods include a systematic review which informed qualitative interviews with 
PLWHA and healthcare professionals (HCP), intervention development, the feasibility cluster 
randomised controlled trial (cRCT) comprising quantitative outcome data collection and a post-




Chapter four presents the findings for the first stage of the MRC complex interventions guidance, 
i.e. results of the systematic review that appraised the evidence for person-centred care models 
of HIV care delivered in community settings. This includes the PRISMA flow diagram showing the 
number of studies retrieved and the number retained for final analysis, data extraction table, study 
quality assessment and the person-centred components within the models. It then critically 
reviews and appraises studies conducted in both developed and developing countries.  
 
Chapter five reports the results of the qualitative interviews with HCP and PLWHA, and the 
intervention development.  
 
Chapter six reports the results of the feasibility cRCT including recruitment and participants flow 
through the trial, baseline data characteristics of study participants of the two parallel groups, 
uptake and adherence of the intervention. Primary and secondary outcomes are discussed 
including the feasibility and acceptability of the intervention. 
 
Chapter seven appraises the strengths and limitations of the study including the qualitative 
intervention development components of the feasibility cRCT comparing findings to other studies 
conducted elsewhere in HIV populations. Finally, this chapter discusses the implications of 
person-centred intervention for practice, policy and training for HIV/AIDS care as well as 






The surveillance definition for AIDS is acquired immunodeficiency syndrome, which is based on 
the signs, symptoms, infections, and associated cancers that comes with the deficiency of the 
immune system as a result of HIV infection [44]. A human retrovirus which causes this life-
threatening immunodeficiency syndrome is the Human Immunodeficiency Virus (HIV) [44]. The 
first AIDS cases were reported in 1981 in the USA and it remains a disease of public health 
importance existing for more than three decades [45].  The cells of the human immune system 
infected by the retrovirus are mainly the CD4 T-cells and macrophage, which are the key 
components of the cellular immune system that this virus infects, destroys and impairs the 
function of the immune system [44]. HIV has no cure. However, treatment with antiretroviral 
therapy (ART) slows or prevents HIV from progressing to AIDS. The main aim of the ART is to 
assist persons infected with the HIV virus by reducing their viral load to an undetectable level for 
them to live healthier and longer lives. When the level of HIV in the blood is too low to be detected 
by a viral load test it is referred to as an “undetectable” level, and maintaining this level means 
that the virus cannot be transmitted to others [46]. The Centers for Disease Control and 
Prevention (CDC) classified HIV infection into three stages including acute and chronic infection, 
and AIDS [46, 47] (see Figure 1). 
 
Figure 1: Stages of HIV infection, adapted from AIDSinfo and CDC [46, 47] 
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1.3.2 HIV/AIDS epidemiology: Global, Africa and Ghana 
In 2018 an estimated 37.9 million people globally (36.2 million adults and 1.7 million children 
under age 15) were living with HIV, with approximately 23.3 million receiving ART, showing a 15.6 
million increase in those accessing treatment from 7.7 million in 2010. The year 2018 also saw 
1.7 million new infections compared to 2.9 million in 1997 (a reduction of 40% since the peak in 
1997). This was due to global expansion in education and scale up in ART treatment, which also 
resulted in around 770,000 AIDS-related deaths compared to 1.7 million and 1.2 million deaths in 
2004 and 2010 respectively (approximately 55% reduction in death since 2004) [1]. Approximately 
74.9 million people have become infected with HIV (of which about 8.1 million did not know they 
were living with HIV), and about 32 million have died from AIDS-related causes since the start of 
the epidemic [1]. UNAIDS set the 90-90-90 targets to ensure that 90% of people living with HIV 
know their HIV status; 90% of people with positive HIV status are put on ART; and 90% of people 
on ART should be virally suppressed [48]. By 2018, 79% of people living with HIV knew their 
status; 78% of people who knew their status were accessing treatment; 86% of people accessing 
treatment were virally suppressed [1], from the UNAIDS 90-90-90 treatment targets set [49]. The 
global HIV estimates have been summarised in Table 1.  





People living with HIV 37.9 million 
Adults (> 15 years) 36.2 million 
Children (<15 years) 1.7 million 
People accessing treatment  23.3 million 
New infections 1.7 million 
Deaths 770000 
 
Progress towards 90-90-90 
 
People who knew their status 79% 
People accessing treatment from knowing their status 78% 
People virally suppressed from accessing treatment  86% 
 
Of the global HIV estimate for the year 2018, the vast majority of PLWHA were from Eastern and 
Southern Africa (the most HIV/AIDS affected region), which had an estimated 20.6 million PLWHA 
with 13.8 million accessing treatment; and Western and central Africa (the 3rd most affected 
region) with approximately 5.0 million PLWHA and an estimated 2.6 million receiving treatment 
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[1]. This makes Sub-Saharan Africa (SSA) the most affected region and home to approximately 
25.6 million (68%) of all PLWHA globally, of which 16.4 million were accessing treatment and 
about 470,000 died from AIDS-related disease [1]. Table 2 is a summary of the 2018 estimates 
for SSA and Ghana. 






Proportion of global 
estimate 
SSA   
People living with HIV 25.6 million 68% 
New infections 1.08 million  
People accessing treatment  16.4 million  
Deaths 470,000  
Ghana   
People living with HIV 330,000  
New infections 20,000  
People accessing treatment  110,000  
Deaths 14,000  
 
1.3.3 HIV/AIDS burden in Ghana 
Compared to most countries within Eastern and Southern Africa, countries within Western Africa 
face relatively low HIV prevalence levels. Ghana, one of the 49 countries in sub-Saharan region 
of Western Africa, as well as one of the largest countries in West Africa in terms of population 
size, had an adult HIV prevalence of 1.7% in 2018 [50], this prevalence is a marked reduction 
from 3.7% at the initial stages of the pandemic [51]. Current estimates show that, of the 90-90-90 
targets set by the UNAIDS [48], Ghana currently have 55% of PLWHA who know their status and 
34% who know their HIV status are on treatment and 23% who are on treatment are virally 
supressed [52] (see Figure 2). With the 90-90-90 treatment targets deadline fast approaching, 
Ghana’s performance on the second and third ‘90’ is very poor and this has been attributed to 
stigma and discrimination which continue to prevent PLWHA from accessing treatment [53]. There 
is a call to fight against stigma to allow PLWHA to access services freely, in addition to delivering 
HIV care services at the community level in order to close the vast gap between Ghana’s 




Figure 2: Ghana's HIV treatment cascade showing 90-90-90 targets progress [52] 
 
1.3.4 HIV service delivery 
PLWHA require access to care and support services to improve their quality of life and 
community-based care is an important alternative when hospital care becomes neither necessary 
nor desirable. Prolong waiting time before seeing a doctor at the hospital continues to be a matter 
of concern [54], therefore an alternative for patients is to self-medicate, resulting in attendance to 
community pharmacies as their first point of call when sick [55]. Taking into consideration the 
increasing number of PLWHA who default, in addition to the aim to achieve the 90-90-90 targets 
set by UNAIDS [48], people continue to advocate for more services to be accessible including at 
the community level where PLWHA can receive high quality care. Home and community care 
services for PLWHA have already gained international recognition [56]. As a result of the 90-90-
90 global campaigns, the number of people aware of their HIV status continue to increase as 




1.3.4.1 Community HIV care delivery 
The scale of the HIV/AIDS epidemic has resulted in decentralization of HIV services through 
community-based approaches, which have been used in many regions with limited healthcare 
resources, in order to overcome the challenges imposed by HIV/AIDS [57, 58]. Although the 
components of community-based care services are common across settings [59, 60], the 
specification of a given model is dependent on contextual factors, which include national policies, 
available resources and non-governmental organizations. Community-based programs that 
address various aspects of the HIV/AIDS continuum of care were introduced in countries affected 
by the epidemic in the 1990s [61, 62]. There is currently a challenge of delivering treatment to 
those in need and providing care for those on life-long treatment [63-65]. Consequently, health 
planners have shown renewed interest in the potential role of community-based programs and 
community health workers in ART monitoring, so as to increase access to ART with scarce health 
professional resources [66].  
Evidence suggest that physician-focused models of care in most contexts have been replaced 
with trained non-physician health worker models [57, 64, 67]. For instance, the nurse-led ART 
program in Lesotho [67], the community-based Health Surveillance Assistants dispensing ART 
and monitoring of patients who are stable in a region of Malawi, and the Kenyan community care 
coordinators [57]. Community-based care services have been shown to increase access to 
essential programs for PLWHA and their families through the mobilization of community interests 
and resources [68]. Evidence affirms that community-based care services could promote 
awareness, at the same time reduce stigma and the burden on the primary-care system, and 
eventually cause a reduction in the incidence of hospitalization [69, 70]. Available data suggests 
that at least in some contexts, adherence and viral load suppression could be enhanced in 
community-based care services relative to hospital-based care [71, 72].  
Meanwhile, with the increase of ART coverage in many contexts, consideration of community-
based care services has become crucial [73]. UNAIDS emphasises the potential role for 
community service delivery and has strategised increased access to care by delivering 30% of 
HIV care in community settings [74]. Community services have played significant roles as part of 
the comprehensive HIV response of many nations [75]. The WHO defined community-based 
health services (CBHS) as “all services provided by people who spend a substantial part of their 
working time outside a health facility, discharging their services at the individual, family or 
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community level, as well as primary health care services provided in small local health facilities. 
The exact boundaries of the definition will differ from country to country” [76]. Two distinct groups 
provide CBHS: formally-trained healthcare professionals (nurses, public health inspectors, health 
visitors, doctors etc.), and community health workers (volunteers, peers etc.) [76].  
There is evidence that community-based care initiatives for PLWHA help to relieve HIV related-
symptoms including psychosocial problems, thereby improving quality of life [77-82]. The WHO’s 
“Global strategy on integrated people-centred health services 2016-2026”, has called for the 
reorientation of care models that prioritise primary and community care services, and deliver 
holistic and comprehensive care that is sensitive to the needs of individuals [26]. Delivering such 
care in a more decentralized manner [83] could facilitate easy access to care, including one-stop 
care and expansion of appointment times for working PLWHA [84]. In order to develop care 
interventions that could optimally provide holistic care for PLWHA, this study used a community-
based approach with a key focus on person-centredness [40].  
1.3.4.2 HIV service delivery in Ghana 
Ghana is administratively divided into ten regions (see Figure 3), with the Greater Accra region 
being the capital of Ghana [85]. The country operates a decentralised structure following a four-
tier system: national, regional, district, and sub-district levels. Health delivery is also decentralised 
and structured with the community level being the first point of the primary health care system 
operating at the sub-district level with clinics and health centres often staffed by nurses and mainly 
led by Physician Assistants. Hospitals at the district and regional levels are led by medical officers 
who provide the secondary level of care. Teaching hospitals operate at the tertiary level with 
locations including the Northern, Ashanti, Greater Accra, and Central regions of Ghana [86, 87]. 
HIV services are structured along the formal health system with facilities providing all services 
including referral of clients along the continuum of care, and these referrals are done based on 
the hierarchy of care delivery in Ghana: primary, secondary and tertiary levels [88]. Referring to 
the various levels of care delivery is dependent on the skill of the service provider, logistics 





Figure 3: Map of Ghana showing the ten administrative regions [89] 
 
Since the identification of the first HIV case in 1986, Ghana has been providing HIV-related 
services including the addition and expansion of services along the continuum over the past 
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decades and ART services being added to its comprehensive care in 2003 [88]. Ghana has in 
place all relevant policies and programs through its National HIV response in promoting the entire 
continuum of HIV services and care. However, community home based care (CHBC) appeared 
to have been abandoned with CHBC activities carried out in a policy vacuum, with no proven 
mechanisms for coordination nor standardized training of service providers. Consequently, the 
Ghana AIDS Commission (GAC) in partnership with stakeholders developed CHBC policy and a 
country-specific guideline to inform harmonised HIV service delivery in the community. A national 
strategy and guidelines are critical to guide the implementation of CHBC interventions in Ghana, 
which are at their nascent stage [90].  
 
Due to the devastating socio-economic impact of HIV infection (stigma faced, impact on 
employment status, family income and expenditure, availability of care and support service), 
coupled with insufficient resources at health facilities, PLWHA have limited access to the 
appropriate care in Ghana [90]. Also, most patients delay attendance to health facilities until their 
symptoms become severe leading to late presentations, when curative treatment is often not an 
option [91]; whereas others resort to the use of informal health services such as attending prayer 
camps and visiting traditional healers [92] among others. Traditional healers are important in 
resource-limited countries including Ghana because they are readily available, affordable, and 
they serve as the main source of healthcare in most rural communities [93]. It has been reported 
that an estimated 70% of Ghanaians rely on traditional remedies for their healthcare needs [94, 
95]. Also, evidence suggest that some PLWHA use traditional healers whiles on ART, because 
the care they receive from these healers is affordable and culturally acceptable [96, 97]. 
Therefore, it appears there is the need to consider incorporating traditional healers in HIV/AIDS 
care through appropriate education if care provision in the community will be a success.  
 
1.3.4.3 Nursing education/ training in Ghana 
Nurses trained in Ghana receive comprehensive training on human anatomy and physiology, 
pharmacology, nutrition and dietetics, community, psychiatric, paediatrics, obstetrics, medical and 
surgical nursing, in addition to psychology among others [98]. The medical focus of undergraduate 
nurse training curriculum for nurses attending the University of Ghana [98], suggests a general 
lack of prioritisation of psychosocial and spiritual needs due to the dominance of biomedical 
discourse among HCP and the necessary rationalisation of HCP time due to the volume of 
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patients seen per day. This is compatible with findings from Gott et al. [99], that the dominance 
of the biomedical discourse and its associated focus on ‘cure’ as the only legitimate approach to 
care is a barrier to the delivery of holistic palliative care at any time but the terminal phase of life.  
In settings where this philosophy of cure is the strongest legitimate form of care, it is likely that 
the perspectives of professionals from primary health [100] and nursing [101], with a more 
established record of holistic multidimensional approaches to care, would be less well received.  
The implementation of a short training package in person-centred care for HCP may help them 
recognise the importance of attending to patients’ psychosocial and spiritual problems, and how 
this contributes to holistic wellbeing in PLWHA.   
 
1.3.5 Symptoms and concerns experienced by PLWHA 
PLWHA frequently experience highly distressing physical, psychological, social and spiritual 
symptoms and concerns [5, 102-104] which negatively impact upon their quality of life [105]. 
Greatest attention has been paid to viral suppression at the expense of broader psychological, 
social and spiritual concerns that persist despite treatment advances [5, 106]. It should be noted 
that there is an interaction between symptoms experienced by PLWHA, e.g. pain can lead to 
depression; psychological problems such as anxiety and depression can worsen many 
symptoms, e.g. pain, breathlessness; social problems, e.g. lack of income or loss of careers, 
affects physical and psychological wellbeing; and spiritual issues affect psychological and social 
wellbeing [107]. Therefore, the care delivered to PLWHA should take into consideration these 
four domains of need including physical psychological, social and spiritual in order to manage 
their needs holistically. Dame Cicely Saunders, also suggested that pain should be understood 
as having physical, psychological, social and spiritual elements [108], a combination of which 
results in ‘total pain’ experience that is specific to every individual patient’s situation. Simms et al. 
[109] argued that, the holism and person-centeredness that characterised HIV care in the pre-
ART era appeared to have been lost, re-echoing the importance of person-centred care in 
HIV/AIDS management. 
 
1.3.5.1 Physical symptoms experienced by PLWHA 
PLWHA experience diverse problems throughout the disease trajectory, including physical pain 
[2] and other symptoms [3, 4]. Although the availability of ARTs in low and middle income 
countries continue to prolong the lives of PLWHA, symptoms of pain continue to affect a 
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significant proportion of PLWHA [110]. Evidence suggest that between 29% to 74% of people 
who receive ART experience pain symptoms [9, 111-114]. Pain is a common symptom reported 
by PLWHA, although the exact cause has not been thoroughly described, pain in PLWHA has 
been attributed to HIV disease symptom, opportunistic infections and side effects of ARTs [112, 
115]. Different anatomic sites have been associated with HIV-related pain [116], including 
headache, peripheral neuropathy, joint pain muscle pain, abdominal pain, bone pain and herpes-
related pain [115]. It has been estimated that 39%–85% of PLWHA experience chronic pain 
compared with 20%–30% of general population [117]. Evidence suggests that pain experienced 
by PLWHA impacts on their wellbeing, quality of life and physical function [5-8]. 
 
1.3.5.2 Psychological symptoms experienced by PLWHA 
Evidence from Africa suggests that, 44-58% of PLWHA irrespective of their treatment status, 
commonly experience depression and other psychological problems [22]. Also, research has 
recognised a negative correlation between depression and adherence which, could pose a real 
threat to global successes of reducing the AIDS epidemic [23, 24]. There is increased risk of 
developing mental health conditions among PLWHA [118, 119], which could undermine their 
health seeking behaviours and reduce adherence to treatment [120] leading to higher rates of 
mortality [121-123] . The most common mental health conditions that co-occur with HIV are 
depression and anxiety; a meta-analysis of studies conducted in sub-Saharan Africa revealed a 
24% prevalence of depression among PLWHA [118]. PLWHA can experience depression and 
anxiety as they adapt to living with HIV/AIDS or anticipating stigma or managing ongoing life 
stressors [124]. Among the predicting factors of depression include unemployment, negative life 
events, greater number of HIV-related physical symptoms, low CD4 counts, impaired function and 
poor social support [122, 125]. Having access to HIV care and treatment including mental health 
services is essential in supporting quality of life. However, even after achieving viral suppression, 
PLWHA may still report lower quality of life than the general population, with depression and 
anxiety contributing significantly to these outcomes [21]. 
 
1.3.5.3 Social concerns of PLWHA 
PLWHA experience social isolation [16] with their significant others also enduring emotional [18] 
and financial [19] hardships. It has been revealed that, disclosing HIV/AIDS status can result in 
adverse personal outcomes such as loss of relationships and social rejection [20]. HIV-related 
33 
 
stigma has been extensively reported and feared by PLWHA and may be in addition to actual or 
perceived stigma associated with their gender, religion, ethnicity and sexuality [15, 126]. Stigma 
has been described as any form of negative attitude, prejudice, discrimination or abuse suffered 
by PLWHA as a result of their HIV status [126, 127].  Living with HIV/AIDS at the family level 
severely compromises household resources as the functional capacity to work is reduced, with 
increasing medical expenditures and the income of both the PLWHA and others affected [128, 
129]. Reduced income further threatens food supply and the ability to pay for the education or 
health of other family members, resulting in the disruption of the entire social fabric of the family 
[128, 129]. AIDS-related stigma has an enormous negative impact on social relationships, access 
to care and psychological wellbeing leading to poor health outcomes [129]. Social interventions 
to support PLWHA are likely to be effective if they are based on holistic assessments and 
evidence-based intervention strategies with collaborative planning [130]. Such intervention 
strategies should focus on context-specific needs assessment and collaborative planning [130]. 
The interplay between the individual, family and social system needs to be recognised and care 
facilitated through effective communication and counselling. 
 
1.3.5.4 Spiritual concerns of PLWHA 
Spirituality is a sense of relationship to something greater than oneself, it is a person’s relationship 
with a supernatural being, which could be known as God, Jesus Christ, Mohammed, Buddha or 
simply the Supreme Being [131]. PLWHA experience spiritual distress [17] throughout the disease 
trajectory however, spirituality can be positively or negatively experienced throughout the life 
course. As a study reported 45% of its participants had increased positive spirituality following 
HIV diagnosis [132]. Evidence also suggest that positive spirituality acted as a protective factor 
for physiological disease progression in PLWHA, compared to those whose spirituality decreased 
following HIV diagnosis [17]. Negative manifestations of spirituality include viewing HIV as a sin, 
anger at God and spiritual struggle, and are linked to poor adherence [133], which results in rapid 
disease progression [17, 132]. Consequently, PLWHAs’ state of spirituality and practices could 
determine whether spirituality will be a protective or risk factor to HIV disease progression.   
PLWHAs’ spirituality predicts well-being and outcomes such as functional health status, 
improvements in life satisfaction and health-related quality of life when controlling for age and HIV 
symptoms [134]. Positive spirituality have been linked to less pain and increased physical function 
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[135], less psychological distress and depression [136-138], better cognitive and social 
functioning with fewer HIV symptoms, and better mental wellbeing [137, 139].  
 
This burden of symptom and concerns (physical, psychological, social and spiritual) experienced 
by PLWHA demands a more concerted, holistic approach to care, and further academic study of 
its potential effect for PLWHA at the level of healthcare systems in countries such as Ghana. 
 
1.3.6 Holistic care 
Jan Smuts (a Prime Minister South African Republic and philosopher), coined the term ‘holism’ 
from which emerged ‘holistic’. He described holism as a concept that the ‘whole’ is more than the 
sum of its systemic parts’ [140]. It has been argued that the human being is made up of body, 
mind and spirit, which is unified into a whole, with inseparable parts. When there is harmony and 
balance within the parts it results in maximum wellbeing [141]. Although health can be defined as 
physical, social, emotional, cognitive and spiritual, a person is truly healthy when they experience 
wellbeing. Percival, who wrote the first textbook of medical ethics advocated for a holistic 
approach and noted: “the feeling and emotions of the patients require to be known and to be 
attended to, no less than the symptoms of their diseases.” [142]. Huljev and Pandak defined 
holistic medicine as taking into account the complete person in terms of physical, psychological, 
social, and spiritual, in the management and prevention of disease [143]. These different states 
are equally important and ought to be managed together with the aim of treating the person as a 
whole. Using the holistic approach implies that HCP is aware of the patients’ whole life situation 
[144]. 
The principles of a holistic approach includes: the patient is a person, not just a disease; proper 
therapeutic care requires a team approach; patient and HCP are partners in the treatment 
process; and treatment involves resolving the cause of the illness, not just managing symptoms 
[143]. It is crucial to know from a person-centred approach, how responding to the holistic needs 
promotes an individual's health and wellbeing. The concept of holistic health is about viewing a 
person’s physical, social, emotional, and spiritual components as an integrated whole, resulting 
in a broader concept of care where a person’s holistic needs are met in maximising health and 




1.3.7 Person-centred approach as holistic care 
Mezzich defined person-centred care as care ‘dedicated to the promotion of health as a state of 
physical, mental, social, and spiritual wellbeing, as well as to the reduction of disease and founded 
on mutual respect for the dignity and responsibility of each individual person’ [146]. The author 
asserts that contextualising care includes cultural diversity as well as spirituality [146]; and 
demonstrating respect for the person behind a serious illness is considered essential in motivating 
person-centred care [147]. Also, it is crucial for clinical care to engage patients in a thoughtful 
manner both as individuals and collectively, including those critical of healthcare, in order to 
restate the dialogic foundation of the medical profession [148]. These assertions appear to argue 
for a more inclusive, holistic, and person-centred perspective to enhance and strengthen the 
foundations of medical care [149]. Mezzich affirms to extend the focus of medicine to person and 
to better understand how the different elements of the person-centred approach influence the 
process and outcome of care, and to respectfully work in collaboration with patients to achieve 
their health and life’s goals. 
 
1.3.7.1 Concepts of person-centred care 
The term ‘person-centered care’ is used throughout this thesis as opposed to ‘patient-centred 
care’, which has been used to describe similar concepts. ‘Person-centred’ is preferred due to its 
broader coverage of care settings and recognition of people as individuals beyond their status as 
‘patients’ [150].  
Various concepts of PCC have been  described including that of the Institute of Medicine (IOM), 
which described PCC as ‘Health care that establishes a partnership among practitioners, patients, 
and their families (when appropriate) to ensure that decisions respect patients’ wants, needs, and 
preferences and that patients have the education and support they need to make decisions and 
participate in their own care’ [34]. Eight concepts of PCC discussed in literature have been 
summarised in Table 3. Of these, three concepts have been widely used and are prominent in 
PCC research area: the Stewart [151], Stewart et al., [152] concept, the Mead and Bower [153] 
concept, and the Epstein et al., [154]. Some of the concepts have been developed with the aim 
of making the key components of PCC more applicable in practice. It should be noted that the 
main focus of the Epstein et al., [154] concept is patient-centred communication rather than a 
wider approach to PCC. Epstein et al.’s concept is deemed relevant due to its focus on patient-
centred communication as the way to achieve patient-centeredness. 
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However, in considering a definition of PCC as a theory to underpin this study, it was important 
to choose a PCC concept that focuses on holistic care to be able to address the domains of need 
(physical, psychological, social and spiritual) experienced by PLWHA. Selman et al. noted the 
importance of holistic assessment to achieve PCC for PLWHA, noting that spiritual wellbeing 
receives less attention [155]. This is supported by McEvoy’s concept analysis of Holistic practice 
[156]. 
 
Table 3: Concepts of PCC described in literature with specific components of delivery 
 
Concepts of PCC 
 
Specific components 
Picker Institute [157]. § Access to care   
§ Respect for patients’ values, preferences and expressed needs   
§ Information, communication and education   
§ Co-ordination and integration of care   
§ Emotional support and alleviation of fear and anxiety   
§ Involvement of family and friends   
§ Physical comfort and pain alleviation   
§ Transition and continuity. 
Kitson et al. [158] § patient participation and involvement,  
§ the relationship between the patient and the HCP, and  
§ the context where care is delivered.  
Sidani and Fox [159] § holistic care,  
§ collaborative care, and  
§ responsive care.  
Mead and Bower 
[153] 
§ the biopsychosocial perspective 
§ the patient-as-person concept 
§ sharing power and responsibility 
§ therapeutic alliance 
§ doctor as person, 
Stewart [151], 
Stewart et al. [152] 
§ exploring both the disease and the illness. 
§ understanding the person as a whole. 
§ finding common ground in three main areas: agreement between the 
doctor and the patient on the nature of the problem; the plan for treating 
or managing the problem; and the role of the patient 
§ incorporating prevention and health promotion 
§ enhancing the patient-doctor relationship 
§ the need to be realistic, both in teamwork and team building and in 
time.    
Morgan and Yoder 
[160] 
§ holistic care,  
§ individualised care,  
§ respectful care, and  
§ empowering care.  
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Mezzich [146] § physical,  
§ mental,  
§ social, and  
§ spiritual wellbeing, as well as to  
§ the reduction of disease and founded on mutual respect for the dignity 
and responsibility of each individual person’ 
Epstein et al., [154] § offering patients opportunities to provide input and participate in their 
care   
§ enhancing partnership and understanding in the patient-doctor 
relationship 
§ considering patients’ needs, wants, perspectives and individual 
experiences  
§ actions taken to achieve patient-centeredness philosophy including 
health systems innovations, technical interventions and interpersonal 
behaviors 
§ patient-centered communication including communication between 
HCPs, the patient and their family to enhance patient-centeredness. 
 
 
Of these concepts of PCC described in Table 3, the concept of PCC chosen for this thesis is the 
one described by Mezzich as care ‘dedicated to the promotion of health as a state of physical, 
mental, sociocultural, and spiritual well-being, as well as to the reduction of disease, and founded 
on mutual respect for the dignity and responsibility of each individual person’ [146]. This 
description was chosen to reflect the domains of need experienced by PLWHA and the focus on 
holistic care delivery. 
 
1.3.7.2 HIV/AIDS and person-centred care 
Among the critical areas of action detailed for achieving the 90-90-90 targets is to keep individuals 
alive and healthy through the delivery of ‘person-centred and holistic care’ [161]. Person-
centeredness is key to quality healthcare [162], and is represented in the statement ‘nothing about 
me, without me’ [163]. The World Health Organisation (WHO) has recognised person-centred 
care (PCC) as a means to achieve the 90-90-90 targets set [41] however, PCC is a Western-
originated concept that is claimed to be potentially applicable universally, despite it not being 
tested in Africa [39, 164].  Evidence from high income countries for conditions other than HIV has 
shown that a shift to PCC enhances collaboration between healthcare providers and patients and 
adherence to treatment plans [165, 166], improves health outcomes, and increases patient 
satisfaction [167, 168]. Moreover, the adoption of person-centred approaches in primary 
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healthcare has resulted in significant benefits for patients, enabling better health management by 
being informed and supported [169]. This will be increasingly important as PLWHA age and live 
with complex comorbidity and clinical uncertainty.  
PCC has been seen as a Western concept which appears to be accepted universally, and has 
not been explored in Africa [39] or in HIV-specific care. Person-centeredness is also context 
specific and may be interpreted and applied differently [39] therefore, there is the need to 
understand what PCC means universally and contextually.  
 
1.3.8 Palliative care and person-centred care 
Palliative care skills might be useful and appropriate to draw on for the delivery of PCC. Palliative 
care is known to deliver holistic and person-centred care for people facing serious illness like 
HIV/AIDS, with the goal of improving their quality of life through early identification, assessment 
and treatment of physical, psychosocial, emotional, and spiritual concerns [43]. Also, the WHO 
state that ‘palliative care is an essential component of a comprehensive package of care for 
people living with HIV/AIDS because of the variety of symptoms they can experience’ [170]. It has 
also been argued that the effectiveness of palliative care is limited when it failed to provide holistic 
care contributing to physical, social, spiritual, and emotional suffering [171]. Therefore, it made 
sense to use palliative care skills as an exemplar of person-centredness order to develop a PCC 
intervention for PLWHA. 
 
1.3.9 Summary and rationale for the study 
HIV/AIDS remains a disease of public health importance especially in the sub-Saharan region, 
although the infection rates have stabilised, access to ART is improving resulting in PLWHA living 
longer. Moreover, the social, psychological and economic impacts of HIV on PLWHA, their 
families and society, notably in resource-limited countries such as Ghana, is an indication for care 
and support approaches that could deliver holistic care for PLWHA. HIV/AIDS has become a 
chronic illness and therefore requires a holistic and person-centred care approach in order to 
meet the physical, social, psychological and spiritual needs of PLWHA.  
Several studies including policy documents have been published on the benefits of person-
centred care [172-174], which has therefore been pivotal to recent moves to enhance global HIV 
care and support [41-43]. However, person-centred care is a construct developed in the West it 
is not known what it means in Africa [39, 164], or in HIV care.  Person-centeredness is context 
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specific and may be interpreted and applied differently [39] depending on the context. 
Consequently, the purpose of this study is to identify the existing models of person-centred care 
in community settings where PLWHA receive care and appraise their effectiveness in improving 
outcomes for PLWHA. This study further sought to use evidence from the existing person-centred 
care models being delivered in the community to explore and understand the meaning of person-
centred care from the perspectives of PLWHA receiving care in community settings in Ghana. 
This information was used to inform a community-based person-centred intervention 




Chapter 2 Aim and Objectives 
2.1 Aim 
To develop a community-based enhanced care intervention to improve person-centred outcomes 
for people living with HIV/AIDS, and to test the “feasibility” of a cluster randomised controlled trial 
in terms of participant recruitment and retention, and intervention delivery.  
 
2.2 Objectives 
Objectives are presented under the headings of the MRC complex interventions guidance 
 
(i) “Identifying the evidence base” 
Objective 1. To conduct a systematic review identifying evidence for person-centred 
models of community HIV management, and their impact on outcomes for PLWHA.   
 
(ii) “Identifying/ developing appropriate theory” 
Objective 2. To explore the views of PLWHA and healthcare professionals (HCP) about 
current HIV/AIDS care, its accessibility, and to determine which person-centred outcomes 
matter to PLWHA.  
 
Objective 3. To map the qualitative data from objective 2 onto the components of person-
centred care theory to determine which components map and what extra components are 
required.  
 
(iii) “Modelling process and outcomes” 
Objective 4. To integrate findings from objectives 1-3, modelling the potential processes, 
outcomes, and mechanisms of action for the intervention.  
 
Objective 5. To deliver and test the feasibility of a cluster randomised controlled trial of 
the intervention in terms of recruitment and retention, and to determine intervention 





Chapter 3 Methods 
3.1 Introduction 
This chapter describes the design and methods for each phase of the study.  
 
Phase 1: The first phase involved a systematic review which identified evidence for person-
centred models of community HIV care and their impact on outcomes for PLWHA. This included 
identifying components of the person-centred models and describing the care structure, 
processes and outcomes of the models delivered using the Donabedian framework of healthcare 
quality [175], with appraisal of the quality of the evidence. 
 
Phase 2: The second phase involved a qualitative interview study of HCP and PLWHA in Ghana. 
The semi-structured interviews explored the views of PLWHA and their HCP about current 
HIV/AIDS care, need for and accessibility of PCC, and determined which person-centred 
outcomes matter to PLWHA. Findings from this interview were mapped onto components of a 
person-centred theory in an expert intervention development workshop and informed contents of 
a proposed intervention. This led to the development of a conceptual model of person-centred 
care (PCC) and a framework that informed PCC delivery for PLWHA. This person-centred 
framework was modelled as a complex intervention (community-based enhanced care 
intervention (CECI)), having a logic model and PCC theory which underpinned CECI development 
and acted as the theory of change. 
 
Phase 3: The third and final phase of this PhD tested the feasibility of delivering the CECI 
intervention in community settings for PLWHA in Ghana. Feasibility studies ask can a study be 
done, should you go ahead with it, and if so, how? [176]. The essential feature of feasibility studies 
is that they answer questions to inform a future definitive study [177] (see Figure 3 for the 
conceptual framework for feasibility studies). This phase of the study involved a mixed methods 
cluster randomised controlled feasibility trial, which comprised quantitative outcome data 
collection and a post-trial exit interviews with a purposive sample selected from trial participants. 
This was reported using the CONSORT extension for feasibility trials. The main uncertainties this 
feasibility trial addressed were participant recruitment and retention, HCP training on the 
intervention, intervention delivery and acceptability, and estimation of the potential effect size of 
the intervention.  
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This trial was registered with the ISRCTN registry with study ID ISRCTN13630241. 
 
 




3.2 Complex interventions 
Complex interventions have traditionally been defined as “interventions with several interacting 
components” [178]. The MRC guidance described complex intervention as interventions which:  
Ø are made up of number of interacting components;  
Ø require number of behaviours by those delivering or receiving the intervention;  
Ø aimed at number of groups including healthcare professionals and patients;  
Ø involve number and variability of outcomes;  
Ø allow for degree of flexibility or tailoring [176]  
 
CECI is a complex intervention as it is made up of several components: training, supervision and 
mentoring HCP on CECI including holistic assessment tools and care plans; it involved groups of 
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PLWHA and HCP; and aimed to change the behaviour of both the HCP and PLWHA so that the 
symptoms and concerns of PLWHA are more holistically assessed and addressed.  
In developing and evaluating complex interventions, there are a number of challenges that relate 
to ensuring fidelity in the design and delivery of the intervention [179, 180]; the influence of the 
contextual factors [181, 182]; the organisational and logistical issues in implementing an 
intervention in clinical practice and the identification of the mechanism of action of the intervention 
and the relationship to the outcomes [183]; as there can be long complication causal chains linking 
interventions with outcomes [183]. The aim of the MRC guidance is to assist researchers to adapt 
appropriate methods while recognising these challenges of developing and evaluating complex 
interventions. The MRC guidance advises that dealing with this complexity depends on the aims 
of the evaluation [178]. However, the intervention may be modified in an iterative manner as 
required once effectiveness has been established. Important questions to ask are: how does the 
intervention work, what are the vital constituents and how do the constituents fit together to exert 
their effect (mechanism of action)? [178, 184].  
The MRC guidance advises that: “best practice is to develop interventions systematically, using 
the best available evidence and appropriate theory, then to test them using a carefully phased 
approach, starting with a series of pilot studies targeted at each key uncertainty in the design, and 
moving on to an exploratory and then a definitive evaluation” [178]. In the present study the CECI 
was developed following a systematic approach recommended by the MRC guidance, using the 
evidence obtained from a systematic review, qualitative interviews to inform intervention 
development with PLWHA and HCP, and utilising the theory of person-centred care. In line with 
the MRC guidance, feasibility of the CECI must be tested to determine whether and how it can 
be optimised and delivered within multiple community HIV care settings with anticipated 
heterogeneity in skills, practice and HCP composition.  
 
3.3 The MRC guidance 
The MRC framework for developing and evaluating complex interventions was initially developed 
and published in 2000 [185]. However, several  limitations were identified with this initial 
framework [176], which prompted recommendations for a greater attention to be paid to early 
phase development and piloting work [186]; a less linear but more flexible model of development 
and process evaluation [187]; integration of process and outcome evaluation [188], recognising 
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that complex interventions tailored to local contexts rather than completely standardised could 
work best  [187], and making greater use of insights provided by theory of complex adaptive 
systems [189]. The initial MRC linear framework was updated and published in 2008, with a model 
that allows for movement between each stage in the development and evaluation of complex 
interventions [178].  
The MRC guidance has four research stages: Development, Feasibility and Piloting, Evaluation 
and Implementation (see Figure 5). The MRC guidance [178] emphases the importance of the 
development stage of an intervention, which involves thee components. The first, ‘Identify the 
evidence base’ including conducting a systematic review to establish what is known about similar 
interventions. The second is ‘Identifying/ developing theory’ the guidance advises the importance 
of developing a theoretical understanding of how the intervention may possibly change process 
by identifying and appreciating existing evidence and theory. Nevertheless, if this evidence is not 
available, new research ought to be conducted with stakeholders. By integrating existing and new 
evidence, a deeper understanding of the theoretical model of how the complex intervention may 
work is then attained [178]. Finally, in the Modelling process and outcomes, the understandings 
and insights from the theory phase are applied to develop the intervention and gain an 
understanding into how the intervention may affect the relationship between intervention and 
outcome [178].  
The feasibility and piloting stage includes Testing procedure (including testing methods for their 
acceptability and feasibility), estimating the likely rates of recruitment and retention of participants 
and the determination of appropriate sample sizes  for the evaluation studies [178]. The Feasibility 
and Piloting stage should aim to address all the uncertainties identified in the Development stage. 
The MRC guidance stresses the importance of this stage. This stage may be repeated multiple 
times (iteration between development and feasibility stages as required) before moving on to the 
formal evaluation of the complex intervention in the Evaluation stage [178]. The MRC guidance 
advises researchers to choose study designs that are suitable to the intervention paying attention 
to the choice of outcomes. In addition, the guidance recommends the use of appropriate 





Figure 5: The four research stages of the MRC guidance adapted from Craig et al. [176] 
 
In developing and feasibility testing of CECI for this thesis, the Development and Feasibility stages 
of the MRC guidance was used. This involved the development of CECI followed by the feasibility 
testing of CECI. The findings from the feasibility study will be used to inform a future definitive 
study as appropriate. The stages of the MRC guidance used in developing and feasibility testing 





Figure 6: The Development and Feasibility stages of the MRC guidance mapped onto study objectives 
 
 
3.4 Mixed methods approach (pragmatism) 
The pragmatist views nature as ‘existential reality’ and knowledge as one that is useful and 
created through a line of action [190, 191]. It is therefore argued that, pragmatism presents an 
alternative approach to research philosophy that requires strict adherence to what underpins 
ontology and epistemology [192]. Ontology (assumptions about the nature of reality) and 
epistemology (the acceptable knowledge in the area of research) are the philosophical stances 
of researchers which affect their research paradigm [193]. Therefore, understanding 
epistemology and ontology depends on the research question or problem under investigation 
[190, 194, 195].   
 
3.4.1 Rationale for using mixed methods design 
A number of factors guide the choice of research methods, which includes: (a) the aims and 
objectives of the research; (b) ontological perspectives being adopted for the research [196]; (c) 
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epistemological perspectives of the research [197]; and (d) environmental and socio-economic 
characteristics of research participants, resources available, and the researcher [198].  
The mixed methods design implemented in this PhD is consistent with the MRC guidance [199, 
200]. Moore et al. [199] propose the use of qualitative study across various stages. For instance, 
in the early phases of evaluation,  
 “…a vitally important early task is to develop a theoretical understanding of the likely 
process of change, by drawing on existing evidence and theory, supplemented if 
necessary, by new primary research, for example interviews with stakeholders” (p.9).  
The author again emphasised the importance of drawing together different research methods at 
the feasibility stage,  
“…a mixture of qualitative and quantitative methods is likely to be needed, for example to 
understand barriers to participation and to estimate response rates” (p.10).   
Therefore, the research objectives for this PhD were developed using the MRC guidance, 
specifically the components listed in the ‘development’ and ‘feasibility’ stages. It was observed 
that different methodological approaches were required in order to address these research 
objectives, necessitating a mixed methods design [201, 202]. Greene argued that “the greatest 
potential of mixed methods inquiry is the generative possibilities that accompany the mixing of 
different ways of knowing, perceiving and understanding” [203]. The use of mixed methods 
approaches also bring different benefits, that together can provide greater depth and breadth of 
inference than a mono-method approach, and on the basis that each method functions as a tool 
that is calibrated to answer specific research questions.  
 
3.4.2 Application of mixed methods design using the MRC guidance 
In the development stage of the MRC guidance, the researcher conducted a systematic review 
together with the adaptation of a person-centred care theory to underpin the intervention 
development. This then led to a qualitative exploratory phase that explored the views of PLWHA 
and HCP on current HIV care, how it is delivered and what constitutes person-centred care for 
PLWHA in more depth, which has been advocated to identify the causal processes and contextual 
factors that could be measured in testing the premise generated [204]. By integrating the existing 
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evidence and the underpinning theory with new evidence from stakeholders, a deeper 
understanding of the theoretical model of how the intended intervention may work was then 
attained in the development stage. In the modelling theory or processes stage, the 
understandings and insights from the theory phase were applied to develop the intervention and 
an understanding was gained of how the intervention could affect the relationship between 
intervention and outcome [178]. Testing the feasibility of the intervention in a cRCT to estimate 
recruitment and retention, and the potential effect of the intervention necessitates a quantitative 
approach; and in order to explain the quantitative results from the cRCT, a final post-cRCT 
qualitative interviews were conducted. Therefore, the feasibility testing phase of this PhD was 
implemented as a sequential explanatory design [202, 205]. 
 
3.4.3 Sequential explanatory design 
Sequential designs involve multiple stages of data collection where the research aim and 
questions determine the specific sequence [206], to enable each stage of the study to shape 
subsequent stages. This study used a sequential explanatory design with the embedded  
qualitative data in the feasibility testing phase. The qualitative data was used to explain or 
elaborate on the quantitative results obtained during the cRCT [207]. This method involved two 
phases: (a) quantitative outcome data collection and analysis, and (b) post-trial exit qualitative 
interviews which were used to explain the results from the quantitative data collected earlier [202, 
208, 209]. Additionally, an important consideration in sequential mixed methods design is the 
weight given to the data elements within the study in determining the theoretical drive of the study 
[210]. It has been suggested that in exploratory designs weight is usually placed on the qualitative 
element of the study, while explanatory designs usually place weight on the quantitative element 
of the study, although this is not always the case [206]. This feasibility cRCT placed equal weight 
on both elements implemented. The quantitative data collection utilised standardised 
measurement scales which brought potential strengths of quantification of results. The 
incorporation of a post-cRCT qualitative stage allowed for the exploration of the potential 
mechanism of action of the intervention, its feasibility and acceptability in addition to its use in 
clinical practice. This qualitative data also helped to explain the quantitative findings, which 
provided valuable insights which could be used to inform a future definitive study.  
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The combination of all these methods focused on the development and feasibility testing of this 
complex intervention and increasing the understanding of outcomes in order to improve the 
intervention. The mixing of the different methods involved in addressing the research aim has 
been described by each study objective and incorporated in the stages of the MRC guidance used 
for this study in figure 7. Details of the various methods used have been described by objectives 
in subsequent sections. Furthermore, the decision to use a particular data collection tool, be it a 
semi-structured interview or structured questionnaire, did not align to a specific ontological or 





Figure 7: Study overview
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3.5 The MRC guidance and the underpinning theoretical model  
3.5.1 The Theory of Change 
A theory-driven approach has been proposed for the design and evaluation of complex 
interventions by the adaptation and integration of programmatic design and evaluation tool, 
Theory of Change (ToC), into the MRC guidance for complex interventions [213]. The ToC is a 
discussion-based process which is intended to generate a ‘description of a sequence of events 
that is expected to lead to a particular desired outcome’ [214, 215]. This description is usually 
captured in a diagram with narratives to provide a guiding framework for the study team and 
stakeholders. ToC is also a practical outline describing how the intervention affects change and 
could be reinforced by embedding behavioural change theories at critical points in explaining why 
particular links happen. The ToC has been proven to strengthen research in many different 
aspects including the development of the intervention, its feasibility and piloting, evaluation, and 
finally implementation (Figure 8) [213]. The ToC was employed throughout this study, 






Figure 8: The integration of Theory of change into the MRC guidance for complex interventions, adapted 
from De Silva et al. [213] 
 
3.5.2 Adapting Person-centred care theory as the ToC 
The theory embedded to strengthen the ToC for this intervention is the theory of person-centred 
care (PCC) which is care ‘dedicated to the promotion of health as a state of physical, mental, 
sociocultural, and spiritual well-being, as well as to the reduction of disease, and founded on 
mutual respect for the dignity and responsibility of each individual person’ [216]. ToC explained 
the causal assumption and mechanism of action by which the intervention components worked 
to bring about change. The MRC guidance also highlights the importance of building a ‘cumulative 
understanding of causal mechanisms’ with the aim of learning from evaluations in order to ‘design 
more effective interventions and apply them appropriately across group and setting’ [178]. 
Therefore, using theory to underpin an intervention development is a crucial starting point, while 
the use of evaluations in testing and refining these theories are important to maximise its 
contribution to a wider evidence-base [217]. The aim of this PhD is to develop a complex 
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intervention to improve person-centred outcomes for PLWHA. Theories of change predict and 
explain how the interactions between the person living with HIV, the intervention components and 
how they are delivered may influence modifiable factors.   
 
3.5.2.1 PCC as the ToC strengthened the development stage of the MRC guidance by 
i. Improving the intervention design in relation to: 
• Building consensus with HCP and PLWHA in a qualitative interview 
• Designing the intervention with the goal of causing change in the way 
HCP delivered care and how PLWHA experienced that care 
• How the intervention was embedded within the local context 
• Providing a frame for ‘theory’ 
ii. Creating realistic prospects of impact of the intervention as stakeholders concede on 
what outcomes are feasible within the context and available resources 
 
3.5.2.2 PCC as the ToC strengthened the feasibility stage of the MRC guidance by 
i. Identifying formative research questions which underscored the knowledge gap 
ii. Highlighting barriers to the implementation of the intervention at the beginning and 
helped to develop strategies to overcome them 
iii. Improving piloting by providing evidence of links between the development stage 




3.6 Setting, translations and ethics as applied to the whole study 
3.6.1 Setting 
The WHO’s “Global strategy on integrated people-centred health services 2016-2026”, has 
called for the reorientation of care models that prioritise primary and community care services, 
and delivers holistic and comprehensive care that is sensitive to the needs of individuals [26]. 
Currently, approximately 95% of HIV/AIDS care delivery is hospital-based. Consequently, one 
of the fast-track strategies to achieve the 90-90-90 targets, is to increase access to HIV/AIDS 
care by delivering 30% of services in community settings to improve retention in care [48].  
UNAIDS has also emphasised the importance of community-wide systems in motivating the 
use of HIV care services and argues for research to be expanded in this area [218, 219]. Given 
that most PLWHA in Ghana have financial challenges that prevent them from accessing 
services delivered in hospitals that required substantive amount of traveling time [220], the 
researcher conducted this study in existing community settings where HIV care is delivered in 
order to reduce financial burden of having to travel long distances to access services.  
     The researcher therefore contacted HIV service providers in Ghana via telephone who 
helped in the identification of existing community-based HIV services to undertake this study. 
The researcher was referred to the West African AIDS Foundation (WAAF). The WAAF was 
contacted also via telephone, through the clinic lead, and the purpose of this study was 
explained to the clinic. The clinic was supportive of the study and agreed for their facility to be 
used as one of the study sites. The clinic lead was made aware earlier on during the discussion 
about the study, that two sites were required for the implementation of the whole study. 
Therefore, the clinic lead at WAAF suggested the Legon HIV clinic as a potential second site 
(as they both provide similar services). This potential clinic was also contacted via telephone 
about the study and the possibility of becoming the second site for study implementation (the 
telephone contact approach was used to identify the two study sites as the researcher was 
based in King’s College London (KCL) when this initial liaison work was done). The clinic lead 
at the Legon clinic was also happy to partner with WAAF to implement this study so long as 
the researcher had ethics approval to start the study.  
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To have the study accepted at these two sites located in the Greater Accra Region of Ghana 
was advantageous as all the components of this study were conducted by the researcher, and 
it would have been difficult to complete this study within the allocated time if the study sites 
were located in different regions. Therefore, these two community clinics were chosen in 
Ghana to implement the whole study (both the intervention development and feasibility testing) 
as they both provide similar HIV care and support services, which is very crucial for the 
feasibility testing, ensuring that no clinic had an undue advantage over the other. Both clinics 
also have trained professionals who could be further trained to deliver the intervention. 
 
3.6.1.1 Participating sites 
West African AIDS Foundation (WAAF) is a registered Non-Governmental Organization 
(NGO) situated in Haatso, a suburb of Accra. WAAF is situated about 17 kilometres east of 
the city centre in the Ga East district of the Greater Accra Region of Ghana. WAAF currently 
provide care to a cohort of 750 PLWHA, with an average of 15 to 40 PLWHA seen on daily 
basis as outpatients only and the caseload are shared among HCP.  
The Legon clinic is attached to the University of Ghana and is therefore managed by the 
University. Legon, a suburb of Accra, is situated about 12 kilometres north-east of the city 
centre in the Ayawaso district in the Greater Accra Region of Ghana. The Legon clinic provides 
care to a cohort of 500 PLWHA with an average of 10 to 30 PLWHA seen daily. 
Both clinics have a primary mission to prevent the spread of HIV/AIDS and to mitigate its 
effects on communities by establishing care and support centres, in addition to developing 
and implementing pragmatic intervention programs. They also serve a geographical area 
characterised by a mixture of low, middle and high socioeconomic income statuses. Table 4 
and Figure 9 has shown the details of services provided by the two clinics used in this study 
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3.6.2.1 Study information sheets, consent forms and topic guide for Phase 2 
All information sheets, consent forms and interview topic guides used in study Phase 2, were 
forward and backward translated into Twi (Twi is one of the local languages spoken in Ghana; 
the population for this study speak both English and/ or Twi fluently; hence the need for this 






translation), by two independent translators: two each for both forward and backward 
translations. The researcher is also fluent in both English and Twi. This translation was done 
to increase the validity of study documents, recognising the potential loss of data quality when 
translation is inaccurate [221]. Also, the researcher recognised the many procedures and 
recommendations for the translation of study documents and the challenges of failing to 
ensure good translation [222, 223].  
Moreover, although these translations were done, it was more difficult for most study 
participants to read the Twi language than the English language. As a result, most participants 
preferred the English version of the documents as they described them as ‘easy to read and 
understand’. Participants also explained that although they could speak Twi fluently, they 
could not read nor write Twi, hence their preference for the English version (English is the 
official language of Ghana, therefore almost everyone in Ghana speaks English).  
 
3.6.2.2 Translation of study documents for Phase 3 
For study Phase 3, Although some study documents and data collection instruments were 
translated, they were not used due to the observation and explanations given by study 
participants regarding their literacy skills in Twi during the implementation of study Phase 2. 
As indicated in section 3.6.2.1, the study participants preferred the English version of the 
study documents, despite being fluent in both English and Twi. 
 
3.6.2.3 Verification of interview transcripts against audio-recordings 
In conducting interviews in Phases 2 and 3 of this PhD, study participants had the options of 
having their interviews in Twi, English or a combination of languages. Therefore, interviews 
that were conducted in Twi only or a combination of both languages were transcribed verbatim 
from Twi to English by the researcher who speak both languages. This category of transcripts 
in addition to the recorded versions were sent to an official Twi to English translator who 
verified the transcripts against the audio recordings for consistency, coherence and to ensure 





3.6.3.1 Ethics approval 
The qualitative development study in the Phase 2 of this PhD was approved by the King’s 
College London (KCL) Research Ethics Committee Reference no. LRS-16/17-4507 
(APPENDIX A). Site specific approval was also received from the Ghana Health Service 
Ethics Review Committee (GHS-ERC) Reference no. GHS-ERC16/06/17 (APPENDIX B); and 
the Noguchi Memorial Institute for Medical Research - Institutional Review Board (NMIMR-
IRB) Reference no. NMIMR-IRB004/17-18 (APPENDIX C). Approval for the Phase 3 of this 
PhD - the mixed methods feasibility cRCT was granted by the King’s College London 
Research Ethics Committee (LRS-17/18-7216) (APPENDIX D), and the site specific approval 
was again granted by the Ghana Health Service Ethics Review Committee (GHS-ERC) GHS-
ERC008/06/18 (APPENDIX E) and the Noguchi Memorial Institute for Medical Research 
Institutional Review Board (NMIMR-IRB) NMIMR-IRB004/17-18 amend. 2018 (APPENDIX F). 
 
3.6.3.2 Ethical considerations 
Conducting research among participants with chronic conditions such as HIV/AIDS raises 
several ethical issues. PLWHA experience physical, psychological, social and spiritual 
symptoms and concerns [5, 102-104], consequently these group of participants are 
considered vulnerable and require special attention in relation to research [224]. Therefore, 
the following ethical issues were considered when designing and conducting this study.  
3.6.3.2.1 Informed consent 
PLWHA at every stage of life deserve the best possible care, as has been the goal of UNAIDS 
and WHO [27, 48]. Informed consent in this study involved four components: providing study 
information to potential participants, the potential participants’ understanding of this 
information to make an informed decision, the participants’ not being coerced to partake in the 
study, and the participants giving formal consent in the form of signing a consent form [225-
228]. The researcher obtained informed consent by giving full information about the study to 
potential participants ensuring that the participant understood this information and had 
cognitive ability to make a decision and voluntarily consented to take part in the study [225, 
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229, 230]. Therefore, in conducting this study, informed consent process included all the 
interactions that occurred during the research process which informed the participant about 
the study in addition to receiving information on the study and signing the consent form. This 
was done to respect participants’ autonomy and to protect their welfare [231].  
3.6.3.2.2 Privacy and confidentiality 
Privacy and confidentiality involves the avoidance of any issue of covert research, which 
violates participants’ privacy [193, 232]. The researcher assured study participants of 
protecting their privacy regarding any disclosure they made during the study. However, prior 
to the interview it was explained that any disclosure that is considered harmful and put 
participants or others’ safety at risk, would need to be discussed with the appropriate 
authorities. Participants were assured that disclosure of such information will be done to 
protect their safety and not to violate their right to privacy. 
3.6.3.2.3 The principle of beneficence 
The principle of beneficence stipulates that the researcher strategised to minimise harm but 
maximise benefits [233, 234]. There are two aspects to the principle of beneficence (a) a right 
to freedom from harm and discomfort for participants and (b) a right to protection from 
exploitation [235]. Before seeking ethical approval to conduct this study, the researcher had 
considered the potential risks and benefits of this study to participants. The risk of harm was 
low as this study did not involve any invasive procedures, hence there was no physical harm; 
however, there was a possibility that psychological harm, loss of privacy, emotional distress 
or embarrassment may have occurred as a result of being involved in the study. Possible 
benefits included accessing a potentially valuable intervention and increased understanding 
of HIV disease [235]. These potential risks and benefits were explicitly stated in the written 
informed consent documents used in this study. The researcher also implemented a distress 
protocol to minimize all forms of distress and harm in aligning with the principle of beneficence. 
Participants were also protected from any form of exploitation by keeping in confidence any 
information provided or disclosed by participants involved in the study, and not to use any 
shared information against the participants. 
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3.6.3.2.4 The principle of justice 
The principle of justice relates to treating study participants fairly and protecting their right to 
privacy. This study used an inclusion and exclusion criteria, which was approved by the ethics 
committees involved in this study to guide the selection of participants who have the 
experience to contribute to the purpose of the study, ensuring that no participant was excluded 
unduly. Fair treatment of participants also relates to fairly treating actual or potential 
participants who declined participating in the study without any partiality [236]. In this study, 
participants were made aware through the information and informed consent documents that 
they had the right to decline participation or withdraw from the study at any time without any 
explanation to the researcher and doing so did not affect the care they receive.  
Participant’s choice regarding HIV/AIDS status disclosure to family or friends were respected. 
This was crucial to protect their rights to privacy and confidentiality [237] due to the level of 
stigma associated with such disclosures. The researcher also managed all data in line with 
data protection legislation to protect participants’ rights to anonymity or confidentiality. 
Confidentiality also required the anonymisation of research participants’ identity [194],  
therefore the identity of PLWHA and HCP who took part in this study were anonymised and 
their data treated with strictest confidence, ensuring that no identity was disclosed throughout 
the research process. Study participants’ names were replaced with identification codes or 
pseudonyms [194], making it impossible to link their data to them. Participants’ consent 
documents which contain identifying data were kept locked in a separate cabinet from other 
data collected and these cabinets are only accessible to the members of the research team.  
3.6.3.2.5 The question of equipoise 
The question of equipoise was also taken into consideration, which refers to sincere 
uncertainty that intervention delivered in one arm of a trial is superior over that delivered in 
the other arm of the trial [238, 239]. It was not known whether the enhanced care intervention 
was going to have any potential effect in HIV population as it was not part of routine care and 




3.7 Data management and storage 
A digitally encrypted audio-recorder with password protection was used to record all interviews 
and data were uploaded to the password protected secured server hosted by KCL, and 
subsequently delated from the digital recorder. Recorded interviews were transcribed 
verbatim and pseudonymised during transcription.  Personal identifiable data from interview 
transcripts relating to names, clinics and geographic locations were removed during 
transcription and participants’ IDs were used in all the quotes from qualitative data in order to 
protect their anonymity. Transcripts were checked for accuracy before they were uploaded to 
NVivo version 11 (for intervention development interviews) and version 12 (for feasibility post-
trial interviews) for analysis. Using this qualitative data management software helped to 
manage the volume of data collected. 
Baseline and follow-up data were entered as soon as possible after collection into an SPSS 
version 25 database. Although ideally a double data entry is recommended [240], not all data 
were double entered, due to limited time and resources. However, all data from ten randomly 
selected participants were double-entered and cross-checked to identify any systematic errors 
in the data entry processes, for which none were found. Two of the outcome measures (APCA 
POS and MOS-HIV) had some items reversed and recoded after data entry. There is a total 
of 7 items on the APCA POS patient version, of this, 4 items were reversed and recoded. 
Likewise, the MOS-HIV has a total of 35 items of which 11 items were reversed and recoded. 
Data collected were stored in accordance with the Data Protection Act (DPA) 2012 [241] of 
Ghana and the General Data Protection Regulation 2018 of the United Kingdom [242] (the 
researcher completed the associated KCL online GDPR training in May 2018). In order to 
ensure anonymity of data, all participants were assigned unique ID numbers, which was used 
on all study related documents except for the consent forms. Consent forms and participants 
list of ID numbers and names were stored separately from the study data. All digitally recorded 
interview files were stored with password protection on a secured server at KCL and, backed 
up on the department server for security and on an encrypted and password protected USB 
stick, which is locked in the filling cupboard at the study site. All soft copy of data and audio 
recordings were encrypted, and password protected, and all hard copies were kept in locked 
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cabinets at the clinic. Participant packs for recording the quantitative data, were stored in a 
locked filing cabinet throughout the data collection period and were stored in the office of the 
clinic lead after data collection and entry was completed. 
Stored data will be accessed by the research team for up to 3 years in accordance with the 
DPA 2012 [241] and GDPR 2018 [242]. After this period, all data will be permanently deleted 
or destroyed, as Creswell [237] argued that it is important to keep data for a reasonable period, 
after which it can be destroyed. This research is the academic property of King’s College 
London and the researcher hence, findings will be used mainly for this PhD and other potential 




3.8 Phase 1: Thesis objective 1 
(MRC Development stage: “Identifying the evidence base”) 
 
To conduct a systematic review identifying evidence for person-centred models of community 
HIV management, and to assess their impact on outcomes for PLWHA.   
 
Review questions in relation to thesis objective 1: 
What are the structures, components, processes and outcomes of person-centred care 
delivered in community settings using the Donabedian framework of healthcare quality? 
 
Are patient outcomes improved by models of community HIV management which aim to be 
person-centred? 
 
What is the quality of the evidence? 
 
3.8.1 Design 
A systematic literature review was carried out in line with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) statement [243]. This review was 
conducted to identify the evidence for person-centred models of community HIV management 
and their impact on outcomes for PLWHA, and to use this evidence to guide a person-centred 
intervention development for PLWHA. This is also consistent with the MRC guidance for 
developing and evaluating complex interventions. The quality of studies included were 
measured using the Standard Quality Criteria for Evaluating Primary Research papers [244]. 
 
3.8.2 Definition of terms 
Person-centred care (PCC) - Mezzich defined PCC as care ‘dedicated to the promotion of 
health as a state of physical, mental, sociocultural, and spiritual well-being, as well as to the 
reduction of disease, and founded on mutual respect for the dignity and responsibility of each 
individual person’ [146]. This definition was chosen because, evidence suggest that PLWHA 
65 
 
often experience distressing physical, psychological, social and spiritual symptoms and 
concerns which impact on their quality of life [5, 102, 104]. Considering this definition of PCC, 
the focus of this systematic review was to identify which components of PCC are being 
delivered in community settings as published in the peer review literature. This review 
therefore considered models of care that are described as person-centred and address 
person-centred components including physical, psychological, social and spiritual wellbeing 
among PLWHA, alongside HIV disease management [143, 146, 155, 245].  
Community-based health services (CBHS) as defined by WHO, include outreach services, 
primary or community or mobile clinics, home visit and home-based care services either 
delivered or led by formally trained HCP [76]. The rationale for choosing only those services 
delivered or led by HCP is that, trained professionals are required to assess, plan and manage 
HIV care including giving appropriate medications, referrals, and delivering PCC as part of 
disease management.  
For the purposes of this review, adults are persons from age 15 years or older [246]. 
 
3.8.3 Search strategy 
Relevant studies were identified by searching electronic databases: CINAHL, Embase, 
PubMed, Medline, PsycINFO and Web of Science. We hand searched reference lists of 
included studies to identify additional studies. Studies spanning from 1980 (HIV was first 
diagnosed in the 80s) to February 2017 (updated in April 2019 and January 2020 respectively) 
were included.  
The search strategy combined the keywords ‘HIV’ OR ‘AIDS’ AND ‘person-centred care’ OR 
‘patient centred care’ OR ‘holistic care’ AND ‘community care’ OR ‘primary care’ OR ‘home-
based care’ AND ‘interventions’ OR ‘implementation’ OR ‘evaluation’ OR ‘effectiveness’. 
Multiple keyword sets were used to broaden the search and increased sensitivity to the 




Table 5: Preliminary literature search using the search strategy 
 
Database Search terms/ Subject Headings Number 
of hits* 
EMBASE (Ovid) 1. HIV or Human Immunodeficiency Virus 381939 
 2. AIDS or Acquired Immune Deficiency Syndrome 209389 
 3. HIV and AIDS 91394 
 4. HIV* 381750 
 5. AIDS* 185363 
 6. HIV* and AIDS* 91904 
 7. 1 or 2 or 3 or 4 or 5 or 6 491921 
 8. Person-centred care 64419 
 9. Patient-centred care 65362 
 10. Client-centred care 755446 
 11. Family-centred care 64144 
 12. Personalised care 755621 
 13. Individualised care 755703 
 14. Holistic care 4325 
 15. Holistic assessment 505 
 16. 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 759573 
 17. Community care 121703 
 18. Community-based are 120135 
 19. Community and home-based care  391 
 20. Home-based care 71604 
 21. Primary care 167866 
 22. Primary-based care 2 
 23. Primary healthcare 157684 
 24. Community healthcare 120024 
 25. 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 380639 
 26. Interventions 529463 
 27. Evaluation 1931730 
 28. Implementation 280930 
 29. Effectiveness 753881 
 30. 26 or 27 or 28 or 29 3177830 
 31. 7 and 16 and 25 and 30 560 
CINAHL  15 
MEDLINE (Ovid)  153 
PubMed  196 
PsycINFO (Ovid)  7 
Scopus  315 
Web of Science  474 




3.8.4 Inclusion and exclusion criteria 
Inclusion and exclusion criteria are presented in Table 6. Primary studies of any design that 
reported on community HIV management described as person-centred delivered or led by 
HCP were included. 
 





• Primary studies of any designs reporting 
models of person-centred care for PLWHA 
led by formally trained HCP and delivered 
in the community 
• Studies of adults aged 15 years and above 
[246]. 
• Studies published from 1980 to date. 
 
• All studies of any design reporting on 
HIV testing/ counselling/ adherence only 
would be excluded.   
• Studies reporting on CBHS for children 
and adolescents (from age 0-14 years) 
• Any CBHS neither delivered by nor/ led 
by professionals will be excluded.   
• Editorials, opinion pieces, conference 
abstracts, descriptive studies, case 
studies and reviews. 
• Studies presenting adjunct services 




3.8.5 Data collection and extraction 
The first reviewer (MA-O) imported all search results to Endnote version X9, removed all 
duplicates, then screened titles and abstracts of all identified studies. Studies retained after 
removing duplicates were screened against the inclusion/ exclusion criteria, any article for 
which inclusion was unclear were discussed with a second reviewer (KB) and if necessary 
adjudicated by a third reviewer (RH). Full texts of the articles were obtained if abstracts did 
not contain sufficient information to determine the relevance of an article. Information of search 
records including duplicates, exclusions and studies retained were reported using the PRISMA 
flow diagram. We extracted studies that used the term ‘person-centred’, including alternative 
spelling or synonyms (see search terms). Studies not meeting the inclusion criteria were 
excluded. Data on study location, aim design/ sample size, care structure, processes, person-
centred and clinical components delivered, outcomes/ measures used, and findings were 
extracted into a common table. Countries where studies were conducted were classified using 
the World Bank classification system [247].  
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3.8.6 Quality appraisal of studies included 
MA-O assessed the quality of studies included using the Standard Quality Criteria for 
Evaluating Primary Research papers [244]. This tool was used to assess the quality of both 
quantitative and qualitative studies separately. The checklist for assessing the quality of 
quantitative studies assessed 14 domains of methodological quality of all the quantitative 
studies included of which points were allocated based on the presence or absence of a 
domain. The presence of a domain is scored ‘YES’ (2) and when a domain is partially 
described it was scored as ‘PARTIAL’ (1) and the absence of a domain is scored ‘NO’ (0). The 
domains assessed have been summarised in Table 7.  
The methodological quality for qualitative studies were assessed based on 10 domains (see 
Table 8 for the domains assessed). After these domains were assessed the total sum scores 
were then calculated as the final quality score for each study, which ranges from 0 to 1. A total 
quality score of 0 is the lowest score, and 1 is highest score. Data quality for the included 
studies were reported in the data extraction table, and studies were not excluded from final 
analysis based on their quality scores. This quality assessment tool was chosen for its strength 
in assessing the quality of both quantitative and qualitative studies.  
 








1 Question / objective sufficiently described?     
2 Study design evident and appropriate?     
3 Method of subject/comparison group selection or source of 
information/input variables described and appropriate? 
    
4 Subject (and comparison group, if applicable) characteristics 
sufficiently described? 
    
5 If interventional and random allocation was possible, was it 
described? 
    
6 If interventional and blinding of investigators was possible, was 
it reported? 
    
7 If interventional and blinding of subjects was possible, was it 
reported? 
    
8 Outcome and (if applicable) exposure measure(s) well defined 
and robust to measurement / misclassification bias? Means of 
assessment reported? 
    
9 Sample size appropriate?     
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10 Analytic methods described/justified and appropriate?     
11 Some estimate of variance is reported for the main results?     
12 Controlled for confounding?     
13 Results reported in sufficient detail?     
14 Conclusions supported by the results?     
 







1 Question / objective sufficiently described?    
2 Study design evident and appropriate?    
3 Context for the study clear?    
4 Connection to a theoretical framework / wider body of knowledge?    
5 Sampling strategy described, relevant and justified?    
6 Data collection methods clearly described and systematic?    
7 Data analysis clearly described and systematic?    
8 Use of verification procedure(s) to establish credibility?    
9 Conclusions supported by the results?    




Summary of studies identified were reported using the PRISMA flow diagram. Data were 
extracted and analysed using the Donabedian framework of quality [175]. These variables 
were considered relevant to answering the review questions and were extracted to a common 
table, including aims/objectives design and sample size, care structure, processes, person-
centred and clinical components delivered, outcomes and measures used, including results 
and effectiveness.  Studies were also mapped based on the components of PCC delivered by 
each study in a table to identify the domains delivered for each model across studies. 
Descriptions of PCC models were analysed based on Mezzich’s definition of PCC. Both 
qualitative and quantitative studies were analysed descriptively, and then findings integrated. 
All studies addressing any component of PCC were retained in the final analysis. 
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Gaps in the literature with regards to person-centred models of community HIV management 
were used to inform a qualitative topic guide that was used to explore the views of PLWHA 
and HCP. The models delivered and their effectiveness in delivering the outcomes that 
mattered to PLWHA were also considered in addition to the outcome measures used by the 
identified studies in measuring study outcomes. This review also helped to provide information 
on the effectiveness of existing person-centred interventions, their variations in terms of 
context, the outcome measures used, their feasibility and acceptability including mechanisms 




3.9 Phase 2: Thesis objective 2 
(MRC Development stage: ‘Identifying/ developing appropriate theory’)     
 
To explore the views of PLWHA and healthcare professionals (HCP) on current HIV/AIDS 
care, its accessibility, and to determine which person-centred outcomes matter to PLWHA.  
 
Research question associated with thesis objective 2 is: 
What are the views of PLWHA and HCP on current HIV care, its accessibility, and what 
person-centred outcomes matter to PLWHA? 
 
3.9.1 Study design 
Findings from the systematic review including gaps in the literature with regards to person-
centred models of community HIV management and PCC components delivered were used 
to inform a qualitative topic guide that was used to explore the views of PLWHA and HCP.  
A qualitative study using semi-structured interviews, reported in accordance with the 
consolidated criteria for reporting qualitative research (COREQ) [249] to enhance 
trustworthiness and transparency of findings. 
 
3.9.1.1 Inclusion and exclusion criteria 
Inclusion for PLWHA  
v Adults from aged 20 years and above [250]; 
v A positive diagnosis of HIV/AIDS, known by the patient for at least 6 months 
to ensure that PLWHA has the experience of care to reflect on; 
v Have cognitive ability to consent to participate in the study as assessed by the 
treating clinician. 
v Well enough to participate 
 
Exclusion for PLWHA  
v Living with HIV/AIDS under aged 20 years;  
v Diagnosed less than 6 months or less; 
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v Do not have cognitive ability to consent;  
v Assessed by the treating clinician to be too ill to participate;  
v Attending the clinic for pre-testing or counselling services only. 
 
Inclusion for HCP 
v HCP including doctors, nurses, pharmacists, counsellors, social workers, 
care assistants, laboratory technician, and human resource manager); 
v HCP providing care for PLWHA for at least six months.  
 
Exclusion criteria for HCP  
v HCP who have worked with PLWHA for less than six months.  
 
3.9.1.2 Sample size 
Purposive sampling focuses on the key characteristics of individuals in order to select 
participants that will reflect diversity and breadth of the sample population [251, 252]. 
Qualitative methods enable a depth and breadth of exploration and seek to achieve saturation 
across the data set to answer the study objectives. It was anticipated that 25 PLWHA and 15 
HCP would be adequate to achieve saturation in the present study, although an iterative 
approach to data collection and analysis was adopted to inform this decision. Saturation 
occurs when the sample generates enough data to ensure the research questions can be 
answered [253, 254].  
 
3.9.1.3 Sampling 
A purposive sampling frame was employed to select PLWHA and HCP for a semi-structured 
interview. Purposive sampling, (also known as judgmental, selective, or subjective sampling), 
is a form of non-probability sampling in which researchers rely on their own judgment to 
choose members of the population to participate in their study [255]. This sampling method 
requires researchers to have prior knowledge about the purpose of their studies so that they 
can properly choose and approach eligible participants. Purposive sampling was chosen 
because the researcher wanted to ensure the recruitment of a wide range of patients in order 
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to understand their viewpoints on the topic of person-centred care. The risk of using 
snowball sampling is that the researcher would keep finding new patients who are similar to 
the ones already interviewed. Also, using convenience sampling means that the researcher 
would have no control over which patients are recruited resulting in the risk of recruiting a very 
homogenous sample. Purposive sampling, however, gave the researcher the flexibility to 
decide what needs to be investigated and sets out to find potential participants who can and 
are willing to provide the information by virtue of knowledge or experience. In addition to 
knowledge and experience, potential participants must also be available, and willing to 
express their experiences to the interviewer. Unlike random studies, which deliberately include 
a diverse cross section of ages, backgrounds and cultures, the idea behind purposive 
sampling is to concentrate on people with particular characteristics who will better be able to 
contribute to the purpose of the study [207, 251, 256].  The sampling characteristics that 
informed the purposeful recruitment of PLWHA include gender, sexual orientation, ART status, 
years of diagnosis, CD4 count, viral load, comorbidities, level of family/friend support, and 
employment status. These sampling characteristics were chosen because they are 
considered important characteristics that may affect an individual’s ability to access and 
meaningfully engage with services [256-258]. These characteristics also helped to achieve 
breadth in the data required to answer the study objectives. 
 
The sampling frame that informed the purposeful recruitment of PLWHA are presented in 
Table 9, including gender, sexual orientation, ART status, years of diagnosis, CD4 count, viral 
load, comorbidities, family/friend support, and employment status. This sampling frame is of 
interest to the researcher to sample from the population of PLWHA and was chosen because 
they are considered important characteristics that may affect an individual’s ability to access 
and meaningfully engage with services [257-259]. The sampling frame was also used in order 




Table 9: Sampling framework for recruiting PLWHA 
Criteria Variable / range 
Gender Male /female /transgender /other 
Sexual orientation Lesbian /MSM /bisexual /heterosexual 
ART status Active/ defaulter /not yet started 
Years of diagnosis 6months or more 
CD4 count (cells/mm3) <200 cells/mm3 / >500 cells/mm3 
Viral load (copies/mL) High or Undetectable 
Comorbidities Hypertension/ cardiovascular/ kidney/diabetes etc. 
Living situation Lives alone/with others 
In employment Yes/No 
 
 
3.9.1.4 Recruitment and consent 
Potential PLWHA participants who met the inclusion criteria were identified daily by the HCPs 
in both clinics, who then referred these participants to the researcher for further screening. 
Rapport was built with potential participants as the researcher took part in their daily health 
screening (weight, height, etc.). Doing this gave the researcher the opportunity to introduce 
the study to potential participants and invited them to take part in the study. Those who agreed 
were taken through the study information (APPENDIX G), giving an opportunity for further 
discussion about the study and answered any question or concerns that potential participants 
had. Where possible, a quiet environment was sought to do this. However, this was not always 
possible and at times these conversations were held in a busy clinic waiting room. There did 
not appear to be any difference in the questions that were asked or refusal to participate when 
this occurred. Any questions that participants had were answered before obtaining consent. 
Potential participants were informed that their choice to participate or not to participate in this 
study would not affect their care and treatment, and that if they decide to participate in the 
study, they were free to withdraw at any time they wished. Potential participants were given 
up to 24 hours to decide whether they wanted to participate in the study. Participants who 
decided to take part in the study were taken through the consent processes by the researcher. 
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Participants either signed or thumb printed the consent forms (APPENDIX H) to prove their 
willingness to participate in the study. The sampling frame was monitored closely as 
recruitment progressed; this was to ensure diversity of the sample according to the purposive 
sampling criteria.  
HCP were identified by the clinical team and the researcher contacted them through e-mail to 
introduce the study by sending them the information sheet (APPENDIX I). HCP participants 
were given the opportunity to discuss or seek clarification about the study, were given the 
required information, and once they were satisfied and willing to participate, they signed the 
consent form (APPENDIX J). Potential participants were informed that their choice to 
participate or not to participate in this study was voluntary, and that they were free to withdraw 
at any time they wished.  
 
3.9.1.5 Interview procedure 
The interview process began by assuring participants that all data would be anonymised and 
kept completely confidential and only accessible to the research team. Participants were made 
aware that the interview would be audio recorded and that if there were any questions that the 
participant did not wish to answer, then they could choose to omit or terminate the interview. 
Also, participants were made aware that if they required a break or wanted to stop the 
interview at any time, they were free to do so. Digital recording of interviews allowed the 
researcher to fully pay attention to PLWHA and HCP and their non-verbal cues without the 
need to take extensive notes during the interview and allows verbatim quotes for accuracy 
[260]. 
All participants were interviewed face to face on their own, allowing the researcher to establish 
rapport with participants, using the researchers’ interpersonal skills in obtaining personal 
information and promote participants’ privacy and confidentiality [261]. The researcher 
considered the type of questions asked and thoroughly discussed issues with confidentiality 
in order to maintain trust and respect for participants through professionalism [262]. Interviews 




3.9.1.6 Interview topic guide 
An interview topic guide was developed based on literature, theories, study objectives [263, 
264], and discussion with supervisors (RH and KB) who have experience of developing 
interview topic guides for PLWHA and in qualitative interviewing. Constructs from the theory 
of person-centred care and literatures on HIV care, were included in the wording of questions 
in the interview topic guide [265].  The topic guide was divided into three sections: section A 
– introduction about the interview and what the participant should expect; section B – focussed 
on participants demographics and areas of interest including age, gender, relationship status, 
religion, ethnicity, occupation, level of education, years of diagnosis, ART status, viral loads, 
CD4 counts and the presence of comorbidities; and section C – was organised based on four 
areas of interest being explored namely ‘place where you receive standard HIV/AIDS care’, 
‘HIV/AIDS care interaction with healthcare professionals’, ‘HIV/AIDS symptoms and concerns 
(Physical, Psychological, Social and Spiritual wellbeing)’ and ‘person-centred care/ 
involvement in care’. There were two separate topic guides: one for PLWHA (APPENDIX K) 
and the other for HCP (APPENDIX L). These guides were tested out with another researcher 
and modified based on feedback received. They were then piloted for flow and 
comprehensiveness with two participants prior to data collection. The interviews were semi-
structured so although the topic guide provided direction and highlighted areas that needed to 
be addressed, it also allowed the participant the freedom to expand on priority areas for them.  
 
The topic guide began with a general exploration of participants’ place of standard HIV care 
(SHC) including challenges of accessing care and interaction with HCPs. Probing and 
questions about living with HIV/AIDS and symptom burden (physical, psychological, social 
and spiritual wellbeing); and person-centeredness in HIV/AIDS care were left till the middle of 
the interview. This was to allow participants to relax and become accustomed to the interview 
surroundings and the interviewer. All issues were explored paying careful attention to verbal 
and non-verbal cues and pauses. Participants were warned that the interview was coming to 
an end to allow them to discuss any issues not covered by the interview but that they felt were 
important. Interviews were concluded with questions about what matters to participants when 
considering a new approach to HIV/AIDS care in the community. At the end of the interview, 
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the researcher summarised the interview to ensure that participants agreed with what has 
been discussed and offering an opportunity to clarify any information that was not clear, and 
further assured participants of confidentiality. Refinement of the interview process continued 
as each subsequent interview was completed through listening back and reading transcripts 
throughout recruitment. 
The researcher had not previously conducted qualitative interviews. Therefore, in preparation, 
the researcher did extensive reading and practice interviews with peers (JB and SP) who 
provided constructive feedback. The researcher also attended a qualitative interview skills 
workshop where lessons were learnt on picking up verbal and non-verbal cues and following 
them up appropriately with the use of silences and gentle probing. The researcher practiced, 
discussed and made plans of how to handle distressed participants with supervisors KB and 
RH. This enabled the researcher to gain confidence and skills in this new area of expertise. 
Initial interviews conducted by the researcher were transcribed and reviewed by supervisors 
KB and RH, who provided feedback on transcribing technique, interview skills and content. 
In conducting the interviews, it was necessary for the researcher to build rapport with 
participants, particularly PLWHA whom the researcher hoped to elicit sensitive information 
from. This involved the researcher gaining their trust and confidence which necessitated some 
emotional input from the researcher in the relationships [266] and the researcher’s  awareness 
of the emotional, practical and physical needs of PLWHA. However, the researcher also 
recognised the impact of feelings and responses reflected back to the interviewee [266]. There 
was the need to strike the right balance between empathy and minimizing influence or bias. 
To facilitate this, the researcher conducted the interviews away from the clinic reception and 
ensured that participants were comfortable throughout the interview process, including 
dressing appropriately to reflect respect for the interviewees and at the same time not to look 
imposing or unapproachable.  
 
3.9.2 Data analysis 
A qualitative approach of thematic analysis was chosen for the analysis of this dataset due to 
its ability to address variety of research questions and topics [267, 268]. NVivo version 11 was 
also used, which helped to manage and index data according to the coding frames. The 
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researcher attended an NVivo version 11 course at King’s College London which helped to 
further refine skills in using this qualitative data management package. 
Braun and Clarke describe thematic analysis as a method used for ‘identifying, analysing and 
reporting patterns (themes) within the data’ [269]. Thematic analysis is a method rather than 
a methodology because it is not restricted to a particular epistemological or theoretical 
perspective [267, 269]. Using thematic analysis for this study provided rich and detailed 
accounts of the interview data, and its flexibility meant that modifications could be made to fit 
the objective of  the study [269, 270]. Thematic analysis is useful for the examination of the 
perspectives of different research participants, which highlights similarities and differences in 
generating an insightful understanding of the data [269]. This approach of analysis also helps 
in summarising key characteristics of large data sets thereby compelling the researcher to 
adopt a well-structured approach to handling data in order to produce a clear and organised 
report [270]. 
 
This analysis used the six phases of thematic analysis recommended by Braun and Clarke 
[269]. These include: familiarisation with the data, generation of initial codes, searching for 
themes, reviewing themes, defining and naming themes and to producing a report [269, 271].  
i. Familiarisation with data: The process of familiarisation with data is the initial phase 
of thematic analysis. This phase is aimed at becoming intimately familiar with the 
content of the data set and to begin to notice patterns that could be relevant to the 
research question. This took several weeks of transcribing the interview data 
verbatim, reading and re-reading transcripts, in addition to making reflective 
comments on the content and nature of the interviews. The process of transcription 
was time consuming however it helped the researcher to be well familiarised with the 
data [272] and participants’ experience of care as PLWHA. This process has been 
described as ‘a key phase of data analysis in interpretative qualitative methodology’ 
[273]. Although the researcher conducted these interviews and had gained an overall 
impression of the data collected, the researcher felt it was important to set ideas into 
context and to ensure that recollections were impartial. As the researcher became 
familiar with the data, notes were made as memory aids and triggered for coding and 
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analysis and line by line coding was started manually to mark the beginning of the 
coding process [268].  
 
ii. Generating initial codes: The next step of the analysis was the generation of initial 
codes from the data set. The codes are a label of an important feature of the data 
which is of potential relevant to the research question, it is both a data reduction 
method and an analytic process [274]. These codes were referred to as ‘potential’ 
because this was the early stages of data analysis, and it was not known what might 
be relevant. Consequently, the researcher was as inclusive as possible in coding 
every interview, as it is easier to reduce the coding frame at a later date if required, 
rather than having to recode the data. The components of the theory of person-
centred care which is, care that promotes health as a state of physical, psychological, 
social and spiritual wellbeing [216]; and the WHO’s five strategic goals for integrated 
people-centred health services [26] were the constructs used to identify deductive 
codes. The initial coding frames generated were appraised by two independent 
researches (LC & SE) who coded the same transcript. The codes generated by LC 
and SE were the same as the initial coding frame though they differed in the way 
codes were named. The three researchers reviewed the proposed coding frame for 
internal consistency of each proposed code, which involved merging and splitting of 
codes and ensuring that each code is substantive and represented a discrete data 
theme [263, 269]. The researchers then reached agreement through discussion [271]. 
Every data item was coded, and all codes and relevant data extracts were collated 
using NVivo version 11. 
 
iii. Searching for themes:  Data analysis began to take shape as the researcher moved 
from codes to themes. Themes are coherent and meaningful phrases or sentences 
that demonstrates the meaning of the data and its relevance to the research objective 
[269]. Searching for themes involved analysing codes to identify similarities and how 
different codes could combine to form an overarching theme; this was an active 
process where the researcher constructed themes and collated all the coded data 
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relevant to each theme [269, 274]. The researcher then considered how relationships 
were formed between codes and themes and between different levels of existing 
themes. Visual models of this process  helped to sort out different codes into themes 
[269]. Some of the initial codes went on to form main themes, sub themes or were 
discarded. This stage of analysis was completed with the grouping of main themes, 
sub-themes and other miscellaneous themes that did not fit into the main themes. 
 
iv. Reviewing themes: This involved checking that themes function in relation to the 
coded extracts and the full data set [269]. The researcher then reflected on whether 
the themes told a compelling and a convincing story about the data and began to 
describe the nature of each theme and the relationship between themes. Connections 
between overlapping themes served as significant sources of information and alerted 
the researcher to the possibility of new patterns and issues in the data. Where 
necessary themes were split into two or more themes, collapsed two themes together 
or discard the main theme entirely and started the process of theme development 
again. 
v. Defining and naming themes: This phase represented the deep analytic work 
undertaken in thematic analysis, and it was key to the shaping and refining of the 
analysis. This involved selecting extracts to present and analyse and then setting out 
the story of each theme with or around these extracts. Here the researcher identified 
the ‘essence’ of what each theme meant [269], particularly how the sub-themes 
interact and relate to the main theme. A comprehensive analysis of each theme was 
undertaken by asking the question ‘what story does this theme tell?’; and the 
importance of each theme were identified by constructing  a succinct name and 
summary for each theme [274]. 
 
vi. Writing up/ producing a report: Even though the final phase of this analysis was to 
produce a report in the form of a journal article or thesis, it was not a phase that only 
commenced at the end of the analysis. Unlike in quantitative studies, writing and 
analysing data are systematically interlaced in qualitative studies, which begins with 
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informal notes and memos to a more formal process of analysing and writing a report. 
This report is expected to tell a compelling story that is grounded in the data and based 
on the analysis, with themes connecting logically and meaningfully and building on 
earlier themes in telling a coherent story about the data. Additionally, this report should 
meaningfully contribute to answering the research question.  
 
3.9.3 Presenting the results 
The same coding frame was applied to HCP and PLWHA datasets, to enable the exploration 
of themes across participant groups. Quotes from the transcripts were used to demonstrate 
data interpretation. This also helped to increase transparency of the analysis process and 
prevented unsupported claims, and to ensure the themes are represented across the dataset 
and participants [269, 275]. Data extracts were selected carefully to elaborate aspects of the 
findings and to deepen understanding to enhance readability [275]. Extracts were chosen from 
both PLWHA and HCP interviews to ensure that everyone’s view was represented. Each 
extract was reported with the corresponding participants’ gender, age and group (PLWHA or 
HCP). Participants quotes were selected across the sample and ID codes were used to 
illustrate themes as well as demonstrate that these quotes did not come from just one or few 
participants.  
 
3.9.4 Trustworthiness in qualitative research 
The usefulness and integrity of the findings of a qualitative research is dependent on the 
transparency of its conduct and trustworthiness or truth value of the study [276] 
The degree of confidence in data, its interpretation, and the methods used to ensure the quality 
of a study is termed trustworthiness [277]. Therefore, it has been argued that for studies to be 
considered worthy by readers it is crucial for researchers to establish the protocols and 
procedures required in conducting them [278]. However, there are debates about what 
constitutes trustworthiness [279]. Therefore, Lincoln and Guba outlined some criteria such as 
credibility, dependability, confirmability, and transferability [280, 281] for qualitative 
researchers in pursuit of trustworthiness. The rationale for choosing to address Guba’s criteria 
for this study is because it is consistent with the criteria used by the quantitative researchers: 
82 
 
Ø credibility (relates to internal validity); 
Ø dependability (relates to reliability); 
Ø confirmability (relates to objectivity). 
Ø transferability (relates to external validity/generalisability [281]) . 
Although Lincoln argued that the area of qualitative research was “still emerging and being 
defined” [282], many qualitative researchers have accepted Guba’s criteria. These criteria as 
applied to this thesis has been discussed in turn. 
 
3.9.4.1 Credibility 
The confidence that can be placed in the truth of the research findings is termed credibility 
[283, 284]. Credibility is established when research findings are considered believable as 
drawn from participants’ original data and represents participants’ original views [280, 285]. 
Strategies to ensure credibility as described by Lincoln and Guba may include: prolonged 
engagement in the field, persistent observation, triangulation, peer debriefing, referential 
adequacy and negative or deviant case analysis [280]. For this thesis prolonged engagement 
in the research site and peer debriefing were used to enhance credibility.  
Prolonged Engagement in Research Site: The researcher engaged with PLWHA and HCP for 
3 months whiles collecting data which allowed for some form of immersion in the environment 
of PLWHA and HCP working in HIV service [286]. This helped the researcher to understand 
the study context and minimised the risk of misrepresentations. The extended time spent by 
the researcher with study participants in the research site resulted in trusting relationships with 
participants and provided greater understanding of participants’ culture, preferences and 
context [287]. The prolonged time spent with the participants was very beneficial in the sense 
that as relationship and trust increased, participants felt comfortable to share sensitive 
information than they did at the start of the study [287]. Thus, this prolonged engagement with 
participants helped the researcher to understand the fundamental issues that could affect the 
quality of the data and to develop trust with study participants.  
Peer debriefing: The researcher continuously availed herself for the thesis progression 
committee to be questioned about judgements made about study data including being 
exposed to probing questions from other PhD colleagues who have listened to the researcher 
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present study data, analysis and results [280]. The researcher also sought support from 
colleagues and members of the academic staff, who were impartial to the study to help with 
coding some interview transcripts during data analysis for consistency and to enhance 
credibility of the process. My supervisors constantly provided scholarly guidance in addition 
to other members of staff during researchers exchange at the department. Feedbacks 
received from peers and other members of staff helped to improve the quality of study findings. 
Consequently when the final report of the study was drafted in the form of a manuscript, 
perception of peers and co-authors were sought, particularly on the study background, data 
collection process and methods, data management, transcripts, data analysis procedure and 
study findings [280, 288]. 
 
3.9.4.2 Dependability 
Dependability is how study findings can be trusted over time [289], and it involves the 
evaluation of study findings, its interpretation and recommendations made to ensure that they 
are supported by participants’ view expressed in the data [290]. Criteria for establishing 
dependability include audit trail, a code-recode strategy, stepwise replication, triangulation, 
and peer examination or iterator comparisons [291-293]. In this study an audit trail strategy 
was used to enhance dependability. 
An Audit Trail: Audit trails involve a transparent description of how data was collected and 
analysed [294, 295]. For this thesis, the study protocol, including the various methodological 
decisions taken in conducting the study, models developed, and conclusions drawn based on 
data serve as an audit trail in the project journal [280, 296-298]. This audit trail demonstrates 
how the systematic review conducted to identify the evidence base informed the qualitative 
interview topic guide that was used to conduct the qualitative interviews. The audit trail also 
shows how the interview data was used to develop a conceptual model of person-centred care 
from the perspectives of PLWHA and HCP which increases transparency, allowing an auditor 
to trace the process of decision making and determine whether the decisions were reasonable 
and consistent and therefore the findings trustworthy [299, 300]. Confirmability is indicated 
when the decisions taken in relation to the evidence presented is coherent. Having two 
independent researchers code some of the interview transcripts concurrently, and checking 
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inter-rater reliability, increased the dependability of findings. This clarified any confusion or 
misunderstanding, which is an added value to the study as each coder brought their own 
interpretive framework [299-301]. This also meant that interpretation was determined by the 
coders experience, theoretical background and discipline among other factors, which 
highlighted the subjectivity acknowledged to be an integral part of qualitative research [299, 
300].  
For this study, the raw data, interview transcripts, observation notes and records collected 
during the conduct of this study collectively serve as an audit trail for crosschecking the inquiry 
process [302]; which also establishes confirmability of the study [302, 303].  
Peer Examination: The researcher discussed the study process, methods and findings with 
PhD colleagues at PhD support group meetings of whom some have also conducted 
qualitative studies or have experience in qualitative studies. During the peer examination the 
researcher was honest about the conduct of the study and peers contribution led to a deeper 
reflexive analysis by the researcher [304, 305].  
 
3.9.4.3 Confirmability 
The degree to which the findings of this study could be confirmed by other researchers is 
termed confirmability [306]. Confirmability is to be able to prove that study data and 
interpretation of the findings reflect participants’ view as expressed in the data and not 
fabricated by the researcher [303]. Confirmability of qualitative studies can be established 
using an audit trial, reflexive journal and triangulation [280, 294, 307]. The researcher used 
audit trail and reflexive journal to enhance the confirmability of study findings.  
The audit trail described under ‘dependability’ is a visible evidence from the methods used to 
conduct the study to the findings, that the researcher had gone through due process to achieve 
the results of the study [294]. 
Reflexive Journal: The researcher kept a reflexive journal during data collection and analysis 
process. Among the entries recorded in this journal include the researchers’ perception of the 
participants and how participants behaved during the interviews in addition to how they spoke. 
These records helped the researcher to recall the meanings of what participants said at the 
interviews during the data analysis process and identified any distractions or comments the 
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researcher felt were important to the findings. The reflexive journal is subjective data source 
where the researcher recorded all personal impressions that could possibly impact on the 
analysis procedures. By recording this subjective information, it was possible for the 
researcher to take note of what should be guarded against regarding subjectivity during data 
analysis. For instance, there was the possibility that the researcher had negative subjective 
responses to participants who expressed that person-centred care or involving PLWHA in their 
care decisions was not important because HCP will make the decision for them. Records 
made about these negative responses in the reflexive journal provided a “place” in the study 
for the researcher’s perceptions.  
 
3.9.4.4 Transferability 
Transferability refers to the extent to which the study findings are applicable to other contexts, 
settings or population [303, 305]. Transferability of this study was enhanced through some 
level of transparency demonstrated by ‘thick description’ and ‘purposeful sampling’ [280, 305]. 
In this thesis a detailed descriptive account of the study and the purposeful selection of 
participants was used to enhance transferability. 
Thick description: A detailed description of study processes, context, methodology through to 
the writing of final study report determines judgments about how well the research context fits 
other contexts [295]; including the use of longer quotes that provide the context for the quote. 
This descriptive account for this study can be found in section 3.9.1 within this section of 
methods and section 5.2.4 in the results section. This thick description could help other 
researchers to be able to replicate this study with similar conditions in other contexts, as it has 
been argued that without this thick description it will be difficult to accept the truth value of the 
final report [308].  
Purposive Sampling: Purposive sampling was used to identify and select participants who 
have the information to contribute the specific purposes of the research [309]. This helped the 
researcher to focus on group of participants, who were particularly knowledgeable of the 
phenomenon under investigation [310], because purposive sampling allows decisions to be 
made about the selection of participants [292, 311]. Purposive sampling allowed the 
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researcher to decide the a reason to use a specific category of PLWHA in the study [311], and 




3.10 Phase 2: Thesis objective 3 
To map the qualitative data from objective 2 onto the components of person-centred care 
theory to determine which components map and what extra components are required. 
 
The research question associated with thesis objective 3 is: 
What are the components of person-centred care as applied to PLWHA in Ghana and how do 
these components align with the theory of person-centred care?   
 
3.10.1 Adaptation of Person-centred theory 
The person-centred care theory was adapted alongside the identification of the evidence base 
in Phase 1 of this PhD. The MRC guidance emphasise the need to systematically develop 
interventions ‘using the best available evidence and appropriate theory’ [178, 313]. Evidence 
suggests that interventions that use theory are more likely to be effective [314]. Therefore, the 
theory of person-centred care (PCC) was identified and chosen to underpin this PhD. Since 
PCC is context specific and has been defined differently in different settings, the definition of 
PCC chosen for this PhD is one that is ‘dedicated to the promotion of health as a state of 
physical, mental, sociocultural, and spiritual well-being, as well as to the reduction of disease, 
and founded on mutual respect for the dignity and responsibility of each individual person’ 
[146]. This definition of PCC was chosen to reflect the domains of need experienced by 
PLWHA and the focus on holistic care delivery. PLWHA frequently experience highly 
distressing physical, psychological, social and spiritual symptoms and concerns [5, 102-104], 
which negatively impact on their quality of life [105]. Greater attention has been paid to viral 
suppression at the expense of broader psychological, social and spiritual concerns that persist 
despite treatment advances [5, 106]. To address these issues, holistic assessment and PCC 
is required. The holistic and PCC approach to care delivery addresses physical, psychological, 
social and spiritual symptoms and concerns thereby restoring balance and enabling patients 
to cope with their conditions and subsequently improve their lives [315]. Figure 10 is a 





Figure 10: The components of person-centred  theory as defined by Mezzich [146] 
 
3.10.2 Mapping person-centred care components onto person-centred theory 
The qualitative interviews conducted with PLWHA and HCP in thesis objective 2, identified 
person-centred care (PCC) components/ needs as applied to PLWHA in Ghana. These needs 
were mapped onto the components of the PCC theory (in an expert intervention development 
workshop discussed in section 3.11.1), to determine which components mapped onto the 
theory with the flexibility of adding additional components if required. Mapping the theory onto 
the components/ needs as applied to PLWHA was crucial as the outcome of the mapping 
helped to identify what was important, applicable and feasible in informing the intended 
objectives, content and delivery of the intervention [316]. The theory selected provides 
explanation for how a range of modifiable factors can be targeted by a person-centred 
intervention component to achieve outcomes that are meaningful to PLWHA. These factors 
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are influenced by each participants’ unique context: their sociocultural beliefs around 
HIV/AIDS, physical, psychological and spiritual symptoms and concerns, the presence of 
comorbidities, stigma and discrimination as discussed during the intervention development 
process in section 3.11.1.  
 
3.10.3 Integration of data from thesis objectives 1-3 
Data from the findings of thesis objectives 1, 2 and 3 were integrated including PCC models 
delivered in community settings for PLWHA alongside the identification of the theory of PCC, 
and qualitative interview study of HCP and PLWHA in Ghana. Several important 
considerations for intervention development emerged from both the systematic review and the 
qualitative data. The experiences of PLWHA and HCP shared in the qualitative data provided 
important understanding of the context where care delivery for PLWHA occurred, which was 
used to tailor a PCC intervention. For instance, issues around the care structure, processes 
of care delivery and expected outcomes, which were consistent with the findings from the 
systematic review. Outcome measures used in some of the identified studies in the systematic 
review were also considered in terms of their appropriateness in measuring person-centred 
outcomes for PLWHA when considering the development of a person-centred intervention for 
PLWHA. Components of the intervention were also considered in the light of the systematic 
review, the PCC theory and the qualitative data. These data sources were integrated to form 
the intervention components, which reflected the outcomes that mattered to PLWHA and the 
process and outcome measures used in measuring the intended outcomes of the proposed 





3.11 Phase 2: Thesis Objective 4 
      “Modelling process and outcomes” 
 
To integrate findings from objectives 1-3, modelling the potential processes and outcomes, 
and the potential mechanism of action of the intervention. 
 
The research question linked to thesis objective 4 is: 
How does the integration of findings from objectives 1 to 3 inform the intervention 
development, its potential modelling processes and outcomes, and the potential mechanism 
of action of the intervention?  
 
3.11.1 Intervention development process 
This section details the steps taken to integrate findings from thesis objectives 1 to 3 with 
intervention development experts at a workshop in order to develop the enhanced care 
intervention. This also included modelling the potential processes and outcomes (including 
selection of outcome measures) and the potential mechanism of action of the intervention to 
improve person-centred outcomes for PLWHA. It has been argued that the best way to 
develop interventions is through partnerships with researchers, the affected population, 
policymakers and interdisciplinary teams of practitioners [317]. Therefore, the researcher 
made use of research evidence, an expert intervention development panel (including 
researchers, epidemiologist and educationalist) and the person-centred needs of PLWHA and 
HCP as identified in a qualitative interview study to develop this intervention. This is because 
the ability of the intervention to address the perceived needs of PLWHA leading to its 
acceptability; practicality; evaluability, including the theorising of causal pathways; and uptake 
by practitioners and the possibility of intervention effectiveness is dependent on such 
coproduction.  
Wright et al.’s [317] six steps in quality intervention development  was used to guide the 
development of this intervention. These six steps include: (i) defining and understanding the 
problem and the cause, (ii) clarifying which contextual factors are pliable and have the greatest 
scope for change, (iii) Identification of how to bring about change (the change mechanism), 
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(iv) identifying how to deliver the change mechanisms (v) Testing and refining on a small scale, 
and (vi) collecting sufficient evidence to justify rigorous evaluation/implementation. This 
section (thesis objective 4) described the first four steps and the last two steps are described 
in the next section (thesis objective 5).  
 
Step (i): Defining and understanding the problem and the cause - The first step in 
intervention development is to clarify the problem using existing evidence [317, 318]. This also 
involves collating research evidence from stakeholders on a specific health problem in a 
specific context to understand the cause of the problem that needs to be addressed. The aim 
of understanding the contextual health problem is to develop an intervention that helps to 
reduce the impact of the problem [319]. Thesis objectives 1, 2 and 3 all explored PCC models 
delivered in community settings for PLWHA, and particularly in the context of Ghana. During 
this stage of defining and understanding the health problem and the cause, the intervention 
development experts, were not involved. In Phase 1, the researcher conducted a systematic 
review to identify domains of PCC delivered in community settings for PLWHA, the care 
structure, processes of care delivery and outcomes achieved. This review also helped to 
provide information on the effectiveness of existing interventions, their variations in terms of 
context, outcome measures used, their feasibility and acceptability including mechanisms of 
action [248], which could be adopted to inform this intervention. Few published studies were 
identified delivering PCC models in community settings for PLWHA, which addressed the 
domains of physical, psychological, social and spiritual wellbeing [320, 321]. Evidence suggest 
that PLWHA perceive that their care does not often address broader psychological, social and 
spiritual concerns, which persists despite treatment advances [5, 106]. Consequently, the 
researcher identified a PCC theory that focused on the domains of PCC described in the 
literature and adopted this theory for the intervention development.  
The researcher identified the existing research evidence and adopted a person-centred theory 
which underpinned the intended intervention [322] as described in the thesis background. The 
definition of PCC theory chosen for this PhD focus on holistic care that promotes physical, 
psychological, social and spiritual wellbeing alongside reduction of disease, as experienced 
by PLWHA. Selman et al. noted the importance of holistic assessment to achieve PCC for 
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PLWHA, noting that spiritual wellbeing receives less attention [155]. This theory is expected 
to translate to practical application, for instance the components of the person-centred theory 
should translate into practical intervention elements that fits the context and the target 
population (PLWHA) attributes [319]. This theory helped to clarify PCC models in order to 
understand the problem with the care delivered to PLWHA.  
The researcher also understood these problems from the perspectives of PLWHA and HCPs 
in the context of Ghana in order that this intervention could address the specific contextual 
problems faced by PLWHA. This was done through qualitative exploration of the views of 
PLWHA and HCP on standard HIV care delivery and what person-centred outcomes matter 
to PLWHA [323, 324], using interview topic guides informed by the systematic review in Phase 
2, thesis objective 2. Themes emerged describing the problems with the current approach to 
HIV care delivery, what constituted PCC from the perspectives of PLWHA and HCP; the way 
PLWHA expected their care to be delivered; what mattered to them most about PCC care 
delivery; challenges faced by HCP during care delivery; and what HCPs needed in order to 
deliver PCC for PLWHA. These themes aligned with the PCC models (physical, psychological, 
social and spiritual wellbeing) described in the PCC theory and as identified in the systematic 
review in thesis objective 1.  
Following the studies identified in the systematic review that delivered the PCC models, they 
reported improving physical, psychological, social and spiritual wellbeing outcomes for 
PLWHA [39, 164] although, only one of these studies used validated outcome measures to 
assess study outcomes [320]. This review also revealed a lack of existing interventions in low 
or middle-income settings that used models of PCC as an intervention delivery mechanism 
for PLWHA. PCC models are particularly poorly described in African context [39, 164]. 
Therefore, merging the systematic reviews with the views expressed by PLWHA and HCP, 
there was a need to develop a context specific PCC intervention, which could add to the few 
existing studies currently delivering the models of PCC for PLWHA. This intervention could 
address the HCP challenges which could improve their approach to care delivery and thereby 
improving outcomes for PLWHA. Therefore, in the next step in this intervention development, 
the researcher together with the expert intervention development panel decided to focus the 
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content of the intervention on the physical, psychological, social and spiritual wellbeing of 
PLWHA. 
 
Step (ii): Clarifying contextual factors and the scope for change - An expert panel was 
involved from this stage of the intervention development consisting of researchers, 
epidemiologist and educationalist with a range of experiences. Panel members expertise 
included outcome measurement and tool validation, HIV/AIDS care in sub-Saharan Africa and 
intervention development and testing (RH); educationalist with a PhD that evaluated palliative 
care training in rural Uganda (JD); priority outcomes for people with HIV/AIDS and 
communication between health professionals and patients in clinical encounters, and how that 
interaction shapes the experience for patients and their families (KB); pain and symptom self-
management among HIV/AIDS, designing, testing and evaluating nursing interventions (KN); 
and use of patient reported outcomes measures in clinical settings, knowledge translation, 
information use and policy development (EN). These experts were assembled based on their 
wealth of experience in working with PLWHA and developing interventions in this population 
across Africa. The expert panel met face to face (with EN joining via skype) in a half-day 
workshop to discuss the evidence identified from the systematic review in thesis objective 1, 
the qualitative data obtained from the views expressed by PLWHA and HCP, the components 
of the PCC theory adopted to underpin the intervention development. The agenda for this 
workshop was for the researcher to present the evidence identified (both from systematic 
review and qualitative interview study) to determine the need for the intervention, examine 
current practice and to develop the intervention to address specific contextual needs. 
 
Expert panel discussion during the intervention development workshop 
a. Determination of needs for the intervention - The researcher presented on the evidence 
identified from the systematic review with the PCC theory components and qualitative 
data from stakeholders (PLWHA and HCP). The panel thoroughly discussed the 
evidence laid before them in order to understand the needs of PLWHA, their preferences, 
perspectives on PCC and the capabilities of both PLWHA and HCP, which was 
fundamental for the intervention development. As the goal for the workshop was to 
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develop an intervention that had the ability to address the problems identified from 
stakeholders’ perspective, and that was feasible to deliver, cost-effective, and replicable. 
Therefore, the panel examined the studies that delivered PCC models identified in the 
systematic review including the care structure, processes and the outcomes derived from 
delivering the PCC models. The panel then discussed and used the qualitative data 
(which included stakeholder perspectives, preferences and needs for PCC) and mapped 
it onto the components of the PCC theory. This mapping was done to determine how 
much of the qualitative data mapped on the theory and if there was a need to add any 
additional component. The outcome of the mapping provided information on the potential 
components of the intervention at this stage. 
 
b. Examining current practice – In order to optimise the successful delivery of the proposed 
intervention within the context of Ghana, the panel also discussed current practice as 
observed by the researcher and as reported by stakeholders during the qualitative data 
collection. This was aimed at thoroughly exploring the context where the intervention was 
meant to be delivered in an attempt to identify facilitators and barriers concerning the 
intervention among PLWHA and HCP so as to augment the practicability of the 
intervention to closely fit the current practice [199]. Having considered all the evidence 
(systematic review findings, PCC theory and qualitative data) and the discussions that 
ensued among panel members, the panel fully named the components of the proposed 
intervention with only one potential overlap in terms of current practice. The qualitative 
interviews data helped to maximise the cultural and local suitability of the intervention as 
recommended by the MRC guidance [176].  
 
Step (iii): Identification of how to bring about change (the change mechanism) - HCP 
interviews were important in understanding their views on challenges and training needs 
required to implement the intervention in preparation towards testing and refining the 
intervention on a small scale. The panel discussion continued on the qualitative data regarding 
the prerequisite skills required by HCP and how they needed to be trained to deliver the 
intervention [325]. Based on the qualitative data from HCP and outcomes that matter to 
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PLWHA, the panel agreed that the content of HCP training is focused on the intervention 
components and to reflect the domains of need described by PLWHA. Taking into 
consideration the current context and practice, a schedule and duration for HCP training was 
discussed and agreed and potential outcome measures to measure the domains of PCC 
identified, among others. During the intervention development, the researcher and the expert 
panel gained insight into how the intervention was operational in practice in addition to 
understanding the dynamics of the implementation context [326]. The panel also discussed 
the need to draw on existing manuals, documents and procedures that could be adopted in 
order to develop a comprehensive but simple PCC training manual for HCPs. The panel 
agreed that palliative care skills might be appropriate to draw on for the training manual 
development. Palliative care is known to deliver holistic and person-centred care for people 
facing serious illness like HIV/AIDS, with the goal of improving their quality of life through early 
identification, assessment and treatment of physical, psychosocial, emotional, and spiritual 
concerns [43]. The WHO state that ‘palliative care is an essential component of a 
comprehensive package of care for people living with HIV/AIDS because of the variety of 
symptoms they can experience’ [170]. It has also been argued that the effectiveness of 
palliative care is limited when it failed to provide holistic care contributing to physical, social, 
spiritual, and emotional suffering [171]. Therefore, it made sense to adopt palliative care skills 
in the development of the intervention training content. 
The expert panel went on to discuss measurable outcomes for the intervention, which at this 
stage of the intervention development became very clear to the panel members that outcomes 
was based on the domain of needs described by PLWHA in the qualitative data, which 
informed appropriate process and outcome measures for evaluating the intervention. An 
agreement was reached regarding the outcomes and the corresponding measures to be used. 
Potential process and outcome measures were suggested for which the researcher selected 
two process and three outcome measures based on their psychometric properties, suitability 
for use in HIV population and their ability to measure intended outcomes [178].  The expert 
panel was dissolved at the end of this stage of the workshop; however, it was agreed that the 
panel was still accessible via e-mail to provide feedback on the logic model and the content 
of the intervention training until the intervention was manualised for feasibility testing. 
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Step (iv): Identifying how to deliver the change mechanism - The researcher modelled 
the components of the intervention and how the care process could deliver these components 
in order to achieve desired outcomes for PLWHA. A logic model was developed, which 
demonstrated the casual modelling of the intervention with all its components and linking it 
with the ToC (person-centred care), the local context, the proposed mechanism of action and 
with the selected outcome measures measuring the domains of physical, psychological, social 
and spiritual wellbeing. The set of PCC needs identified from the qualitative data and the 
mechanism to achieve these outcomes for PLWHA were mapped onto the process and 
outcome measures selected. Modelling provided a guide to link the process and outcome 
measures selected to the intervention components for testing [186]. The logic model which is 
underpinned by the ToC was used to integrate and illustrate the intricate paths within the 
intervention [327], which helped to clarify the causal assumptions. The approach used in 
developing the logic model involved identification of a logical flow starting from planned input 
activities and ended with specific outcomes [327]. The specific logic model was tailored to the 
characteristics of PLWHA population, their social context, wellbeing and disease outcomes. 
The ToC, evidence obtained from literature and qualitative data from stakeholders were used 
to guide the selection of intervention components, training needs of HCP, their expected 
approach to care delivery and what outcomes to measure [186]. This theoretical modelling 
helped to understand and simulated the intervention [328] by describing: the active ingredients 
and how these ingredients worked to effect change; the outcome measures used to assess 
the effect of the intervention; how the active ingredients related to each other; every key 
mediators and moderators, and the PCC theory (ToC) which underpinned the effects and 
related to the intervention implementation [328]. 
 
Process and outcome measures selected for the intervention 
a. APCA Palliative Outcome Scale (APCA POS): APCA POS is a multidimensional person-
centred assessment tool, which was adapted from earlier versions of the Palliative Care 
Outcomes Scale (POS), validated for use in Africa [329-332] and has been used in HIV 
population. It is a seven-item (patient only) measure covering physical, psychological, 
social and spiritual dimensions of care. APCA POS also has three items which focus on 
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the carer of the patient however, this study was not designed to include carers therefore 
the carer items were not assessed. Participants could respond verbally, or by use of their 
hand to indicate the severity of each symptom and concern, with each finger counting as 
a point on the Likert scale, and a closed fist as 0. Scoring is on a Likert scale of 0-5, from 
no symptom or concern to overwhelming symptom or concern for each item. Four items 
on the APCA POS use 0 to indicate the worst symptom or concern, where there are 
symptom or concern; and three items are also scored in the reverse, where 0 represents 
best state of health or no symptom or concern. This is to ensure that participants paid 
attention to all items or questions. The validation involved 682 patients and 437 family 
carers, interviewed in 8 different languages. Phase 1 - Qualitative interviews (n=90 
patients; n=38 carers) showed POS items mapped well onto identified needs; cognitive 
interviews (n=73 patients; n=29 carers) demonstrated good interpretation; Phase 2 – POS-
Missoula-VITAS Quality of Life Index (MVQoLI) Spearman's rank correlations were low-
moderate as expected (n=285); Phase 3 - (n=307, 2nd assessment mean 21.2 hours after 
first, SD 7.2) Cronbach's Alpha was 0.6 on both datasets, indicating expected moderate 
internal consistency; test-retest found high intra-class correlation coefficients for all items 
(0.78-0.89); median time to complete 7 minutes, reducing to 5 minutes at second visit [330]. 
The las four items on this measure was recoded to align with the remaining items so that 
they score in the same direction. 
b. Medical Outcomes Study – HIV (MOS-HIV): Initially developed from Medical Outcomes 
Survey (MOS) in 1997 [333], the MOS-HIV has been adapted from the MOS as a quality 
of life measure specific for HIV positive populations [334]. It is a 35-item self-report quality 
of life measure, which assesses participants’ reported function and well-being in eleven 
subscales (general health perception, pain, physical functioning, role function, social 
functioning, energy/fatigue, mental health, health distress, cognitive functioning, quality of 
life and health transition).  It has been validated in the United States [335, 336], several 
European countries [337], Zimbabwe [338], Uganda [339] and Rwanda [340]. A total of 532 
PLWHA (305 PLWHA and 227 with HIV+ liver disease (LD)) were included in the validation 
study. Although both groups had relatively poor self-reported MOS-HIV physical function, 
the HIV+LD group had significantly lower scores (p=.018) (M=60.6, SD±31.4) than those 
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with HIV only (M=68.1, SD±29.1). Additionally, persons with HIV+LD had significantly 
lower self-reported quality of life (p=.009), as measured by the MOS-HIV quality of life 
subscale score (M=58.6, SD±24.4) compared to the HIV group (M=62.9, SD±24.0). 
Spearman’s rho correlations demonstrated a moderate correlation between income and all 
MOS-HIV subscale scores for both groups (r=.300). The Cronbach’s alpha as a measure 
of internal consistency for the MOS-HIV was α=.970 for the HIV group and α=.965 in the 
HIV+LD group. A multi-group confirmatory factor analysis was performed on the 10 items 
of MOS-HIV using maximum likelihood estimation with robust adjustments to test for factor 
invariance between HIV+LD and HIV groups. The combined model showed a good fit [341]. 
The raw scores for each sub-scale are linearly transformed to a scale of 0-100 according 
to the guidance from MOS-HIV developers [333]. This measure was mainly chosen 
because it is disease specific and validated in populations from countries in sub-Saharan 
Africa. Eleven items on this measure were recoded to align with the rest of the items on 
the scale. 
c. Picker Patient Experience Questionnaire (PPE-15): The PPE-15 [342] is a 15-item self-
reported measure which measures patient experience along the domains of 
communication; emotions; short-term outcomes; barriers; and relations with staff. The 
PPE-15 can be used to gain feedback on the practitioner-patient relationship across these 
domains. The PPE-15 is a brief instrument which can be used to examine specific aspects 
of patient experience. To validate PPE-15, a total of 62,925 questionnaires were returned, 
with response rates of 65% (UK), 74% (Germany), 63% (Sweden), 52% (Switzerland), and 
46% (USA) for the validation study of PPE-15. Item total correlations recommended level 
of 0.3 (Spearman correlation) was achieved for all items for the UK (0.42–0.54), 
Switzerland (0.36–0.49), and Germany (0.34–0.58). However, one problem score fell 
below this criterion in Sweden and the USA: question 8 (‘Doctors sometimes talked as if I 
wasn’t there’) achieved a correlation of 0.23 for Sweden and 0.25 for the USA. All other 
correlations exceeded the criterion of 0.3 (Sweden 0.32–0.48; USA 0.42–0.57). Removal 
of the item did not substantially increase reliability, and it also has high face validity as an 
important aspect of patient care, therefore this item was retained in the final measure. The 
PPE-15 index was highly correlated with the total number of items selected as ‘problems’ 
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on the original measure [correlations ranged from 0.93 (P < 0.001) for Sweden to 0.95 (P < 
0.001) for the UK, Switzerland, Germany, and the USA] [342]. Although the PPE-15 was 
developed for use by doctors, the questions are generic and could be easily adapted to be 
used by other health professionals. It takes up to 10 minutes to complete. 
d. Consultation and Relational Empathy (CARE) Measure: The CARE Measure is a 10-
item person-centred process measure that measures the amount of empathy that a patient 
feels they have received during consultation [343]. The CARE Measure has been 
rigorously developed, tested and validated for use by most health professionals in adult 
out-patients. The initial version strongly correlated (r = 0.85) with the Reynolds empathy 
measure (RES) [344] and the Barrett-Lennard empathy subscale (BLESS) [345] (r = 0.63), 
however, the skewed distribution was high (skew 1.879, kurtosis 3.563). Interview study 
with 20 patients, GPs and expert researchers led to the revision of the initial version. The 
revised version of the CARE measure also strongly correlated with the empathy measures 
(r = 0.84 vs. RES and r = 0.77 vs. BLESS) however, the skewed distribution was low (skew 
0.634, kurtosis 0.067). The internal reliability at this stage was high (Cronbach’s alpha 
0.92). Interview study with 13 patients led to a minor revision. The final version of the CARE 
measure proved validity with the other empathy measures (r = 0.85 vs. RES and r = 0.84 
vs. BLESS) and face validity with 10 patients in an interview study [343]. Participants 
complete the measure after consultation in their own time and takes up to 10 minutes to 
complete. 
e. Positive Outcomes HIV PROM: Recently developed at the Cicely Saunders Institute 
(2018), Positive Outcomes is a 23-item patient-centred PROM that reflects the range of 
outcomes relevant for PLWHA across six domains: physical, cognitive, psychological, 
social, welfare and information needs [346]. The data on the psychometric properties of 
this person-centred measure is unpublished however a discussion with the authors 
revealed that it meets the criteria for COSMIN properties [347]. 
 
The APCA POS, MOS-HIV and Positive Outcomes have been chosen to measure physical, 
psychological, social and spiritual wellbeing among PLWHA; and the CARE Measure and 
PPE-15 were chosen to measure the processes involved in care delivery.  
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Intervention and training content design 
Following the expert panel recommendation to adopt palliative care skills to inform the 
intervention training content for HCP, the researcher selected and adopted existing palliative 
care resources including those used during the TOP Care trial [320]; African Palliative Care 
Association training resources [348]; and the palliative care training manual and tool kit [107, 
349]. These resources were used in conjunction with the PCC theory and the qualitative data 
to draft the intervention training content (APPENDIX M) and the holistic assessment tool 
(APPENDIX N). The holistic assessment tool used in the TOP Care trial was modified and 
adapted for this intervention because it captured most of the PCC care domains described by 
PLWHA in the qualitative data. The training content was also developed to reflect the content 
of the holistic assessment tool and incorporating the qualitative data from stakeholders.  A 
care plan (APPENDIX O) was developed and mirrored the domains of PCC needs identified, 
the holistic assessment tool as well as the training content. This ensured that the content of 
these documents developed from the above resources mapped onto the qualitative data, the 
PCC theory and most importantly the process and outcome measures selected for the 
intervention. The content of training, care plan and the holistic assessment tool draft were 
circulated among the expert panel members via email for feedback and review before final 
draft was concluded.  
At this stage, details on the training content, number and duration of sessions to be attended 
by HCP, number of intervention appointments (dose) and duration of the intervention for 
PLWHA were concluded in the draft. The researcher also clarified the conditions and 
resources required to implement the intervention successfully and the related risks and 
assumptions. For instance, the availability of HCP for training and the cooperation of the clinic 
leads in allowing time for the intervention training and delivery. It was also anticipated that 
there could be potential unintended effects of the intervention, this anticipation informed the 
researcher to be prepared to minimise any harmful effects that could arise. Some of these 





Step (v): Feasibility testing and refining the intervention - The final stage of the 
intervention development was to test the content and processes incorporated in the logic 
model. This final stage involved feasibility testing procedure (including testing methods for 
their acceptability and feasibility), estimating the likely rates of recruitment and retention of 
participants and the determination of appropriate sample sizes for the evaluation studies [178]. 
This Feasibility stage also aimed to address all the uncertainties identified in the Development 
stage (see section 3.12, Phase 3: thesis objective 5 for detailed method).
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3.12 Phase 3: Thesis objective 5 
(MRC “Feasibility stage”) 
To deliver and test the feasibility of a cluster RCT of the intervention in terms of recruitment, 
retention, intervention delivery, estimate of potential effect and to appraise measures. 
 
The research questions linked to thesis objective 5 are: 
 
What is the feasibility of recruitment and retention of participants, and the potential effect size of 
the intervention? 
 
What is the acceptability and fidelity of delivering the intervention among PLWHA and HCP? 
 
How does the experience of the intervention and the process of delivering it help to refine the 
intervention? 
 
3.12.1 Feasibility trial registration 
This feasibility trial was registered on the ISRCTN registry with study ID ISRCTN13630241. 
 
3.12.2 Feasibility outcomes 
The primary outcomes for this feasibility cluster RCT are: 
1. Recruitment rate 
2. Retention rate  
 
Secondary outcomes include: 
1. Fidelity of the intervention training and delivery 
2. Intervention delivery and acceptability, experience of the intervention and processes/ 
mechanisms of delivery 






3.12.3 Feasibility studies 
Feasibility studies are very important in trial preparation, especially in planning evaluation of 
complex interventions [176]. In order to allocate resources for a future trial with the optimal chance 
of effective delivery, it is crucial to determine feasibility of recruitment, retention and intervention 
delivery [351]. Feasibility studies are “pieces of research done before a main study in order to 
answer the question ‘can this study be done?’’ They are “used to estimate important parameters 
that are needed to design the main study” [352]. The objectives of this feasibility study as outlined 
above is to deliver the newly developed person-centred intervention and to determine rates of 
recruitment and retention of participants, estimate the potential effect size and to establish 
acceptability and fidelity (extent to which the intervention was delivered as intended). 
Achievement of these objectives will  determine whether the intervention can be implemented, 
could be evaluated in a trial, could be potentially effective and therefore warrant a future definitive 
trial [353]. By design, this feasibility cluster randomised controlled trial (cRCT) involved 
quantitative outcome data collection with a post-trial qualitative exit interview.  
 
 
3.12.4 Quantitative component of the feasibility trial 
3.12.4.1 Study design 
A parallel group design with an allocation ratio of 1:1 was used for this feasibility cluster 
randomized controlled trial (cRCT) and reported in accordance with the CONSORT extension to 
randomised pilot and feasibility trials [354].   
A cluster RCT was chosen for this study, which involves the allocation of  groups of subjects 
(PLWHA) to different treatments arms [355, 356] rather than individual randomisation, in order to 
reduce/ minimise treatment ‘contamination’ [357] between the intervention and control arms (see 
Figure 11 for the feasibility cRCT flow diagram). Contamination of the control arm could reduce 
the estimate of the effect size of the intervention in a full trial; and this reduction could result in a 
type II error (rejection of an effective intervention as ineffective as the observed effect size will 
neither be statistically nor clinically significant) [358]. A cluster RCT is appropriate for this 
intervention as it involved training and mentoring of HCP to implement a new care approach, 
which would be generally acceptable than randomisation at the individual level [359]. Also, cRCT 
allowed for the assessment of the direct and indirect effects of intervention which provided a 
measure of the overall effect of implementing intervention in HIV population.  
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3.12.4.1.1 Measures to check for contamination 
The researcher did not anticipate any contamination between the two clusters as the shortest and 
longest drive time distance between the clusters is about 6.2 and 8.6kilometers respectively as 
indicated in Figure 9 in section 3.6.1.1. However, in order to guard against any form of 
contamination, participants were asked to notify the researcher or the HCP if between their last 
appointment they fell ill and have had to access medical services at another clinic other than their 
respective HIV clinics. The researcher also asked each participant about attendance to other 
clinics during outcome data collection. 
  
3.12.4.2 Inclusion criteria 
Refer to section 3.8.1.1 for inclusion criteria. 
 
3.12.4.3 Setting 
This feasibility cRCT was conducted in two community clinics in Ghana. Location of the two clinics 
used for the feasibility testing is shown in Figure 9, and clinic details have been described in 
section 3.6.1.  
 
3.12.4.4 Sample size 
As this is a feasibility study, a formal power calculation based on detecting evidence for 
effectiveness was not conducted. In order to determine feasibility of recruitment to inform a future 
definitive trial, a sample size of 30 has been recommended to estimate a parameter such as a 
standard deviation for the calculation of sample size [360]. Therefore, a total of 60 participants 
were recruited across the two clusters in a ratio of 1:1, that is n=30 per clinic to participate in the 




















3.12.4.5 Participant identification, consent and recruitment 
Patients were initially approached by their HCP about the study, those who expressed interest in 
taking part in the study had their details passed on to the researcher (MA-O). The researcher then 
approached these patients, screened and assessed their eligibility for recruitment. Participants 
who met the inclusion criteria were taken through the information and consent process 
(APPENDIX P) in a separate private space, respecting the patient flow of the clinic. Participants 
who were willing to take part in the study provided written consent (APPENDIX Q) either by 
signature or thumb print. Participants were offered a minimum of 24 hours to consider participation 
in the study, after which consent was taken. Participants were allocated unique identifying 
numbers to protect their privacy. Detailed records of screening and recruitment were documented 
(APPENDIX R) and used in determining recruitment and consent rates of participants. 
 
3.12.4.6 Baseline data collection 
Baseline data were collected at the two study sites once participants provided written consent 
and prior to randomisation. Demographic questionnaire was used to collect demographic data on 
gender, age, partner status, number of children, number of financial dependents, level of 
education among others. In addition to this, the selected process and outcome measures for this 




After providing consent and baseline data collection, the two clinics were allocated to ‘Control’ or 
‘Intervention’ by independent off-site statistician conducting computerised randomisation. Clinic 1 
was allocated to the control arm and clinic 2 was allocated to the intervention arm. The control 
arm continued to deliver Standard HIV Care (SHC) throughout the trial, and the intervention arm 
had their HCP trained to deliver the intervention. 
 
3.12.5.1 Control arm 
Standard HIV care (SHC) was selected as the control arm in order to assess the potential impact 
of the intervention as compared to existing practices in HIV clinics. Participants in the control arm 
continued to receive SHC provided by HCP who have had no exposure to the intervention. In 
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Ghana, SHC generally consists of one-monthly, two-monthly or three-monthly clinical 
appointments depending on when PLWHA started ART or their adherence status. PLWHA who 
started ART treatment within the last six months usually fall within the one-monthly or two-monthly 
appointments depending on their adherence status, and those who have consistent records of 
adherence have the three-monthly appointments.  Patients may attend the clinic for repeat 
prescription of ART only, referrals to ART adherence support, nutrition support or may request 
more frequent appointments if they experience specific problems.  
At the control arm, in line with the clinic protocols, PLWHA initially attend the clinic for ART repeat 
prescriptions on a monthly, two or three-monthly basis depending on how long they have been 
on ART, and their adherence history. However, for the purpose of this study, all participants 
recruited into the study were scheduled to attend their appointments once every month for the 
duration of the study irrespective of their regular clinic appointments, in order to assess outcomes 
for both arms on a monthly basis so that any difference cannot be attributed to additional 
appointments. 
 
3.12.5.2 Intervention arm 
The newly developed community-based enhanced care intervention (CECI) was delivered by 
HCP in the intervention arm who were trained on CECI components and tools in order to equip 
them to deliver CECI according to protocol. 
 
3.12.5.3 HCP training on the CECI intervention 
HCP in the intervention arm received training on the CECI delivered by the researcher (MA-O). 
This training was divided into three main sessions namely: person- centred communication and 
holistic assessment; psychological and social wellbeing; and physical and spiritual wellbeing (see 
APPENDIX M). Among the topics discussed under the three main sessions included 
communication, the holistic approach, quality of life, intimacy and sexuality, psychosocial 
assessment and management, pain assessment and management, the different aspects of 
spirituality demonstrated using the HOPE checklist, cultural issues, teamwork, counselling, the 
importance of holistic assessment, how to complete assessment tools and documentation. HCP 
were provided with copies of the holistic assessment tool and copies of care plan during the 




The training lasted two hours per day for three days, and each training session consisted of 
PowerPoint presentation, discussion and a role play acted by selected HCP to demonstrate what 
had been taught. Of the two hours allocated to each training session, one hour was dedicated to 
the discussion and PowerPoint presentation, and the remaining hour was dedicated towards the 
role play (see Figures 12 for CECI training session).  
 
 
Figure 12: CECI training underway 
 
Certificates (APPENDIX S) were awarded to HCP who completed all three training sessions. In 
addition to the certificates, daily refreshments were provided to HCP after each training day.  
MA-O was mentored by Dr Edwina Opare-Lokko, a local palliative care lead, who also reviewed 
the content of PowerPoint slides on the training before the training commenced (see Figure 13 





Figure 13: Diagram on intervention training 
 
3.12.5.4 Holistic assessment tool and care planning 
In the intervention arm, HCP holistically assessed PLWHA using the holistic assessment tool 
which assesses the domains of physical, psychological, social and spiritual wellbeing, including 
family, economic and emotional wellbeing. This holistic assessment tool was developed by 
drawing on tools and models used in sub Saharan Africa, which has been adapted for use in this 
study. PLWHA were assessed on current and anticipated care, symptoms and concerns were 
discussed, and an action plan agreed, leading to collaborative individualised care planning. The 
care plan aimed to provide quality comprehensive person-centred assessment with clear action 
plan on management. Where appropriate, PLWHA requiring services provided outside the clinic 
jurisdiction were referred after HCP communicated with providers of these services about the 
need for patient referral. Every clinical assessment item is being covered at each visit, with a 
particular focus on the problems identified at previous clinic visits. In order to track PLWHA 
progress during the trial, an ongoing summary record was kept highlighting areas of concern. This 
record is a summary document that was used to monitor PLWHA progress and to ensure chronic 
problem follow up. Predominantly, this summary record was used to document problems and 
concerns identified by the HCP and PLWHA during assessment and the action plan agreed and 
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subsequently revised on PLWHAs’ progress or deterioration. The holistic assessment tool was 
designed as a prompt to ensure that assessment of PLWHA is holistic. 
 
3.12.5.5 Mentorship for HCP and CECI supervision meetings 
MA-O provided two-weekly mentorship and supervision meeting with HCP after the intervention 
training until the study closed. At these meetings, issues or challenges encountered during the 
delivery of the CECI, issues regarding the assessment tool, assessment and management of 
symptoms and concerns were discussed. Also, all PLWHA assessed during the week were 
discussed, case notes reviewed, and decisions appraised. The support meeting sessions also 
involved discussions around how PLWHAs’ concerns were assessed, documented and reported 
on the assessment form in order to ensure that HCP were complying with the details on the 
assessment tool. HCP were asked about their experiences of using the holistic assessment tool, 
how they were completed and whether the assessment tools were partly or fully completed. MA-
O took time to address the four domains of assessment for example, pain assessment (physical): 
and asked HCP how they assessed pain during the week; and if there were any challenges 
regarding pain assessment, HCP were taken through pain assessment to ensure that they were 
conversant with it. This process was followed for the various domains of assessments to ensure 
the completeness of the holistic assessment tool (see Figure 14 for mentorship and supervision 
meeting).  
As part of this supportive meetings, MA-O also discussed with HCP, complex issues they 
encountered and felt unable to manage, for example, complex cases of psychosocial issues or 
pain, and these were referred appropriately. Clinical decisions made were jointly reviewed and 
discussed with HCP, this encouraged problem solving and skill development. MA-O also 
encouraged HCP to be reflexive about the care they were providing, how it impacted on them 




Figure 14: CECI supervision meeting underway 
 
Step (vi): Collecting enough evidence to justify rigorous evaluation/ implementation 
 
3.12.5.6 Prespecified criteria used to judge how to proceed with future definitive trial 
Following Avery et al. [361] recommendation on specifying progression criteria for feasibility 
studies, these criteria were set for this feasibility trial for progression to a definitive cRCT : 
1. Recruitment of 30 PLWHA within 8 weeks for each cluster  
2. Retention of 80% of the total sample at T3 follow up  
3. Establish intervention acceptability 
 
3.12.5.7 Assessments to facilitate estimation of recruitment and retention rates 
Three specific questions were asked in relation to thesis objective 5 (see the feasibility cRCT in 
section 3.12). The specific assessments recorded and used to address the first question, which 
also focused on the primary outcome of the study include: 
i. % of eligible participants  
ii. % of participants approached and screened 
iii. % of participant that meet the inclusion criteria 
iv. % of participants that consented and entered the trial 
v. % of participants who declined participation 




3.12.5.8 Data collection timepoints for the estimation of potential effect size of CECI 
Data was collected monthly over three months after baseline data collection and training of HCP 
on CECI delivery (see Table 10). A participant pack was allocated to each participant, which was 
stored securely in the locked cabinet within the clinics. Each set of outcome measures 
(APPENDIX T) were colour coded to distinguish each month of data collection and different colour 
coding of outcome measures were presented to participants at each visit to facilitate progress 
monitoring. Participants had the freedom to choose whether to conduct the interviews in Twi or 
English or both languages. MA-O contacted participants who failed to attend an appointment and 
reminded them to attend. A two-week window was allowed after missing a scheduled 
appointment, after which non-attendance was recorded as missing. Data collection was recorded 
at four time points: baseline (T0), one month after intervention training was carried out (T1), two 
month post-intervention (T2), and three months post intervention (T3). At each time point, PLWHA 
received either the CECI or SHC before completing an outcome and process measures. Data 
was collected in the counselling room or a private space within the clinic when the counselling 
room was in use. The researcher on most occasions read aloud the questionnaires for participants 
to respond to, and responses were written in participants’ respective packs in order to minimise 
the effect of varying levels of literacy in the sample. 
The timeline comparing research activities at the two cluster sites from participant screening and 
recruitment through to the end of the post-trial qualitative interviews are reported in Table 11. As 
indicated in Table 11, HCP at the intervention site started delivering the intervention at week 3 
when intervention training was completed at the end of week 2. However, study participants 
monthly appointments started at week 6. This was to allow HCP to get a sense of how the 
intervention was expected to be delivered before study participants start their first intervention 
appointment. 
Table 10: Data collection and timepoints n=30 
Both study arms Baseline 
Includes 
Demographic data 






APCA POS, MOS-HIV, 
CARE Measure, PPE-
15 and Positive 
Outcomes  









Table 11: Detailed comparison of CECI and SHC to timelines and timing of CECI delivery 








Participant recruitment into the study and baseline data collection 
using demographic questionnaires and baseline quantitative 
outcome data collection 
Randomisation 
Week 1 Informed will be delivering CECI and training 
scheduled 
Informed will 
continue to deliver 
SHC 
Week 2 CECI training started and completed in 3 
days 
-  
Week 3 CECI delivery by HCP including twice-weekly 
supervision meetings 
- 
Week 4 CECI delivery by HCP including twice-weekly 
supervision meetings 
- 





1st CECI appointment and repeat of baseline 
quantitative outcome data collection 
1st SHC 
appointment and 




Week 7   
Week 8   
Week 9   
Month 2 
Week 10 
2nd CECI appointment and repeat of baseline 
quantitative outcome data collection 
2nd SHC 
appointment and 




Week 11   
Week 12   
Week 13   
Month 3 
Week 14 
3rd CECI appointment and repeat of baseline 
quantitative outcome data collection 
3rd SHC 
appointment and 




Week 15   
Week 16   
Week 17 End of feasibility trial 
Week 18   
Week 19   
Week 20  
Post-trial exit qualitative interviews for purposefully sampled 
PLWHA participants from both clusters and only HCP who 







3.12.6 Qualitative component of the feasibility trial 
3.12.6.1 Sampling and participant recruitment 
PLWHA and HCP were recruited from the two clinics who participated in the feasibility cRCT. 
Both PLWHA in the intervention and control arms were approached to take part in the post-trial 
interviews, and HCP in the intervention arm only. This was important to further explore any 
potential therapeutic effects of participating in the trial beyond the potential benefits of the 
intervention as well as checking the acceptability of methods for control arm (what was it like 
being ‘control’). Although Lowther et al [362] reported this type of effect as a methodological issue, 
due to the stigma attached to HIV disease and the social isolation experienced in this population 
[363], it was anticipated that taking part in a research where PLWHA regularly interact with the 
research team could potentially influence some effects, which are rarely examined. Participants 
were selected a minimum of two weeks after exiting the trial to allow them some time to reflect on 
their participation in the feasibility trial and how it may have affected them. The researcher 
contacted potential participants to enquire whether they would be interested and available to 
discuss their experience in the trial.  
Purposive sampling was used to achieve maximum variation based on trial completion/non-
completion, and age. All participants provided written informed consent (APPENDIX U) prior to 
interview.  
 
3.12.6.2 Post-trial interview topic guide 
A topic guide was developed and piloted for flow and comprehensiveness with one participant 
prior to data collection. The topic guide was structured chronologically to assess participants’ 
perspective of their state of wellbeing before, during and after their participation in the trial, with 




The specific topic guide developed for participants in the intervention (APPENDIX V) was used 
to ask about the participants’ physical, emotional, social and spiritual wellbeing before the study 
began, and the effect on their ability to perform their activities of daily living, including work and 
other responsibilities. Participants were afterwards asked to describe their wellbeing during and 
after the trial had ended including their experience and thoughts on the most important aspect of 
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the intervention as well as their participation in the trial. Additionally, specific questions were 
asked about their experience of being recruited and data collection, receiving the intervention 
including components they found helpful or important to their wellbeing, which components they 
attributed improvement or deterioration to and the key differences they identified between the 
intervention and standard HIV care. 
 
3.12.6.4 Control 
Specific topic guide was developed for participants in the control arm (APPENDIX W) who 
participated only in the trial without receiving any aspect of the intervention. The topic guide 
explored participants’ wellbeing in relation to their physical, psychological, social and spiritual 
wellbeing before, during and after participating in the trial. Specific questions were asked about 
how participating in the trial had affected or changed them in any way including their wellbeing in 
general. If change was reported, participants were asked the importance of this change taking 
place; and if no change reported, they were asked about what they needed to be happier. 
Participants were also asked about their experience of being recruited and data collection. 
 
3.12.6.5 Data collection 
Participants were contacted by the researcher about sharing their experience in the trial and those 
who consented, a date and time was agreed for the interview. On the day of the interview, 
participants were taken through the consent process including a discussion of the purpose of the 
interview, details on data protection and their right to privacy. Participants who were happy to 
proceed signed/ thumb printed the consent form prior to starting the interview. It was explained 
that the interview would be audio recorded and that if there were any questions that participants 
did not wish to answer, they could choose to omit or terminate the interview. In addition, it was 
explained that if the participant required a break or had any questions which they did not wish to 
be part of the interview, then the interview could be stopped. Participants who received the 
intervention were interviewed on their experience and receipt of the intervention, and participants 
in the control arm who received standard HIV care were also interviewed about their experience 
in the trial to further explore any potential therapeutic effects of participating in the trial beyond 
receipt of the intervention. HCP were interviewed about the intervention training, implementation, 
mentorship and support including fidelity monitoring. 
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Interviews were audio-digitally recorded. All interviews were conducted in participants’ respective 
clinics including HCP. No participant objected to the interview being recorded nor did anyone ask 
for the recording to be stopped during the interview. 
 
 
3.12.7 Data analysis 
3.12.7.1 Quantitative component of the feasibility trial with descriptive analysis 
This analysis reported data on the primary outcomes (estimated recruitment and retention rates) 
and secondary outcomes (missing data; mean difference of baseline (T0) compared to T1, T2 
and T3 and 95% confidence interval using descriptive and inferential statistics). The potential 
effect size of CECI was estimated, and measures appraised. To estimate the effect size, analysis 
of covariates (ANCOVA) was conducted, with the outcome measures endpoint as the dependent 
variable and treatment centre as the fixed factor and baseline score, age, gender and CD4 count 
as covariates. Partial eta squared statistics were calculated using Cohen’s d effect size 
references.  A cross-sectional analysis of the baseline data T0 and the final time point T3 was 
conducted to assess change scores between T0 and T3; and change scores over T0, T1, T2 and 
T3. Analysis were conducted in SPSS v25 and reported in line with the CONSORT diagram for 
randomized pilot and feasibility trials [354]. 
 
3.12.7.2 Primary outcome – trial recruitment and retention 
In terms of trial recruitment, the proportion of the target sample achieved including eligible 
participants, participants approached and screened, those meeting the inclusion criteria, those 
that consented and entered the trial and those who declined participation were used to estimate 
the recruitment rate. The CONSORT flow diagram shows the total number of potential participants 
screened, number meeting the eligibility criteria, reasons for excluding participants, number 
randomised, number missing appointments during the trial, and numbers retained at each 
timepoint (month 1, 2, and 3) in the trial follow-up. Descriptive statistics were presented for key 
feasibility outcomes, including recruitment rate achieved, participant eligibility rate in addition to 
retention rate of participants. Retention rates will be estimated using the proportion of participants 




3.12.7.2.1 Baseline characteristics 
Descriptive statistics were reported for the baseline and demographic characteristics of 
participants, by treatment arms (control and intervention), with means, standard deviations, or 
numbers and proportions reported as appropriate.    
 
3.12.7.2.2 Adherence to the allocated treatment 
The proportion of participants attending their appointments and adhering to their treatment in each 
arm including those attending 1, 2, or all 3 appointments were reported, if possible, reasons were 
given for any participant who missed an appointment both in the control and intervention arms.  
Fidelity checklist was used to appraise the intervention training, delivery and receipt of the 
intervention. The twice weekly meetings held with HCP throughout the intervention delivery were 
used to assess how the intervention was being delivered as well as addressed any challenges 
faced by HCP in the course of the intervention delivery. 
 
3.12.7.3 Quantitative data with inferential analysis 
3.12.7.3.1 Missing data  
The analysis of missing data for this PhD considered number of items missing (single questions), 
number of units missing (missing all questionnaires for a time point), and the number of 
participants who may have exited the study early with reasons if available. Data collection was 
closely monitored allowing the researcher to document and account for reasons for missingness 
whenever possible in order to understand the extent of missing data in this dataset. Missing data 




Table 12: Template for reporting summary of missing data 
Time points Missing data type Control Intervention Total control & 
intervention 
Time 0 Missed single item 





   
Time 1 Missed single item  





   
Time 2 Missed single item 





   
 
 
3.12.7.4 Secondary outcome – estimation of the potential effect size of the intervention 
Symptoms and concerns were described for all timepoints (from baseline to final time point 3), 
and data plotted to show how scores changed for all three timepoints; however, the potential 
effectiveness was estimated using baseline and final timepoints scores. 
Numbers and proportions of participants in both arms were reported, along with those who 
experienced more severe levels of symptom. Summary scores were tabulated and reported.  
The analysis of change described the courses of symptoms and concerns over time. This was 
analysed for the whole study sample in both control and intervention arms in a ‘forward’ direction, 
from study entry to the final time point. Symptoms, concerns and experiences of care were likely 
to vary according to the treatment arms, and/or how often participants received the CECI.  
Summary statistics (mean and 95% confidence intervals) at each time point were reported for 
control and intervention arms. This demonstrated how symptoms, concerns, and care processes 
of the whole study population changed over time from study entry until participants exited from 
the trial.  
Statistics of means and standard deviations were first calculated for all outcome measures used 
(APOS, MOSHIV, CARE Measure, PPE-15 and Positive Outcomes) for both the control and 
intervention arms from baseline to final timepoint. The mean scores for each of these measures 
at every timepoint were presented. For all the outcome measures, higher scores indicate lower 
symptoms burden, except for the APOS and Positive Outcomes where lower scores indicate 
higher symptom burden.  The values for the mean scores, standard deviations, range, and the 
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size of the sample from which these summary statistics were derived are presented at each time 
point. One of the secondary outcomes for this feasibility trial was to estimate the potential effect 
size of the intervention. Consequently, an exploratory analysis was conducted to estimate the 
potential effect size of the intervention. This was done using ANCOVA using the outcome 
measures endpoint as the dependent variable, and treatment centre as the fixed factor and 
baseline scores, age, gender and CD4 count as covariates. Before the ANCOVA was conducted, 
normality test was conducted to check whether data was normally distributed, however, no 
significant outlier assumptions were conducted. Group difference estimates and associated 
confidence intervals were reported.    
For outcome data, data completeness was measured at each timepoint for both the intervention 
and control arms, and results plotted to check for flooring and ceiling effects (to guide and inform 
primary outcome selection). Data completeness was reported and means/ standard deviations or 
medians and IQR (depending on data normality/symmetry of distribution) plotted for each 
timepoint. 
 
3.12.7.5 Methods for handling multiple comparisons 
No adjustment for multiple comparisons was undertaken as this was a feasibility study and 
therefore not powered to test for efficacy based on a specified outcome. Consequently, caution 
should be applied regarding the interpretation of inferences in group differences on secondary 
outcomes.   
 
3.12.7.6 Qualitative analysis 
Digital recordings of the post-trial interviews were transcribed verbatim and analysed using 
thematic analysis [269]. MA-O read transcripts to familiarise with data, before line by line coding 
was done to generate an initial coding framework. Three independent researchers (SE, LB, LC) 
reviewed six randomly selected transcripts, performed line by line coding of each individual 
transcript using the initial framework generated by MA-O, in order to develop a mutually agreeable 
coding framework. These researchers (MA-O, SE, LB, LC) met and agreed on the coding 
framework through discussion. This unified coding framework was applied to both PLWHA and 
HCP data sets. QSR NVivo 12 was used to assist data management and analysis.  




3.12.7.7 Data integration for thesis objective 5 (mixed methods feasibility cRCT) 
Findings from the analysis of each data set in a mixed methods study can be integrated at data 
collection, analysis or data interpretation [205]. For this thesis, findings were integrated at the 
data interpretation stage (after the quantitative and qualitative components of the feasibility cRCT 
were analysed separately). Quantitative data analysis findings were used to interrogate the 
qualitative data and vice versa in order to address the secondary outcomes on CECI delivery and 
acceptability. The findings from the quantitative and qualitative analysis for thesis objective 5 were 
then presented and discussed, highlighting the qualitative explanation for findings from the 
quantitative analysis, and any incongruence or convergence in findings. First, the components of 
care delivered as part of CECI and how they differed from SHC were described. Post-cRCT 
qualitative data analysed thematically identified active ingredients of CECI and their mechanism 
of action and therapeutic aspects and processes attributed to study participation. PLWHA were 
asked directly in the interviews, what they attributed any change in their health status to, and how 
this attributed aspect might have an effect in the light of the quantitative results.  This data was 
used as a starting point to identify any possible active ingredients of the intervention, with the rest 
of the interview data also examined.  
 
3.12.8 Rigour and data quality 
Throughout the conduct of the study, Skype calls (remote supervision) were held between the 
researcher and supervisors (RH and KB) a minimum of once every two weeks; including a face 
to face or telephone call with a mentor (EO-L) based in Ghana at least once a week. During these 
calls the researcher updated RH, KB and EO-L on number of participants screened, recruited and 
exited at different time points and discussed any matters arising. 
The researcher was always present at the study sites and recorded recruitment data for each 
days’ screening activities and sent copies to supervisors periodically including the daily and 
weekly totals of numbers of participants screened, eligible, recruited and consented. When 
recruitment was completed, RH and KB were informed before randomisation of the sites was 
conducted. 
Progress on participants attending the data collection appointments were monitored daily and 
follow-up calls were made to participants who failed to attend appointments and were reminded 
to attend, and missing values were recorded two weeks after a participant failed to attend an 
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appointment. In so doing, the quality of the data was maintained, and the amount of avoidable 
missing data was reduced.  
There was a distress protocol which was employed if a participant became distressed during data 
collection. Participants were made aware that if the researcher become concerned about their 
welfare (i.e. suicidal thoughts or abuse disclosures), their consent would be sought first before 
referring them to the clinic lead for appropriate support. 
 
 
3.12.9 Feasibility criteria for progressing to a definitive trial 
Although a variety of progression criteria may be used to assess the probable success of a 
definitive trial, the three predominating criteria include: trial recruitment, protocol adherence and 
outcome data [361]. Trial recruitment has been the main focus of progression criteria and has 
been considered the highest priority for both researchers and funders [364-368]. Therefore in this 
feasibility trial, % of participants approached and screened [369], % of participant that met the 
eligibility criteria [369], % of participants that consented, randomised  and entered the trial [369, 
370], % of participants that were present at each time point (T1, T2 & T3) of data collection after 
the CECI commenced and % of total clinic population eligible were recorded for the estimation of 
recruitment and retention rates. Therefore, the pre-existing data from these clinics in the 
quantitative component of the feasibility trial: the number of patients seen daily and the available 
data on the number of eligible patients in the clinic population, was used to inform a progression 
criterion on recruitment for this feasibility trial.   
For the purpose of this study, the second progression criterion was a focus on protocol adherence 
for which assessment could include all procedures outlined in the protocol [371]. In this study, the 
focus of protocol adherence has been on the CECI and trial procedures. ‘Cross-over’ is one of 
the types of non-adherence that could occur [372] which is participants not receiving their 
allocated intervention but rather an alternative trial intervention not allocated to them. Cross-over 
causes the study arms to be more similar, reducing the power of the study and a smaller difference 
between the overlapping arms than expected [357, 373]. 
Another progression criterion was monitoring the completeness and quality of outcome data 
during the feasibility trial, which provided a valuable opportunity to identify any issues that could 
be amended to improve the conduct of data collection in a definitive trial. Each participant was 
expected to contribute complete data at predetermined time points, as outlined in the protocol 
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however, missing or inadequate data are inevitable, resulting in some participants not being 
included in the final outcome assessment. Among the reasons for missing or inadequate data 
include attrition, loss to follow-up, problems with the feasibility or acceptability of the outcome 
assessment protocol, or the issues with the outcome measure themselves. The amount of missing 
data can have important implications for the trial’s required sample size. Sometimes, the available 
data may be of poor quality due to partly completed patient-reported outcome measure or data 
not collected promptly resulting in only a small percentage of usable data within the acceptable 
timepoint. Therefore, assessing completeness of outcome data to report with the progression 
criteria could be useful in forming the focal point for progression criteria in some clinical settings.  
Following the traffic light system of green (go), amber (amend) and red (stop) recommended by 
Avery et al. [361], when specifying progression criteria for feasibility studies, these criteria were 
set for this feasibility trial for progression to a definitive RCT : 
i. Recruitment of 30 PLWHA within 8 weeks for each cluster  
ii. Retention of 80% of the total sample at T3 follow up  
iii. Acceptability of the intervention, training manual, and the intervention components by 
PLWHA and HCP in the intervention arm only trial design. 
 
3.12.9.1 Feasibility 
Success of the feasibility trial was measured in terms of our a priori criteria stated above, and if 
necessary, refined methods by integrating the qualitative and quantitative data. If success criteria 
were met, refinements were aimed at improving the design. 
 
3.12.9.2 Acceptability 
CECI acceptability was assessed using findings from the post-cRCT qualitative interviews with 
PLWHA and HCP. 
 
3.12.10 Measures put in place to protect against bias 
The following steps were taken, and their feasibility and acceptability were examined to reduce 
the risk of bias in a definitive trial:  
a. Randomisation to the trial arms were performed after recruitment, consent and baseline data 
collection was completed by an independent statistician who was not involved in the study. 
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b. Although contamination due to movement of PLWHA between sites allocated to the different 
trial arms was possible, we anticipated this was minimal and therefore had little impact. 
c. In order to have a complete outcome and process data, every effort was made to obtain data 
from all participants who did not withdrew consent. 
d. To prevent selective outcome reporting, a comprehensive analysis plan was developed for the 
feasibility cRCT before data analysis commenced. 
 
  
3.12.11 Refining the intervention using the data generated and the logic model 
Qualitative data analysis explored the acceptability of the intervention, the extent to which 
participants and HCP engaged with it, perceptions of how the intervention influenced HCP 
behaviour and contextual factors. The analyses tested the hypothesised causal pathways 
expressed in the logic model and the intervention’s theory of change (PCC). This information is 
necessary to inform the study design of a future definitive trial by determining which elements of 
the intervention worked well for PCC behaviour change in HCP, how they delivered the 




Chapter 4 Results 1. Phase 1 (thesis objective 1)  
4.1 Systematic review 
4.1.1 Study characteristics 
This review was registered in PROSPERO - CRD42019127913. 
The search retrieved 1,720 papers and hand searching yielded 9 additional papers as shown in 
the PRISMA flow diagram in Figure 15 [243]. Of the 1,393 papers screened, 1,352 were excluded, 
leaving 41 papers for full-text review. Of these, 36 papers were excluded as they did not meet the 
inclusion criteria. Five papers were retained for final analysis. A total of 327 PLWHA and 68 HCP 
participants were included in the five studies retained. Three studies were classified as pilot and 
feasibility studies [374-376]; one qualitative observational study [377]; and one randomised 





Figure 15: PRISMA flow diagram 
 
Of the five studies retained, n=4 papers (80%) reported data from USA, a high-income country 
and n=1 paper (20%) reported data from Kenya, a lower-middle income country in line with World 
Bank classifications [378].  
The median and range of the study design quality score of all retained studies are 0.7 and 0.6 – 
0.9 respectively.  
 
4.1.2 Person-centred care models 
Components of care delivered were categorised according to Mezzich’s definition (promotion of 
physical, mental, sociocultural, and spiritual well-being, alongside the reduction of disease [146], 
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see Table 13. Of the five studies retained, n=1 delivered two components, n=2 three components 
and n=2 delivered all four components. 
 
Table 13: PCC components delivered in studies retained as mapped onto Mezzich's [146] domains 
Study Physical Psychological Social  Spiritual 
Bendetson et al. [376] ü  ü  ü   
Lowther et al. [320] ü  ü  ü  ü  
Morgan [374] ü  ü  ü  ü  
Robinson et al. [379] ü  ü  ü   
Steward et al. [377] ü  ü    
 
 
As demonstrated in Table 13, although all these studies claimed to deliver PCC, only two studies 
delivered all domains defined by Mezzich [146]. All five studies delivered care that addressed 
physical and psychological wellbeing, and 4 studies added social care, confirming previous 
reports that less attention has been given to spiritual wellbeing [155]. Details of data extracted 
from the retained studies can be seen in Table 14. 
 
4.1.3 Details of PCC components delivered 
(i) Physical wellbeing  
All five (100%) studies delivered PCC domains that focused on physical wellbeing of PLWHA 
(see Table 13). These include medical treatment, selfcare, nutrition, pain other symptoms 
management [320, 374-377] and using tools like yoga, meditation and Reiki practice (Reiki is a 
Japanese technique for relaxing and reducing stress). 
 
(ii) Psychological wellbeing 
All five (100%) studies retained provided psychological care in addition to the physical care for 
PLWHA. The main forms of psychological care provided include counselling delivered through 
motivational interviewing, relationship building, and yoga, meditation and Reiki (as described 
above) [320, 374-377]. 
 
(iii) Social wellbeing 
Four (80%) of the studies retained provided social care in addition to physical and psychological 
care to PLWHA [374, 376, 380]. Social care provided included support for developing meaningful 
relationships to reduce stigma, discrimination, social isolation and burden of disclosure; support 
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with legal issues, transportation, housing, the burden of caregiver and breadwinner roles as well 
as childcare issues.  
 
(iv) Spiritual wellbeing 
Two (40%) of the five studies retained included spiritual assessment [320] and provided spiritual 
support [320, 374] for PLWHA in addition to physical, psychological and social care. This spiritual 
care included supporting PLWHA to identify a reason to feel at peace, and to renew relationships 
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4.1.4 Using the Donabedian framework of healthcare quality 
This review used the Donabedian framework structure, process and outcome components [381], 
to assess the quality of care delivered in the retained studies.   
 
4.1.4.1 Care structure 
Structure represented the physical setting where care was delivered including HCP who delivered 
the care. Three studies utilised outpatient services within primary and community clinics [320, 
376, 377], and the remaining two studies delivered services in a home-based and residential 
facility (where PLWHA lived permanently) [374, 375]. Services provided for PLWHA within these 
care structures were delivered or led by trained HCP.  
 
4.1.4.2 Care process 
Process comprised the approaches used to deliver care, which was dependent on the care 
structures or mechanism and resources required to deliver care, bringing about result that 
impacted on patient outcomes. Care processes described by all studies included consultations, 
yoga, meditation and Reiki practice for medical treatment, adherence, selfcare, nutrition, fatigue, 
muscle aches, weakness, pain other symptoms assessment and management, (physical); 
counselling delivered through motivational interviewing, relationship building, and yoga, 
meditation and Reiki practice for depression, perceived stress and psychological distress 
(psychological) [320, 321, 375-377]. 
Those who provided social care also utilised client-centred communication and Reiki practice to 
develop meaningful relationships and provision of material support  to mitigate against stigma and 
discrimination, social isolation, burden of disclosure, legal issues, transportation, housing, the 
burden of caregiving and breadwinner roles [320, 321, 375]. Moreover, those who provided 
spiritual care supported PLWHA through meditation and Reiki practice to identify a reason to feel 
at peace, and to renew relationships with faith or other supernatural being considered important 
to them [320, 321]. 
Authors also described linkage to care specialist (LTC-S): a licenced clinical social worker with 
experience in crisis counselling, developed a novel client-centred approach to linkage to care. 
The LTC-S draw on motivational interviews and strength-based case management techniques in 
addressing negative emotions (fear and stigma) surrounding new HIV diagnosis by seeking to 
redirect these natural reactions into productive health-seeking behaviours. LTC-S are flexible and 
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available through frequent meetings, phone calls text messages and/or email as individual needs 
dictates [376]. 
HCP were also trained to use a standardised multidimensional assessment and care planning 
instrument developed from existing assessment schedules from palliative care (PC) services 
across Africa and systematically assessed and addressed physical, psychological, social, and 
spiritual wellbeing, and PLWHAs’ understanding of their illness and adherence to ART. Care plans 
were included to plan and review care against prioritised needs. The HCP had a weekly clinical 
support with their clinical PC mentor to review complex cases [320]. Additionally, practical holistic 
self-care tools including Yoga, JourneyDance, Meditation (a state of heightened mental 
awareness and inner peace), Reiki Healing Circles (a Japanese practice for relaxation) and 
Reflective Journaling (a guided questioning and restructuring strategies) were utilised in 
managing symptoms and concerns of PLWHA  in the domains of psychological, physical, social 
and spiritual wellbeing [321]. 
A palliative care approach was also used to identify and manage physical and psychosocial 
symptoms including numbness/ tingling of feet and toes; muscle aches; weakness; numbness 
and tingling of legs; fatigue; painful joints; thirst; depression; shortness of breath with activity; and 
difficulty concentrating [375]. Furthermore, HCP promoted patient activation including expanded 
clinic hours, same day appointments, patient electronic health record portals to collaboratively 
develop and implement care plans [377]. 
 
4.1.4.3 Outcomes  
Various outcomes were described including linkage to care, adherence, retention in care, viral 
suppression, and improvement in physical, psychological, social and spiritual wellbeing. Of these 
outcomes only one study used validated measures to measure care outcomes [320]. The most 
common outcomes assessed in these studies were adherence, retention in care, viral 
suppression, linkage to care and improvement in physical and psychological wellbeing [320, 321, 
375-377]. The least outcomes assessed were social [320, 321, 375] and spiritual wellbeing [320, 
321]. 
The client-centred linkage intervention process used was effective in linking n=111 (94%) newly 
diagnosed PLWHA to care within an average of 25.5 days and retained 91.9% of the sample 
linked. Linkage to care was described as a face-to-face visit with an HIV medical provider within 
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3 months of diagnosis; and retention in care described as two HIV medical visits at least 3 months 
apart within a 12-month period [376]. 
The HCP trained to use standardised multidimensional assessment and care planning [320], 
resulted in multidimensional outcomes measured with validated tools as follows: pain measured 
with APCA POS comparing a PCC intervention to standard care found no significant effect on 
pain (coefficient -0.01, 95% CI -0.36 to 0.34, p=0.95); physical health measured with MOS-HIV 
had no significant effect on physical health (coefficient 0.44, 95% CI 0.02 to 0.91, p=0.06) but was 
effective on mental health (coefficient 0.61, 95% CI 0.13 to 1.10, p=0.01). Furthermore, 
psychological morbidity measured with GHQ-12 was effective (coefficient -0.50, 95% CI -0.97 to 
-0.03, p=0.04). Also, concerns such as APCA POS worry (coefficient -0.37, 95% CI -0.09 to 0.83, 
p=0.11); ability to share feelings (coefficient 0.93, 95% CI 0.28 to 1.57, p=0.005); feeling life 
worthwhile (coefficient 0.23 95% CI -0.48 to 0.94, p=0.52); feeling at peace (coefficient 0.37 95% 
CI -0.18 to 0.93, p=0.19); help and advice for family to plan for the future (coefficient 0.78 95% CI 
0.28 to 1.28, p=0.002) were all significantly effective on the wellbeing of PLWHA [320].  
 
The use of practical holistic self-care tools including Yoga, JourneyDance, Meditation, Reiki 
Healing Circles and Reflective Journaling was reported to be effective in improving mood, 
perceived stress, quality of life in addition to promoting physical, emotional, mental, and spiritual 
healing in PLWHA, although these outcomes were not measured with validated tools [321].  Also, 
the palliative care approach used reported improvement in physical, psychological and social 
wellbeing [375]. Finally, patient activation process used especially attributes on open 
communication was effective in improving stigma and clinic utilisation, as PLWHA were able to 




This review highlights the lack of research evidence in terms of PCC components (physical, 
psychological, social and spiritual wellbeing) delivered alongside HIV clinical management in 
community settings. Findings also indicate that PCC interventions that focus on training HCP to 
holistically assess and manage clinical symptoms and concerns of PLWHA as part of the care 
delivery process, can improve outcomes including wellbeing and quality of life for PLWHA. 
Consequently, future plans for PCC intervention development should focus on training HCP to 
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identify and manage multidimensional needs of PLWHA, as well as explore context specific PCC 
components for PLWHA to inform future PCC interventions and policy recommendations that can 






Chapter 5 Results 2. Phases 2 (thesis objectives 2, 3 and 4) 
5.1 Phase 2. Thesis objectives 2, 3 and 4: Qualitative interview 
This section reports findings from the development phase qualitative interview study addressing 
thesis objectives two, three and four. 
Thesis objective 2. To explore the views of PLWHA and healthcare professionals (HCP) about 
current HIV/AIDS care, its accessibility, and to determine which person-centred outcomes matter 
to PLWHA.  
Thesis objective 3. To map the qualitative data from objective (2) onto the components of 
person-centred care theory to determine which components align with the theory and what 
additional components are required.  
Thesis objective 4. To integrate findings from objectives 1-3, modelling the potential processes, 
outcomes, and mechanisms of action for the intervention.  
Figure 16 indicates the phase of the MRC guidance that this section addressed. 
 
 
Figure 16: Qualitative intervention development stage of the MRC guidance 
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5.2 Thesis objective 2 
To explore the views of PLWHA and healthcare professionals (HCP) about current standard 




What are the views of PLWHA and HCP on current HIV care, its accessibility, and what person-
centred outcomes matter to PLWHA? 
 
5.2.1 Details of participants recruited for interviews 
Fifty potential participants were approached across PLWHA and HCP participants of which n=11 
declined to be interviewed resulting in a recruitment rate of 78% (with eligible PLWHA and HCP 
each achieving a recruitment rate of 69% and 100% respectively) See Table 15 for participant 
recruitment details. 
 

























Number of potential participants 








Main reasons for declining participation 
 
Ø Lack of time 





















Of the n=39 participants consented to be interviewed, n=24 were PLWHA and n=15 were HCP. 
All eligible HCP approached agreed to take part in the interviews and comprised doctors, nurses, 
pharmacists, counsellors, social worker, human resource managers, laboratory technicians and 
healthcare assistants (see Table 16 for participant characteristics). 
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Of the PLWHA sample interviewed, 50% were female and median age was 42.5 years (range 20 
to 65). Median interview duration was 50 minutes (range 45 to 73 minutes). Likewise, the HCP 
sample interviewed had 53% female participants and a median age of 34 years (range 24 to 56). 
Median HCP interview duration was 45 minutes (range 40 to 67 minutes). 
 
Table 16: Summary of participant characteristics n=39 





Men who have sex with men 
Heterosexual 









Median (range)  
Clinical: 
Median years since diagnosis   


















5.5 (6months -18 years) 
16 (67%) 
 
HCP (n=15)  
Median Age  
Profession: 
Doctor 




























5.2.2 Achievement of purposive sampling frame for PLWHA 
The a priori purposive sampling frame used to guide the recruitment of PLWHA included gender, 
sexual orientation, ART status, years of HIV diagnosis, CD4 count, viral load, comorbidities, living 
situation and employment status. Of the n=24 PLWHA participants who took part in the interview, 
there were n=12 male and female. There was no transgender or any other gender identification. 
For sexual orientation, a sample of n=16 heterosexual people, and eight people from sexual 
minority groups (n=7 men who has sex with men (MSM) and n=1 woman who have sex with 
women (WSW)) were recruited. The researcher also recruited n=21 participants who were active 
on ART and n=3 who had defaulted, with years of HIV diagnosis ranging from 6 months to 18 
years. Moreover, n=15 and n=10 participants’ viral load and CD4 count records respectively could 
not be found (either these participants did not have money to enable them to have these tests 
done or the test results were not available at the time of the study). Furthermore, n=16 participants 
had comorbidities (with n=2 participants having two comorbidities), n=18 and n=22 lived alone 
and were in employment (which includes petty trading, receptionist and construction) respectively. 
Table 17 is a summary record of how the a priori sampling criteria was met.  
Worthy of note is that 29% for this sample were MSM, highlighting the successful recruitment of 
this category of participants. In Ghana same sex relationships have not been legalised and those 
in same sex relationships face significant risks if they disclose their sexual orientation. 
 




Sampling criteria met Criteria not 
met 
Gender Male n=12 Female 
n=12 
Transgender n=0 Partially met 
Sexual 
orientation 
WSW n=1 MSM n=7 Bisexual n=0 Heterosexual n=16 Partially met 
ART status Active n=21 Defaulter n=3 Fully met 
Years of 
diagnosis 
6months to 18 years  Fully met 
CD4 count 
(cells/mm3) 
1 to 1,500 cells/mm3 Partially met 
Viral load 
(copies/mL) 
10,000 copies/mL to undetectable Partially met 
Comorbidities N=16 Partially met 
Living 
situation 
Lives alone n=18 With others n=8 Fully met 
In 
employment 
Yes n=22 No n=2 Fully met 
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The above purposive sampling frame were not fully met as the researcher was not able to recruit 
any transgender or bisexual participants. Furthermore, it was not feasible to use CD4 and viral 
load as a sampling criterion as not all patients could afford to have these tests done, which is an 
important cultural/ Africa specific challenge of using these biomedical markers in sampling. See 
Table 18 and 19 for the details of sampling criteria recruited for PLWHA and details of HCP 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 19: Details of HCP participant sampled n=15 
ID Age Gender Role in clinic Years of 
working in this 
clinic 
SQID1 32 Male Social worker 2 
SQID2 38 Female Nurse 6 
SQID3 32 Female Nurse 8 
SQID4 46 Female Doctor 14 
SQID5 34 Male Nurse 6 
SQID6 56 Male Counsellor 2 
SQID7 37 Female Human resource manager 0.5 
SQID8 24 Female Nurse 0.5 
SQID9 32 Male Laboratory technician 8 
SQID10 33 Male Counsellor 5 
SQID11 25 Male Healthcare assistant 0.8 
SQID12 35 Female Doctor 0.5 
SQID13 32 Female Nurse 2.5 
SQID14 40 Male Pharmacist 1 
SQID15 42 Female Pharmacist 2 
 
 
5.2.3 The interview processes  
This section presents how the researcher transitioned from clinical to research interviewing and 
using gentle probing to elicit sensitive information from participants. 
 
5.2.3.1 Transition from clinical (nurse) to research interviewing 
During the early interviews, the researcher had challenges of accepting the new “research” role 
as distinct from the “nurse” role. Particularly she struggled with putting aside the nurse role and 
the desire to counsel or offer help to participants. Having identified this challenge at onset of the 
interviews, the researcher critically reflected on her degree of comfort and preparedness to 
conduct the interviews. The searcher also discussed this challenge with her supervisors KB and 
RH, who helped the researcher to identify aspects of the interview that was challenging as well 
as acknowledging that while the researcher have clinical skills or experience that was related to 
the subject of enquiry, those experiences and skill could not be applied in the research interview 
in the same way that the insight sought would be used clinically. 
This reality reflected the researchers’ underlying shift from being someone whose expertise was 
being sought (nurse), to someone who was an inquirer (the researcher) seeking out the 
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experience of PLWHA in order to better understand their symptoms and concerns. After this 
period of reflection and discussion with supervisors, the researcher applied lessons learnt from 
qualitative interview training sessions completed and the Research Methods and Statistics 
module attended. Consequently, the researcher adopted a different approach for subsequent 
interviews and throughout the whole study and data collection. This included refraining from 
counselling participants during interviews and where appropriate offered advice or counselling for 
any issues that were raised that made participants upset when the interview was over. Doing this 
for each interview gradually transitioned the researcher (nurse) into the actual role of being a 
qualitative researcher. This was done in order not to influence the information gathered during 
interview process. Achieving this balance was crucial in identifying the real care needs of PLWHA 
in order to develop appropriate interventions that would best address their needs rather than just 
offering support during the process of the interviews.  
Although the interview process was emotionally draining and it took hard work to complete, the 
researcher experienced personal satisfaction from the sustained contact over time with these 
participants. The researcher felt a genuine pleasure in learning more about HIV/AIDS and the 
care experiences of PLWHA and felt privileged that participants felt able to open up about 
intensely personal issues. 
 
5.2.3.2 Probing during interviews and participants’ joy of being part of the interview  
There were times when participants were reluctant to disclose their marital relationships and 
sexual orientation and their impact on their wellbeing, however on gentle and careful probing 
(Could you tell me a little more about that?, Could you give me an example of that?, When you 
say that, what gave you that impression, What exactly was it that you liked?, How did you respond 
when?, What did you feel when?, Why do you think this is important?, What effect did that have 
on you?, Did that help in any way? What makes you say that?, What was it about this that made 
you feel/ do/ decide to etc, How was that helpful/ unhelpful/ difficult?, Could you explain what you 
mean by...?, Before you said …. But you also say …. [highlighting contradiction], and What are 
the main feelings you’re left with?) participants opened up and reveal their issues and concerns. 
Participants seemed motivated to take part in the interviews largely because they are rarely asked 
about their care and involvement in planning this care. A number of participants expressed their 
happiness of being part of the interviews and the fact that they have been considered worthy to 




5.2.4 Thematic framework 
Three main themes emerged from the qualitative data: 
Theme 1 - Care structures are not currently built around the person;  
Theme 2 - Priority outcomes and components of PCC; and  
Theme 3 - Re-engineering HIV care to be more person-centred. 
 
Views of PLWHA and HCP are presented alongside each other for themes 1 and 2, allowing a 
demonstration of themes within and across participant groups. For theme 3, data were presented 
from HCP only because theme 3 was captured in HCP topic guide only and not in PLWHA one. 
This was necessary as the researcher wanted to understand from the perspectives of HCP (since 
they deliver care to PLWHA) issues/ challenges in relation to person-centred care delivery in the 
context of HIV management. The themes and subthemes are described in turn below, and 
illustrative quotes with unique identifiers (participant group with their respective ages and 
genders) provided to support the themes. 
 
5.2.4.1 Theme 1 Care structures are not currently built around the person 
Participants discussed multifaceted factors including discrimination, stigma, and care structures 
and processes that hinder access to HIV care services. 
 
5.2.4.1.1 Discrimination and stigma 
HIV related stigma and discrimination remain a major barrier to PLWHA accessing care services. 
Discrimination and homophobic behaviours from HCP prevented PLWHA from accessing 
services at both private and public health facilities:  
 
“Due to mistreatment from health workers some of us stopped attending such clinics 
until we find a place where we are treated as human beings. Another issue is when you 
attend the clinic and you are a man with the complains of diarrhoea, even without 
asking you what or how did the diarrhoea started, staff just assumed that you are gay 
they will just leave you there without any medical assistance, is as if they wish you die 
at that moment with your symptoms. This is very demoralising you know most 
importantly when you soil yourself with the diarrhoea, no health worker is even willing 
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to change your soiled clothes or linen, this really gives you a low spirit and also you 
begin to have self-stigma.” (QID9 PLWHA, male, age 25). 
 
Participants also described perceptions and experiences of stigma related to an HIV diagnosis. 
Stigma emerged as self-stigma, as well as perpetrated by family and community. Expectations 
and experiences of stigma were a major barrier to accessing care services: 
 
“Stigma is also another major barrier that prevent PLWHA from being free in 
themselves and to utilise the services available for them. Sometimes when you are 
being nice to the clients, they don’t understand why you should be nice to them because 
they have always been stigmatised even at health facilities” (SQID4 HCP, female, age 
46). 
 
5.2.4.1.2 Fear of status disclosure 
Fear of recognition as someone living with HIV also acted as a barrier to accessing care. For 
example, signposts placed in front of clinics describing services provided at the clinic (including 
HIV and related services) was identified as a barrier for PLWHA to accessing the clinic: 
 
“I think a good care should be delivered in the community where it is near to the 
community members to access however, there should not be any signpost indicating 
that the clinic cares for HIV/AIDS clients, otherwise people will start to know our status 
and we may have to abandon those community clinics for other ones that are not closer 
to us” (QID13 PLWHA, male, age 26). 
 
These barriers were also recognised by HCP who emphasised effects of these signposts in front 
of the clinic:  
 
 “We had enough signpost around the community however, some members of the 
community realising what we do, begun to label any client that comes to the clinic, 
some even went to the extent of discriminating against some of our staff because they 




5.2.4.1.3 Dual burden of disclosure of HIV status and sexual orientation 
For MSM, the dual burden of disclosure of HIV and sexuality were a major concern since same 
sex relationships have not been legalised in Ghana. Participants felt they could not disclose their 
sexual orientation to family, friends or work colleagues for fear of homophobic reactions from 
these people. Unable to disclose to their families, some MSM described challenges when family 
members found out about their HIV or relationship status themselves, causing high levels of 
distress: 
 
“My family has not accepted me with my HIV status, my dad doesn’t talk to me, he only 
talks to me when he thinks I should conform to his rules then he will address me with 
my status; my house is like mummy and daddy makes the rules and you are only to 
conform but I am very stubborn, so I don’t usually obey what mum and dad says so it 
looks like I am the odd one out. My mum keeps reminding me of how she is at risk of 
getting HIV from me, dad also tries to say things that will make me feel guilty like he 
will say things like I am a disappointment to the family and telling me to give birth 
because he thinks am going to die soon” (QID4 PLWHA, male, age 20). 
 
5.2.4.1.4 Poverty, community care and waiting times 
Furthermore, many participants described poverty as their biggest barrier to accessing 
appropriate care. Although ART is dispensed free of charge, PLWHA have financial difficulties 
that prevented them from attending and accessing services or adhering to treatments, such as 
the cost of transport to and from the clinic: 
 
“The main discussion has been around finances because even though the ART is free, 
there are other supplementary drugs or lab investigations that clients need to do. 
Generally, clients think that because the HIV/AIDS treatment is free, everything else 
that comes with it should be free; others may also come, pay for all their treatment and 
when it is time to go home, they tell you they don’t have money for transport. So the 
clinic has to find a way to pay for their transport or if these clients live close by, then 




For some, this was compounded by the decision to travel long distances in order to access care 
far from home to avoid being identified by people in their own community: 
 
“The main thing that will prevent me from attending my appointments will be when I 
don’t have money to take car to the clinic because I don’t have a straight car from my 
house to the clinic, I had to chatter a taxi that will bring me closer to the town before I 
take a commercial vehicle from town to the clinic. And I don’t want people to see me 
going to the clinic and be asking questions” (QID8 PLWHA, female, age 43). 
 
The importance of care services being located in the community and flexible to the needs of 
PLWHA was however recognised. Most participants described wanting their care to be available 
in community and with walk in services to enable easy access to care when needed and when it 
is possible for them to attend: 
 
“I think that the care in the community is good because it is less formal and you don’t 
need an appointment to go to the clinic” (QID1 PLWHA, female, age 52). 
 
However, extended periods of waiting in the clinic, where their status may be disclosed was an 
additional barrier to accessing care for PLWHA: 
 
“I expect that the moment I arrive in the clinic, they will just see me, give my medications 
then I go because we MSM we know ourselves and I am a bit popular too so when I 
am delayed in the clinic, other MSM will come to the clinic and identify me the same 
way I will identify them, and they will go and talk about the fact that they saw me in the 
clinic and the rest of us will like to know why I was at the clinic” (QID20 PLWHA, male, 
age 27). 
 
5.2.4.1.5 Care communication and continuity of care 
HCP described the importance of careful communication to retain PLWHA in care and ensure 
adherence to their ART. Due to the stigma associated with HIV and ART, HCP identified creative 
and innovative approaches of discussing and reminding PLWHA about medication including the 




“So now the concern is what can we do to keep our clients in care? And because clients 
take their pill every day when you go back to talk to them that please take your pills, 
they feel derailed, they want to see other innovations that are interesting to them like, 
pill boxes, colourful text messages. I noticed that most of my clients don’t want to hear 
you asked them have you taken your drugs, so I have started using things like pebbles, 
so like have you taken your pebbles, just things that will not remind them of what they 
are taking. Most of them are getting used to it that I get messages from them like ‘my 
pebbles have finished can I come and get some more?” (SQID10 HCP, male, age 33). 
 
Communication between PLWHA and HCP was further described in relation to topics of 
discussion. PLWHA described interactions with HCP being mainly focused on their HIV and ART, 
not broader psychosocial domains:  
 
“Staff usually speak to me about my ART and how to take my medication regularly so 
that my viral load will go down. But they don’t ask me about my home and my life 
outside HIV” (QID2 PLWHA, female, age 43). 
 
They also described frustration due to lack of continuity of care, with staff changes undermining 
relationship building and discouraging disclosure of concerns: 
 
 “It’s also important to me that the same staff is maintained at the clinic because I hardly 
open up to people about my issues and concerns. The last time I came I met a doctor 
who was nice to me so I started sharing my issues and concerns with her but today 
when I came to the clinic, the doctor that saw me is a new doctor as a result, I couldn’t 
discuss my issues and concerns with her because she is new to me and I have to try 
and develop a relationship with this doctor before I can open up to this doctor about my 
issues which will really take a while to happen” (QID9 PLWHA, male, age 25). 
 
5.2.4.2 Theme 2 Priority outcomes and components of PCC 
When asked what mattered most to them, PLWHA described outcomes across broad domains of 
need including symptoms, living a “normal life”, marriage, having children and being employed. 
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This strongly contrasts those outcomes identified by HCP, which focused on biomedical outcomes 
such as achieving high CD4 counts and lower viral loads; and adherence to treatment with normal 
kidney and liver function tests. 
 
5.2.4.2.1 Physical, psychological, social and spiritual wellbeing 
PLWHA described the need for support for symptoms and concerns in four domains: physical, 
psychological, social and spiritual.  
Participants described a range of physical symptoms that affect their activities of daily living, 
wellbeing and quality of life: 
 
“I have headaches, pain, fatigue and weakness in my body which sometimes prevent 
me from going to work. The pain can be unbearable to the extent that I am not able to 
get out of my room.” (QID17 PLWHA, female, age 42). 
 
Living with HIV also impacted significantly on the psychological wellbeing of PLWHA.  In particular 
they described worries for their future, fears regarding disclosure of their HIV status, and, regrets 
and anger regarding contracting HIV, and how it has affected their life to date: 
 
“I worry most of the time about how I got HIV, I feel if it hadn’t been for this HIV, I would 
have achieved greater heights in life. I feel that being HIV positive has really drawn me 
back in life, this makes me sad and am filled with regrets.” (QID2 PLWHA, female, age 
43). 
 
This psychological morbidity was compounded by the social, economic and physical environment 
for PLWHA. They particularly expressed concerns about lack of family support, unemployment, 
and lack of money to support them self and their family: 
 
“My husband does not treat me well since he got to know my HIV status. He won’t look 
after the children and he will insult me sometimes in front of the children making me 
feel that I am not a human being. I don’t have any money because when I got HIV and 
news of it went round, it made people stopped buying from me which has rendered me 
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jobless because people feel they will get HIV if they buy from me or even talk with me.” 
(QID10 PLWHA, female, age 35). 
 
The overwhelming impact of HIV across physical, psychological and social domains resulted in 
PLWHA questioning the meaning of their existence. They described spiritual distress, feeling the 
need to be at peace with God, and the importance of spiritual support to engender hope and bring 
meaning to their lives: 
 
“May be God is even the one who punished me with the HIV because when I had a 
girlfriend I was not diagnosed of HIV until I started dating a man. I don’t really 
understand my life anymore, I am always praying for God’s forgiveness.” (QID13 
PLWHA, male, age 26). 
 
5.2.4.2.2 Family and intimate relationship 
Concerns for PLWHA also extended to intimate relationships. They described a need for person-
centred care that also addressed these relational needs, in particular information about starting 
sexual relationships with an HIV negative person and having children: 
 
“What I want to ask staff, is about me and my wife, we want to have another child but 
we are not sure if we can have a child whiles on treatment or if it is even possible to 
have children at all because we have been advised to have protected sex so we are 
not sure if we can have unprotected sex let alone have a baby. I have been thinking 
about this for a while now but have not had the courage to ask the doctor or any other 
staff” (QID15 PLWHA, female, age 41). 
 
PLWHA also expressed uncertainties around fertility and their ability to have children while living 
with HIV, particularly in the cases where one partner is HIV negative.  They described a lack of 
information on these resulting in them questioning the future of their relationships: 
 
“I just wanted to have unprotected sex with this other woman so that perhaps she might 
get pregnant for me, then I can have a child of my own because after my wife had the 
still birth I wasn’t sure if she will be able to carry another pregnancy for me so that is 
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why I decided to date this other woman to see if I stand the chance of having another 
child even if it is outside my marriage who cares” (QID7 PLWHA, male, age 43). 
 
5.2.4.2.3 Involvement in care and personalised care 
In addition to the inadequate information, PLWHA also felt they were not actively involved in 
making decisions about their own care, as involvement in care was rare and they felt unable to 
have a say:  
 
“I am not involved in my care and staff don’t ask me my opinion about my care. I am 
not sure if I have a role to play in my care if I do, then staff have not told me about the 
role I need to play in my care. Staff don’t ask me what matters to me and I don’t think I 
have a say in my care.”  (QID5 PLWHA, female, age 36). 
 
PLWHA described a need for care that addresses what is important to them, involving them 
meaningfully in care decisions, and delivered by professionals who are interested in them as a 
person and not only their HIV: 
 
“Staff should have other conversations with us regarding other aspects of our life apart 
from HIV. Staff should also ask us about what is most important to us so that we can 
tell them about it. Staff should not assume they know all things, they should also treat 
us like human beings because our HIV status is not written in our faces to scare them 
of, we are human beings just like staff” (QID21 PLWHA, male, age 61). 
 
5.2.4.2.4 What is person-centred care? 
Some HCP did recognise the construct of PCC, describing the importance of considering the 
psychosocial and spiritual needs of the individual in order to see beyond the HIV diagnosis to the 
whole person: 
 
“Like dealing with PLWHA is very different because when you are caring for PLWHA 
you are psychosocially and spiritually involved with their issues that are related or 
intertwine, so you see that you are sitting there trying to help someone’s child enrol in 
school, or you are talking to somebody’s husband who is discriminating against her. So 
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you are involved in so many levels, and that is what is interesting about HIV care, 
because strictly PLWHA mainly come here for their counselling and medication refill 
but what we need to have at the back of our mind is we are not focusing on just HIV, 
we are dealing with a whole human being” (SQID4 HCP, female, age 46). 
 
However, HCPs described PCC differently, as ‘tailored care’ and ‘targeted care’: 
 
“When we talk about person-centred care it should be having tailored care or targeted 
care because people are different. For me person-centred care is having differentiated 
models that will suit their needs. So we call it targeted care because a married man 
walking to the clinic who is HIV positive will have different needs to a young man who 
is HIV positive, and it will also be different with MSM who walk into the clinic.” (SQID5 
HCP, male, age 34). 
 
Although this care is targeted toward the individual, decisions around what that care should 
include, and care needs are led by the HCP’s view of what is important not by the expressed 
priorities of PLWHA. 
 
5.2.4.3 Theme 3 Re-engineering HIV care to be more person-centred 
5.2.4.3.1 Achieving person-centred care 
HCP identified a need for training to understand what PCC means and how it could benefit 
PLWHA: 
 
“Yes, it is possible to practice person-centred care but only when we are trained to 
understand what it means to be person-centred and what benefit it will be to PLWHA. 
Because what I observe is that one doctor mostly consults on Saturdays due to her 
busy schedules on weekdays; but because of her approach to caring, most of the 
PLWHA prefer to come for the Saturday clinic” (SQID1 HCP, male age 32). 
 
Alongside training for professionals, HCPs identified the need for support in coordinating and 
integrating adjunct services to address the holistic care needs of PLWHA, and more evidence 
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from research undertaken in Ghana, that reflects the local needs and culture to inform service 
design and delivery: 
 
“I think the only thing we need to do is what we call integration of services and resource 
ourselves to do more capacity building and training for health workers to understand 
what person-centred care means so that they are fit to handle some of problems and 
concerns of PLWHA. Another thing too is that we need to do a lot of research because 
for us in Ghana we need research to tell us what influences what we do and because 
we don’t have the research most of the time we do things the old way” (SQID10 HCP, 
age 33). 
 
HCP also outlined challenges related to resources required to deliver PCC, including financial, 
human and time resources: 
 
“I think we need both financial and human resources because before you can have a 
discussion with a client with psychological issues to come out smiling you need more 
than 30minutes with that client. And as you are having such conversation with clients 
you will realised that there are financial issues that you may need to help the client with, 
like paying their transportation etc. I find it difficult to ask my client ‘what is really 
bothering you?’ And I am not happy that when clients share such problems, I am not 
able to help them so I will rather not ask” (SQID12 HCP, male, age 35). 
 
They also identified challenges specifically in relation to providing care for key populations.  One 
solution proposed was to train selected staff in providing care to these highly stigmatised 
communities, and to support their specific needs: 
 
“Or we can also identify and train staff to be able to handle such things, because we 
have at least 5 nurses we can identify at least 2 nurses who can be trained to support 
our clients especially MSM with these psychological issues, then we know we have 
such team in place. We should also focus our conversation on the client like trying to 
find out what is happening in the person’s life before touching on HIV related issues at 




5.2.4.4 What constitutes person-centred care for PLWHA and HCP 
This data provides novel insight into what constitutes PCC for PLWHA beyond the original 
western-oriented concept. The four sub-themes ‘physical, psychological, social and spiritual 
wellbeing’, ‘family and intimate relationships’, ‘involvement in care and personalised care’ and                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
‘what is person-centred care?’, which emerged from the main theme “priority outcomes and 
components of person-centred care”, relates to the component of PCC envisaged by both                                                                                             
PLWHA and HCP in Ghana.   
PLWHA described a need for care that is focused on addressing their physical, psychological, 
social and spiritual wellbeing, that involves them in care decisions and delivers personalised care 
to them. For HCPs, most expressed a need for human and financial resources and training in 
order to undertake holistic assessment and practice PCC. 
While some views regarding PCC were common across the PLWHA and HCP interviews, others 
were specific to one or other of the participant groups. Both PLWHA and HCP in Ghana described 
PCC as care that should be delivered in the community, free from stigma and discrimination, that 
addresses financial, human and time resource issues. We present a conceptual model of PCC in 
Figure 17, demonstrating the differences and commonalities of views expressed by participants. 
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                   Figure 17: A conceptual m
odel of person-centred care from









5.2.4.5 Views of PLWHA and HCP on person-centred care 
PLWHA and HCP expressed common and differing views on what PCC care is and what 
outcomes matter to them. PLWHA understand PCC as care that involves them in their care 
decisions, which is concerned about the whole person and not only treatment adherence and 
viral suppression and addresses what matters to them. PLWHA also view PCC as addressing 
broader social issues: living a normal life (‘like anyone else’), getting married and having 
children, and being employed. In contrast, HCP described PCC as ‘tailored care’ and ‘targeted 
care’, however, this was focused on their own perspectives as to how they would ‘target’ or 
‘tailor’ care according to an individual’s characteristics, rather than through the expressed 
needs of PLWHA.  This was borne out in HCP data, which identified priority outcomes as 
biomedical (CD4, viral loads). This contrasts starkly with PLWHA data, which described social 
outcomes (living a normal life, getting married and having children). These differing priorities 
resulted in care that was not person-centred, as HCP expressed uncertainty about how PCC 
could be practiced, and a need for training [346]. Participants described perceptions and 
experiences of stigma related to an HIV diagnosis. Stigma emerged as self-stigma, as well as 
perpetrated by family and community. Expectations and experiences of stigma were a major 
barrier to accessing care services however, a recent study demonstrates the potential to 
increase PLWHAs’ resistance to stigma using PCC delivery [382].  
 
In order to implement and achieve PCC in community settings for PLWHA, there is the need 
for: 
Ø Relationship building between stakeholders through effective communication, and 
acknowledgement of patients as experts in their own healthcare through partnerships 
that allow for sensitivity to patient’s values, needs and preferences for care. 
Ø Ongoing education and training for providers on PCC delivery, with a specific focus on 
holistic patient assessment, management of symptoms and concerns, collaborative 
care planning and delivery. 
Ø Increased understanding of patient’s perspective for PCC in order to inform the content 
of HCP training.  
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This data provides, for the first time, an understanding of the meaning of PCC in HIV population 
in Ghana, from the perspectives of key stakeholders. The next section mapped the contextual 
meaning and components of PCC as applied to PLWHA in Ghana onto a PCC theory to 
determine which components aligned with the theory and what extra components are required.
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5.3 Thesis objective 3 findings 
To map the qualitative data from objective 2 onto the components of person-centred care theory 
to determine which components mapped and what additional components are required. 
 
Research question 
What are the components of person-centred care (PCC) as applied to PLWHA in Ghana and how 
do these components map onto the theory of PCC? 
 
5.3.1 Mapping the qualitative data onto the theory of PCC 
The features of PCC identified from the qualitative data were mapped onto a theory of PCC (see 
Figure 18), to better understand the components of PCC as applied to PLWHA in Ghana. The 
mapping of the qualitative data was strengthened by the critical thought of how the context 
influenced the intervention, including the motivation and contribution of PLWHA and HCP and the 
divergent interpretations about how and why the process of change came about [383]. The key 
intervention features indicated that developing a PCC intervention required guidance and 
education/training in symptom control for HCP. Secondly, the person-centred intervention 
focused on addressing the holistic domains of need: physical, psychological, social and spiritual 
symptoms and concerns, alongside medical management of HIV.  
The proposed process and outcome measures selected to measure the care process and 
outcomes were also mapped onto the PCC theory which ensured that these measures measure 





Figure 18: Qualitative data mapped onto components of PCC theory   
 
 
Figure 19: Process and outcome measures mapped onto components of PCC theory 
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5.3.2 Implication for intervention development 
Key considerations for intervention development emerged from the qualitative dataset. PLWHA 
in a community setting in Ghana agreed that they want their care to address broader aspects of 
wellbeing beyond physical needs including psychosocial and spiritual wellbeing. The existing 
approach to delivering HIV care in the community focused primarily on the physical wellbeing of 
PLWHA and did not involve them in decisions about their care. However, HCP described 
concerns that PCC would only be possible if they were trained to deliver it. This implies that 
PLWHA require PCC interventions which are focused on addressing broader psychosocial and 
spiritual wellbeing and involves them in their care decisions to be added to existing HIV clinical 
management in order to meet their person-centred needs. The experiences shared by PLWHA 
provide important understanding of the context in which care is delivered, which can be used to 
tailor a PCC intervention. For example, the description of the psychological, social and spiritual 
symptoms and concerns, which are not currently being assessed and addressed in the current 
care, could be used to inform the intervention content. These domains of need could only be 
identified and addressed when HCP are skilled to undertake holistic assessment of the symptoms 
and concerns of PLWHA, as HCP in this study also emphasised the importance of training to 
acquire skills for holistic assessment and PCC practice. 
Evidence suggest that study findings and recommendations for practice have not always been 
embedded successfully in the delivery of care resulting in variations in practice [34, 384-386]. It 
has been reported that 30 - 40% of care delivered to patients are not properly based on relevant 
guidelines, and, similarly disturbingly, 25% of patients receive improper or potentially harmful 
treatment [387]. The ToC for this study was vital to ensure study evidence could potentially be 
taken up, strengthening the paths to influence and impact.  
 
Barriers to PCC in current HIV care delivered in community settings as highlighted in the 
qualitative data: 
• Limited access to information on treatment options 
• Non-involvement of PLWHA in care and care decisions 
• Care not addressing physical, psychological, social and spiritual wellbeing, 




5.3.3 Framework to inform PCC delivery 
Following this understanding of PCC from the perspectives of PLWHA and HCP, a framework to 
inform PCC delivery was developed informed by the WHO’s framework on integrated people-
centred health services [388], as shown in Figure 20. This framework detailed five key areas 
including clinic relationship building with PLWHA in identifying their general symptoms and 
concerns; skills training for HCP; building HCP-PLWHA relationship to create person-centred 
environments; PLWHA participation by involving and engaging them in their care decisions; 
leading to collaborative decision making between HCP and PLWHA, which could result in 
improving care outcomes and impact on the wellbeing of PLWHA.  
The next section is the theoretical modelling of CECI components with selected outcome 







        
 










ork on integrated people-centred health services 
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5.4 Thesis objective 4 findings (“Modelling process and outcomes”) 
To integrate findings from objectives 1-3, modelling the potential processes, outcomes, and 
mechanisms of action for the intervention. 
 
5.4.1 Main findings from thesis objectives 1, 2 and 3 
Objective 1: PCC models of care delivered alongside HIV clinical management:  
• Although models of person-centred HIV management are effective in improving physical, 
psychological, social and spiritual wellbeing, the evidence is weak. 
• Exploration of contextual meaning and practice of PCC, development of more PCC 
interventions focusing on the specific contextual needs within the domains of physical, 
psychological, social and spiritual wellbeing of PLWHA; measuring these outcomes with 
validated tools; and additional examination of the feasibility and acceptability of such 
interventions were identified as potential future research direction.   
 
Objective 2: A summary of views on current practice by PLWHA and HCP data include:  
• Care is mainly focused on physical wellbeing,  
• PLWHA not involved in their care,  
• PLWHA not asked what matters to them  
• HCP feel unprepared to assess psychological, social & spiritual problems 
• HCP require training in order to assess and manage these domains of problems  
 
Objective 3: Mapping of the qualitative data from thesis objective 2 onto the components of the 
theory of change (PCC): 
• The qualitative that aligned with the components of PCC theory 
• The only overlap was physical wellbeing, as PLWHA described their care was primarily 
focused on physical wellbeing   
• The findings from these interviews and literature [48] strongly suggested that a person-
centred and holistic approach was most likely to address the diverse symptoms and 
concerns experienced by PLWHA.  
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5.4.2 Results from expert intervention development workshop 
Present at the half-day intervention development workshop were the researcher (MA-O) and 
experts including: RH – a health services researcher with range of experiences in outcome 
measurement and tool validation, HIV/AIDS care in sub-Saharan Africa and intervention 
development and testing; JD – an educationalist and palliative care clinician with a PhD that 
evaluated palliative care training in rural Uganda; KB – working on priority outcomes for people 
with HIV/AIDS and communication between health professionals and patients in clinical 
encounters, and how that interaction shapes the experience for patients and their families; KN - 
pain and symptom self-management among HIV/AIDS, designing, testing and evaluating nursing 
interventions; and EN - use of patient reported outcomes measures in African clinical settings, 
knowledge translation, information use and policy development.  
These experts were assembled based on their wealth of experience in working with PLWHA and 
developing interventions in this population across Africa. The experts together with the researcher 
discussed the findings from the systematic review (thesis objective 1) and the qualitative interview 
findings (thesis objective 2) including the theory of PCC and identified the person-centred 
domains from the perspectives of PLWHA and HCP in Ghana. These findings were then mapped 
onto the PCC theory and determined the findings align with the theory and informed the 
components of the proposed intervention. The expert panel determined the need for the 
intervention, examined current practice, used HCP interview data to identify the training needs. 
The panel then recommended that the researcher draw on palliative care skills and existing 
manuals, documents and procedures used in the studies identified in the systematic review to 
develop the PCC training content for HCPs. The panel finalised the content of the training with a 
schedule for delivery, and person-centred domains with some specific symptoms and concerns 
described by participants with corresponding selected outcome measures to measure these 
domains in the feasibility cRCT. 
 
This novel person-centred intervention developed addressed: 
Ø The training needs of HCP on the use of a person-centred approach, holistic assessment 
of symptoms and concerns, collaborative care planning and delivery  
Ø PLWHA involvement in care and care decisions  




A logic model (Figure 21) of the proposed intervention was developed demonstrating detailed 
components relating to context, training, implementation, mechanism of action and outcomes of 
the CECI intervention. This person-centred approach is reflected in the broad content of the 
intervention and its steps of delivery, including the training of HCP. PLWHA support the 
intervention components targeting broader domain of needs including physical, psychological, 
social and spiritual wellbeing in addition to involvement in their care decisions. 
 
5.4.2.1 Purpose of the intervention 
The overarching purpose of this person-centred intervention is to optimise HCP’s skills in the 
holistic assessment and management of symptoms and concerns of PLWHA using a person-
centred approach. This was achieved through the development of a training content and a 
schedule that was used to train HCP on how to deliver care using a person-centred approach. 
The person-centred approach brought together PLWHA’s priorities for care through person-
centred holistic assessment using a holistic assessment tool. The findings from the holistic 
assessment led to collaborative care planning between HCP and PLWHA in achieving care goals 
that mattered to PLWHA most.  
The name ‘community-based enhanced care intervention’ (CECI) was chosen for the intervention 
to emphasise its community focus of delivery and an enhancement of standard HIV care.  
 
5.4.2.2 Intervention description 
CECI consisted of three-session training programme for HCP, holistic assessment tool which 
assessed physical, psychological, social and spiritual symptoms and concerns, a care plan which 
facilitated collaborative care planning and delivery, and a twice weekly mentorship and fidelity 
monitoring. Participants in the CECI arm received care delivered by their HCP who received the 
three-sessions training programme. CECI participants received a minimum of three appointments 
with HCP after the four-month course of CECI delivery. For each appointment, participants had 
their symptoms and concerns assessed in four domains: physical, psychological, social and 
spiritual wellbeing using a holistic assessment tool, then a care plan was used to facilitate 
collaborative care planning between HCP and PLWHA before care was delivered based on the 
care plan. The implementation of the CECI included four levels of activities: (a) HCP training on 
CECI delivery; (b) use of holistic assessment tool to assess symptoms and concerns, (c) a care 
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plan to facilitate collaborative care planning and delivery; and (d) mentorship and support for HCP 
with fidelity monitoring.  
 
5.4.2.3 Mechanism of action/ impact of the intervention 
Mechanisms of impact are the means by which CECI causes change resulting in an outcome. 
The theory of change (PCC) was used to support understanding of what mechanisms can be 
expected to result in desired outcomes and therefore influenced the selection of CECI 
components and its delivery. The theoretical mechanisms targeted by CECI involved physical, 
psychological, social and spiritual responses and approaches described in the logic model in 
Figure 21.  




                 
 















Figure 22: A graphical depiction of CECI with its sequential steps of implementation 
 
5.4.2.4 Intervention training content and schedule 
The intervention training contents consisted of five modules on communication and person-
centred care; physical wellbeing; psychological wellbeing; social wellbeing and spiritual wellbeing 
(see Table 20 for training content and schedule). 
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The outcomes of care delivered were measured using selected outcome measures which have 
been mapped onto the specific symptom and concerns domains described by participants (see 
Table 21). 
 
Table 20: Intervention training content and schedule for HCP 
Days Time Training modules Data source 
Monday 3pm to 4pm Module 1: Communication and Person-centred care 
Communication skills guidance 
Holistic care (assessment of physical, psychological, social and 
spiritual problems and concerns)  
Refreshments 
Qualitative data 
Tuesday 3pm to 4pm Module 2: Physical wellbeing 
Assessment and treatment of pain 
Assessment and treatment other symptoms 





Wednesday 3pm to 4pm Module: 3 Psychological wellbeing 
General counselling and emotional support 
Treatment of psychological problems such as depression and 
anxiety 





Thursday 3pm to 4pm Module 4: Social wellbeing 
Help with managing stigma and discrimination 
Social isolation 





Friday 3pm to 4pm Module 5: Spiritual wellbeing 
Spiritual counselling 
Life review counselling 
Respecting beliefs and practices 
Course Summary/ Overview 

































APCA POS (physical and psychological 
symptoms, spiritual, practical and emotional 
concerns and psychosocial needs)  
 
MOS-HIV (role function, pain, physical 
functioning, cognitive functioning, social 
functioning, general health perception, mental 
health, health distress and vitality) 
 
Positive Outcomes (physical and emotional 
health and wellbeing, home and social life, sex 
















































































Am I being 
punished by 
God? 
What is the 
value of my 
life? 
What will 




Participants also described concerns regarding the process of care delivery, and some of these 
concerns are listed in Table 22, with selected process measures to measure the domains 





Table 22: Process of care delivery described by participants mapped onto selected process measures 
Care process 
domains 
Specific concerns Source of data Selected process measures 







PPE-15 (measures patient 
experience along the domains 
of communication; emotions; 
short-term outcomes; barriers; 
and relations with staff) 
 
CARE Measure (measures the 
amount of empathy that a 
patient feels they have 
received during a consultation) 
Not asked what 
mattered to them 
 
Collaborative care 
planning and delivery 
 











5.4.2.5 CECI structure and flexibility of delivery 
CECI allowed for a high level of flexibility in its delivery. CECI is intended for PLWHA especially 
those receiving care in community settings and the only indication for use was to be diagnosed 
with HIV for at least six months. HCP trained to deliver CECI at the intervention site were given 
copies of CECI content and sequential steps of delivery, which ensured HCP’s confidence to 
deliver CECI according to the processes set out in the steps.  
At the first CECI appointment, HCP informed the patient about the aim and scope of CECI and 
invited questions. This was followed by a person-centred assessment using the holistic 
assessment tool, which guided the care interaction, engaged and elicited participants’ concerns. 
The HCP and participant agreed on priorities and concerns that could be addressed during care 
planning and delivery. Strategies were selected and personalised to address the priorities and 
concerns set out in their care and action plan. The second and third CECI appointments followed 
the same structure. The initial part of the appointment included a review of the participant’s current 
wellbeing, priorities, concerns and action plan from the first appointment. Towards the end of the 
second appointment, HCP began to warn participants that the next appointment will be the last 
CECI appointment. 
Structured documentation for recording CECI delivery supported recording of CECI components 
delivered including process items (time of first appointment and mode of delivery, duration, 
involvement and number of sessions) and outcome items (physical, psychological, social and 
spiritual wellbeing). HCP were supported to reflect on CECI delivery, highlighting non-specific 




5.4.2.6 Holistic assessment and care planning 
The HCPs delivering CECI used a holistic person-centred approach during participant 
assessment to elicit and identify symptoms and concerns. They assessed wellbeing in the 
domains of physical, psychological, social and spiritual aspects of life. The HCP supported the 
participant to express their expectations of care. During the opening conversation, the HCP 
assessed for cues which indicated any immediate and pressing concerns that the participant had, 
these were verbally or non-verbally communicated. If present, the HCP began the assessment 
by exploring these concerns first. If no immediate concerns are reported, the HCP continued and 
supported participants by encouraging them to participate and contribute to their care decisions. 
HCP also explored the daily life roles and activities that are important to participants to identify 
any pressing issues. If symptoms and concerns are not volunteered, the holistic assessment tool 
with specific questions in the domains of physical, psychological, socioeconomical and spiritual 
screening questions were used to holistically assess participants wellbeing. It was assumed that 
the presence of symptom and concern was distressing or that the participant was unable to 
resolve these symptoms themselves. Therefore, HCP asked participants about their own thoughts 
about how symptoms were impacting on their wellbeing, how they perceived the causes, 
consequences and potential solutions. 
 
5.4.2.7 CECI care process implemented with PCC as the ToC 
PCC was the ToC which underpinned the implementation of CECI, see Figure 23 for how the ToC 
influenced the CECI intervention. 
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Chapter 6 Results 3. Phase 3 (thesis objective 5) 
To deliver and test the feasibility of a cluster randomised controlled trial of the intervention in 
terms of recruitment and retention, and to determine intervention delivery, estimate of potential 
effect and suitability of measures. 
 
6.1 Mixed methods feasibility testing of CECI 
Feasibility testing of CECI was conducted as recommended by the MRC guidance [176] to 
determine its feasibility and acceptability. Testing was conducted through a parallel mixed 
methods design with post-trial qualitative exit interviews. This section reports on the results of the 
feasibility and acceptability of CECI including the feasibility of recruitment and retention of 
PLWHA, acceptability of CECI by HCP and PLWHA, and estimate of potential effect size of CECI. 
Results on the primary outcomes was presented followed by the that of the secondary outcomes. 
Figure 24 represents how the feasibility cluster RCT is situated in the overall study plan 
implemented using the MRC guidance. 
 
 





6.1.1 Primary and secondary outcomes 
The primary outcomes for this feasibility cluster RCT were: 
i. Recruitment rate 
ii. Retention rate 
 
Secondary outcomes 
i. Fidelity of the intervention training and delivery 
ii. Intervention delivery and acceptability, 
iii. Estimate of potential effect size 
 
6.1.2 Participating clinics 
Recruitment and baseline data collection started from July 2018 at two HIV community clinics: 
West African AIDS Foundation (WAAF) and the HIV clinic at the Public Health Unit of Legon 
Hospital. These clinics are situated about 6.2km apart in the Greater Accra Region of Ghana. 
WAAF currently provide HIV care services to a cohort of 750 PLWHA with an average of 15 to 40 
PLWHA seen daily, whiles the Legon HIV clinic also provide HIV care to a cohort of 500 PLWHA 
with an average of 10 to 30 PLWHA seen daily.   
 
6.1.3 Screening and recruitment 
For the primary outcome, n=83 PLWHA were screened of which n=69 (83%) were eligible. Nine 
of those eligible declined participation and n=60 (87%) consented and were recruited into the trial 
within 6 weeks of recruitment starting. Recruitment was rapidly rolled out in these clinics with the 
aim of achieving an average recruitment rate of 5 participants per week at each clinic. Recruitment 
at the Legon clinic closed a week ahead of WAAF. An overall recruitment rate of 16.7% per week 
was achieved with 5 accruals per week at each site. See Table 23 and Figure 25 for participant 
screening and recruitment details. Following randomisation by ratio of 1:1 to intervention and 
control, 93%, 98% and 97% completed follow-up outcome measures at month 1, month 2 and 
month 3 respectively. The CONSORT extension for feasibility trials was used to report participants 
















Total recruited  












Week 1 8 - 7 - 5 - 
Week 2 8 7 8 5 7 4 
Week 3 8 13 6 12 6 10 
Week 4 9 8 7 6 6 5 
Week 5 8 7 7 5 6 5 
Week 6 - 7 - 6 - 6 




Figure 25: Accrual by clinic per week 
 
6.1.3.1 HCP involvement in recruitment and achievement of recruitment targets 
HCP in the respective clinics supported with participant recruitment by helping to identify potential 
participants and referring them to the researcher for further assessment. The participant screening logs were 
completed with the details of each participant screened, as HCP who helped in completing the logs reported 
that its completion was practical and feasible. The researcher was present at the clinics throughout the 
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recruitment period, which also motivated HCP interest to be involved in the recruitment process. During the 
recruitment and baseline data collection some participants expressed concerns about their inability to 
complete the outcome measures without the researcher’s support in helping them to understand each 
question/ item on the measures. The researcher took these concerns into consideration and supported most 
participants with the completion of the measures by reading out and explaining the questions to participants 
before they provided their response.  
The recruitment targets for both sites were achieved within 6 weeks (30 participants each) and the reason 
for PLWHA non-participation are described in addition to the researchers’ experience of HCP involvement 
during the recruitment process. Going forward, the findings from this recruitment process will be useful in 
informing the inclusion criteria for a future definitive trial.  
 
6.1.3.2 Reasons for non-participation in the feasibility trial 
A screening log was kept across the two study sites to determine reasons for not approaching eligible 
PLWHA and reasons for refusal to participate in the study for PLWHA who were approached. See the 
CONSORT flow diagram [354] in Figure 26 for details of participant flow through the trial and non-
participation. Nine PLWHA who met the inclusion criteria declined participation as four said they did not have 





Figure 26: CONSORT extension for feasibility trials - flow diagram 
 
6.1.4 Baseline and clinical data collection 
Baseline characteristics of the consenting participants were similar in the intervention and control 
arms as presented in Table 24. There was no significant difference between the intervention and 
control arms with regard to age, gender sexual orientation, or CD4 count. The mean age of 
participants in the intervention was slightly younger compared with the control arm (36.6 vs 38.9) 
and the intervention had more female (18 vs 13) and heterosexual participants (25 vs 19). No 
statistical significance tests or confidence intervals were calculated for the difference between the 
randomised clusters on any baseline variables as this was a feasibility trial and the main outcome 
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of interest is recruitment and retention of participants. In terms of education, 43% of participants 
in the control arm had education up to the diploma level compared to 13.3% in the intervention 
arm. Also, whereas 50% in the intervention arm were educated to the secondary school level, 
those in the control arm was 23.3%. Additionally, in terms of employment, about 50% of 
participants in the control arm worked as the section of the middle class with the lowest social 
status, generally composed of shopkeepers, lower clerical staff, etc compared to 67% in the 
intervention arm; and 30% in the control arm were unemployed compared to 23% in the 
intervention arm. Most participants have partners 63% and 67% in the control and intervention 
arms respectively, with children and financial dependants. Also, with regards to the WHO clinical 
staging of HIV infection, 70% and 80% of participants in the control and intervention arms were 
in stage two respectively.  
 
Table 24: Baseline and clinical characteristics 
 
Characteristics 
Control arm (n=30) Intervention arm (n=30) Total (n=60) 
 





























































































































































































































































































































6.1.5 Secondary outcomes 
This section reports on the secondary outcomes including fidelity of the intervention training and 
delivery; intervention delivery and acceptability; and estimate of potential effect size of the 
intervention and study design.  
 
6.1.6 CECI training for HCP at the intervention site 
A total of 3 training sessions was delivered to HCP in the CECI arm instead of the original 5 
sessions planned. Originally, 5 sessions of one hour each was planned for the training of HCP 
and this was scheduled to cover the content of the training which included: person-centred care, 
communication and the holistic approach on day 1; symptom and concerns assessment, care 
planning and delivery for physical, psychological, social and spiritual wellbeing for day 2, 3, 4 and 
5 respectively. However, this original schedule for the training was changed to 2 hours per session 
for 3 days in order to cater for HCP shift patterns.  
The researcher expected mainly HCP in the category of doctors, nurses, counsellors and social 
workers to be at the training because these categories of HCP provide hands on care to PLWHA 
who mainly see these categories of HCP each time they visited the clinic. For these categories of 
HCP, the researcher expected n=10 to be at the training. On the first day of training n=13 HCP 
attended; then n=11 on day 2 and n=12 on the final day 3 (see Table 25 for HCP details).  HCP 
reported in the training evaluation that there was improvement in their knowledge regarding 









Category of HCP 
expected 
Category of HCP present N (%) Total number 
of HCP present 
Day 1 2-4pm Doctors  
Nurses  
Counsellors  




Social workers  
Healthcare assistants 
Laboratory technician Human 









Day 2 2-4pm Doctors  
Nurses  
Counsellors  




Social workers  
Healthcare assistants 















Social workers  
Healthcare assistants 
Laboratory technician  











6.1.6.1 CECI implementation, adherence/ compliance 
All the HCP who participated in the CECI training were actively involved in the delivery of CECI. 
CECI adherence was achieved; all 30 participants recruited and randomised to the intervention 
arm received CECI with each participant receiving at least two sessions, and no participant 
dropped out during CECI delivery. A total of 3 CECI sessions were completed one session each 
per month. Overall, 30 appointments were offered each month for 3 months, which n=28 (93%) 
attended at month 1 (T1), n=30 (100%) at month 2 (T2) and n=28 (93%) at month 3 (T3) 
respectively (see Table 26 for details).  
Over all 100% of participants attended at least one CECI appointment and 7% did not attend at 
least one of their appointments. At the first and third (final) CECI appointment 97% attended, and 
then 100% of participants attended at the second appointment. The appointments were 
scheduled on a monthly basis and participants who did not attend their scheduled appointments 
had a two-week window to attend after a reminder call was placed to them. However, where a 
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participant failed to attend, it was counted as missing. Therefore n=2 participants each in the first 
and final CECI appointments failed to attend their appointments. At 3-month trial end point, only 
two participants were missing. 
Each intervention session lasted 30 to 61 minutes and the length of each CECI session was 
adaptable to meet the needs of each participant. 
 

















































6.1.6.2 Outcome of the HCP mentorship and supervision meetings 
The mentorship and supervision meetings were held twice weekly after HCP professionals were 
trained, and this continued throughout the trial. At these meetings, the intervention and how it was 
being delivered was discussed including the coping mechanisms of HCP in terms of the new 
interventions. Generally, HCP discussed their (i) adaptation to the intervention and delivery, (ii) 
how they felt about the intervention and their source of motivation to deliver it, (iii) how the 
intervention is changing their practice and (iv) challenges with time taken to assess and manage 
one participant, especially when the clinic was busy and other clients were waiting to be seen. 
The outcomes of these meetings are discussed in turn: 
(i) HCP adjustment to CECI delivery: HCP discussed that the intervention delivery was a bit 
challenging at the start as it was their first time of using the holistic approach, so it took some time 
for them to  get adjusted to the whole process of holistic patient assessment, collaborative care 
planning and delivery of care based on the agreed plan. HCP also noted that PLWHA were initially 
hesitant to contribute to their care decisions as this was a new experience for them as well. The 
researcher discussed with the HCP to use their initial rapport building with the participants to also 
warn them that they were expected to play an active role in their care and constantly encourage 
them to contribute to the process of care delivery. This information was reinforced throughout the 
trial period at each meeting as HCP fed back on these issues. HCP and the researcher also 
discussed their understanding of the person-centred holistic care process, which HCP said the 
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understanding of the process started on a lower level but they praised the weekly meetings as 
the major factor that increased their understanding of the person-centred care delivery process. 
They also discussed that, if the researcher had left them alone after the training to deliver the 
care without the supervision meetings, they would have given up on the comprehensive process 
of assessment, care planning and delivery.  
(ii) Motivation to deliver the intervention: HCP discussed that most of them initially were just 
delivering the intervention out of curiosity to know the difference it will make compared to how 
they used to deliver care because they did not think that the input of PLWHA in their care would 
have made any difference. However, they were motivated to continue delivering the intervention 
as a result of the response they received from PLWHA, their enthusiasm and the joy on their 
faces when they were offered the opportunity to participate in their care. The researcher reiterated 
and discussed with HCP about the importance of making participants feel respected and valued 
members of the care team to build trusting relationships with them. HCP confessed that as the 
participants started trusting them, they became very comfortable with them and discussed issues 
openly.  
(iii) Change in practice with the intervention: The tangible change in participants attitude 
towards the intervention corresponded to HCP changing their approach to care delivery as most 
of them discussed that they continue to engage the participants in the decision-making process 
towards their care. The importance of changing the approach to care delivery was discussed in 
association with the multidimensional problems that PLWHA continue to experience despite the 
presence of ART and the need to address these problems holistically to achieve viral suppression 
and improve their quality of life. HCP confessed that when they compared their previous approach 
to practice, the holistic approach was promising due to the effect it had on PLWHA and the 
fulfilment they (HCP) had in being able to partner with PLWHA during care delivery.  
(iv) Challenges with time taken to deliver the intervention: Among the challenges faced by 
HCP while delivering the intervention included the time taken to assess participants’ symptoms 
and concerns, plan and deliver care, and the amount of paperwork (records) required to be 
completed. These issues were discussed at every meeting in order to find lasting solutions to 
them. The main concern about time has been that HCP got lost in the assessment of participants 
problems that they feared to stop participants even when these issues were repetitive. HCP also 
agreed that they tend to enjoy the conversation with participants resulting in some time loses. 
Both HCP and the researcher agreed that the initial assessment of participants took time because 
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there was a need to capture all the issues that the participant had at the first assessment. 
However, subsequent appointments were to review initial problems assessed as well as assess 
new problems and concerns that occurred after their last visit. HCP confessed that most of the 
time there were no new issues, but they could not stop participants from chatting with them, so 
they end up spending more time. Solutions discussed included prioritising the review of 
participants problems from last visit and any new issues that came up and respectfully told 
participants the researcher was waiting to have more discussion with them. This solution seemed 
to have worked.  
The challenge about the paperwork could not be resolved completely at the time of the trial. 
Therefore, the researcher discussed and encouraged HCP to persevere and report all their issues 
directly to the researcher as these challenges were the reason for the feasibility trial, so that the 
issues reported would be addressed before planning a definitive trial. Overall, HCP discussed 
that they felt satisfied that despite the time constraint they faced while delivering the intervention, 
they were very content to be able to assess and manage PLWHA using available clinic resources.  
 
6.1.7 Follow up 
The CONSORT flow diagram in Figure 26 shows that no participant within each cluster was lost 
to follow-up. The number of participants providing data for each outcome measure at baseline 
and subsequent monthly follow-ups are also presented in Figure 26. Intervention compliance was 
high, only four participants from the intervention arm missed one session and none missed more 
than one. Outcome measure compliance was also high; 11.7% (n = 4 for the intervention arm and 
n = 3 for the control arm) of data were lost for Month 1, 2 and 3 for all outcomes, which was 
predominantly due to participants missing their appointments. All outcome measures were 
completed face to face with each participant. Participants usually saw the researcher after each 
intervention appointment to complete the outcome measures after receiving their respective 




Table 27: Follow up rates 






Whole sample n=60 
n (%) 
Month 1 (T1) 28(93%)  28(93%) 56(93%) 
Month 2 (T2) 30(100%) 29(97%) 59(98%) 
Month 3 (T3) 28(93%) 30(100%) 58(97%) 
 
 
6.1.8 Intervention implementation fidelity and adherence 
Implementation fidelity is how an intervention is implemented as intended, which also helps in 
increasing confidence in the study outcomes as being influenced by the intervention [389, 390]. 
There is evidence that the success of an intervention is dependent on the fidelity with which it is 
implemented [390, 391]. Table 28 demonstrates how CECI fidelity was implemented during the 
feasibility trial. 
 
Table 28: CECI fidelity checklist 
Items What was planned What was done 
 
Intervention training 
To deliver 5 sessions of 1hour 
per session per day 
Delivered 3 sessions of 2hours 
per session for three days 
Who was at the training 2 doctors, 4 nurses, 2 
counsellors, 1 social worker, 2 
care assistants. 
1 doctor, 4 nurses, 2 
counsellors, 1 social worker, 2 
care assistants and 2 laboratory 
technicians.  
Training provider All training sessions will be 
delivered by the researcher 
(MA-O) 
All training was delivered by the 
researcher 
Mode of training Face to face training, 
PowerPoint presentation, 
Discussions and role play 
Face to face training, 
PowerPoint presentations, 
discussions and role plays.  
Training resources/ materials/ 
certificates 
To provide training on the use of 
holistic assessment tool and 
care plan with copies to practice 
with. 
 
To provide training certificates 
for HCP who attended all 3 
training sessions 
 
Holistic assessment tool and 
care plan were provided to 
record participant assessments 
and aid collaborative care 
planning 
 
HCP who attended both 2 and 3 
sessions of the training were all 
provided with training certificates 
Skill acquisition and 
maintenance of skills post 
training 
To conduct twice-weekly 
mentorship, supervision and 
monitoring meetings with HCP 
Twice-weekly meetings were 
held with HCP to supervise, 





No. of CECI appointments To have 3 CECI appointments 
scheduled monthly for 3 months 
3 appointments of CECI was 
provided over 3 months with 
participants attending their 
appointments once every month 
Length of each appointment Each appointment to last 
between 30-45 minutes 




Ensuring that the intervention is 
delivered as intended 
To conduct twice-weekly 
mentorship, supervision and 
monitoring meetings with HCP 
 
Completion rates of outcome 
measures  
Twice-weekly meetings were 
held to assess HCP 
performance and challenges 
 
Outcome measure completion 
rates were recorded as 93%, 





No of participants who received 
the intervention 
N=30 participants to receive the 
intervention for monthly for 3 
months. 
N=28/30 received the 
intervention in month1 
N=30/30 received the 
intervention in month 2 
N=28/30 received the 
intervention in final month 3 
Intervention acceptability To conduct a post-trial 
interviews with 6-8 HCP and 
n=10 PLWHA to establish 
intervention acceptability 




6.2 Summary of feasibility findings 
The primary outcome findings have been summarised in Table 29.  
Table 29:Primary outcome findings 
Primary outcomes  Results 
Number of potential participants screened N=83 
Number of eligible potential participants N=69 
Number of participants consented and 
recruited into the trial 
N=60 
Recruitment target achieved 60 participants within 6weeks at a rate of 
87%. 
Proportion of participants who dropped out 
during the intervention delivery 
No participant dropped out 
Total number of intervention sessions 
delivered 
N=3 
Total number of participants present at final 
timepoint 
58/60 
Retention rate target set 80% 
Retention rate target achieved 97% 
Number of participants lost to follow-up None 




6.3 Outcome measures 
A total of five measures (3 outcome and 2 process measures) were used during the feasibility 
trial of CECI. The 3 outcome measures used were APCA POS, MOS-HIV and POSITIVE 
OUTCOMES. These outcome measures were preferred because they assess and measure the 
four domains of needs (physical, psychological, social and spiritual wellbeing) that PLWHA want 
support with. There were 2 process measures: PPE-15 and CARE Measure which assesses and 
measures the process of care delivery. 
 
6.3.1 Missing data 
A total of 180 data collection appointments were offered, which could have been attended, 
however, 7 of these appointments were not attended, as a result there is no missing data for any 
outcome measure (7 missing out of a possible total of 180: 3.9% missing).  Whilst the figure of 
3.9% missing data is low, of this 3.9%, 4 of the 7 missing data points (57%) occurred in the 
intervention arm due to participants missing their appointments. Among the completed post-trial 
interviews, there was no missing data. All other attended data collection appointments had 
complete data. See Tables 30 and 31 for summaries of missing data by time point and data 
completeness for completed measures. 
 
Table 30: Summary of missing data from outcome measures by timepoint and trial arm 
Time 
points 








































Deceased 0 0 0 





























Deceased 0 0 0 
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Deceased 0 0 0 
 
 
Table 31: Data completeness for completed measures by timepoint 


















Baseline 60 7 60 (100%) 0 0 
 
 
T1 56 7 56 (93%) ****7 1% 
 
 
T2 59 7 59 (98%)     *7 <1% 
 
 
T3 58 7 58 (97%)   **7 <1% 
MOS-HIV (0-100) 
 
Baseline 60 35 60 (100%) 0 0 
 
 
T1 56 35 56 (93%) ****35 <1% 
 
 
T2 59 35 59 (98%)     *35 <1% 
 
 
T3 58 35 58 (97%)   **35 <1% 
PPE-15 (1-55) 
 
Baseline 60 15 60 (100%) 0 0 
 
 
T1 56 15 56 (93%) ****15 <1% 
 
 
T2 59 15 59 (98%)     *15 <1% 
 
 
T3 58 15 58 (97%)   **15 <1% 
CARE Measure  
(1-50) 
Baseline 60 10 60 (100%) 0 0 
 
 
T1 56 10 56 (93%) ****10 <1% 
 
 
T2 59 10 59 (98%)     *10 <1% 
 
 





Baseline 60 23 60 (100%) 0 0 
 
 
T1 56 23 56 (93%) ****23 <1% 
 
 
T2 59 23 59 (98%)     *23 <1% 
 
 
T3 58 23 58 (97%)   **23 <1% 
****7 four persons missed seven items on the APCA POS, 35 items on MOS-HIV, 15 items on PPE-15, 10 
items on CARE Measure and 23 items on Positive outcomes HIV PROM at T1. *7 one person missed 
seven items on APCA POS, 35 items on MOS-HIV, 15 items on PPE-15, 10 items on CARE Measure and 
23 items on Positive outcomes HIV PROM at T2; **7 two persons missed seven items on APCA POS, 35 
items on MOS-HIV, 15 items on PPE-15, 10 items on CARE Measure and 23 items on Positive outcomes 
HIV PROM at T3. 
 
 
6.3.2 Outcome measures and time to complete  
Sixty participants completed the baseline data collection, fifty-six completed the follow-up 
outcome measures at time point 1 and then fifty-nine and fifty-eight participants completed the 
follow-up data at time point 2 and time point 3 respectively. For the five measures used, the APCA 
POS, PPE-15 and Positive Outcomes lower scores indicate better outcomes, whereas the MOS-
HIV and CARE Measure higher scores indicate better outcome. Participants took approximately 
30 to 45 minutes to complete all the outcome measures (those who completed it without any 
assistance with reading and explaining what each item on the measure meant used 30 minutes 
and those who required assistance spent 45 minutes). 
 
6.3.2.1 Outcome measure data 
The outcome data collected focused on the physical, psychological, social and spiritual wellbeing 
of PLWHA. The mean and standard deviation for the outcome measures (APCA POS, MOS-HIV 
and Positive Outcomes) for both the control and intervention arms are reported in Table 32 with 





Table 32: Mean scores with corresponding standard deviations 
 


















































































































Potential Effect size 
[95% CI] of the 
intervention at Time 3 








































0.7 [0.17 to 1.23] 
1 Lower scores= better outcomes 
2 Higher scores= better outcomes 
 
 
6.3.2.2 Process (experience of care) measure data  
The process measure captured data on the approach to care delivery, communication, 
relationship with HCP, patient involvement in care decisions and the empathy felt by PLWHA at 
care delivery. Data is normally distributed for the mean and standard deviation, mean and 
standard deviation for the process measures (CARE Measure and PPE-15) for both study arms 
are reported in Table 34 with the corresponding change scores in Table 35.  
 













































































































Potential Effect size 
[95% CI] of the 


































0.8 [0.27 to 1.31] 
1 Lower scores= better outcomes 
2 Higher scores= better outcomes 
 
 
6.3.3 Potential effect sizes 
An effect size is a quantitative measure of the difference between two groups. An exploratory 
analysis conducted to estimate the potential effect size of the CECI intervention described the 
results in terms of magnitude as the p-value showed whether the intervention was effective 
statistically, and the effect size explains the degree of the effect on participants involved [392]. 
The potential effect sizes were estimated using standardised mean difference [393], and reported 
using Cohen’s d effect size ranges of small (0.2), medium (0.5) and large (0.8) effects. The 
corresponding confidence intervals (CI) have also been reported. The potential effect sizes 
ranged from 0.7 to 1, however with reference to the CI, the CECI intervention achieved small to 
medium potential effects, these are reported in Table 36. 
 
Table 36: Potential effect size estimates by measure 
Measure Partial Eta Squared statistics 
for Potential Effect size (ηp2) 
95% CI p-value 
APOS 0.7 
 
[0.17 to 1.23] p<0.001 
MOS-HIV 0.7 
 
[0.17 to 1.23] p<0.001 
CAREM 
 
1.0 [0.45 to 1.55]  p<0.001 
PPE-15 0.8 
 
[0.27 to 1.31] p<0.001 
PO 0.7 
 





6.3.4 Comparison of outcome measure mean scores for control and intervention arms 
Outcome measure mean scores recorded for the control and intervention arms have been 
compared and plotted in Figures 27, 28 and 29 to identify any change over time.  
Figure 27 compared mean scores for APCA POS obtained over time from baseline to final 
timepoint 3 for both control and intervention arms. The APCA POS measured physical and 
psychological symptoms, spiritual, practical and emotional concerns and psychosocial needs. As 
observed in Figure 27, the control arm recorded a mean score of 12 at Baseline, which increased 
to 13 and 16 at Times 1 and 2, then decreased to 14 at Time 3.  Comparatively, the intervention 
arm also recorded a mean score of 14 at Baseline, which decreased to 11 at Time 1, and further 
decreased to 9 at Time 2 and remained the same at Time 3. Since lower APCA POS scores 
indicate better outcomes, this implied that from Time 1 to Time 2, the symptoms and concerns of 
participants in the control arm worsened but began to improve from Time 2 to Time 3. Likewise, 
participants in the intervention arm experienced a gradual improvement in their symptoms and 
concerns from Time 1 to Time 2 however, there was no further improvement at Time 3, as the 
mean score did not change from Time 2. 
 
 
Figure 27: APCA POS mean scores plotted for control and intervention arms 
 
Figure 28 compared mean scores for MOS-HIV obtained for the control and intervention arms from Baseline 
to final timepoint 3. The MOS-HIV measured pain, general health perception, mental health, health distress 
and vitality in addition to role, physical, cognitive and social functioning. As shown in Figure 28, participants 
in the control arm recorded a mean score of 30.1 at Baseline, which decreased to 25.5 at Time 1and further 






decreased to 19.5 at Time 2 and a sharply increased to 53.2 at Time 3.  Relatively, the intervention arm 
recorded a mean score of 26.6 at Baseline, which sharply increased to 66.4 at Time 1, and a steadily 
increased to 74 and 83 at Times 2 and 3 respectively. As higher MOS-HIV scores indicates better outcomes, 
these results indicate that participants in the control arm experienced worsening symptoms and concerns 
from Time 1 to Time 2, but from Time 2 to Time 3, they experienced significant improvement in their 
wellbeing. Similarly, participants in the intervention arm experienced steady improvement in symptoms and 
concerns from Time 1 through to Time 3. 
 
 
Figure 28: MOS-HIV mean scores plotted for control and intervention arms 
 
Figure 29 also compared mean scores for Positive Outcomes obtained from Baseline to final timepoint 3 for 
both the control and the intervention arms. The Positive Outcomes measured physical and emotional 
wellbeing, home and social life including sex and intimate relationships. As indicated, the control arm 
recorded a mean score of 30 at Baseline which slightly decreased to 28 at Time 1, then a sharply increased 
to 38 at Time to and significantly decreased to 30 (back to baseline score). In contrast, participants in the 
intervention arm recorded a mean score of 26 at Baseline, which marginally decreased to 23, 18 and 16 at 
Times 1, 2 and 3 respectively. As lower Positive Outcomes scores indicate better outcomes, these results 
suggest that symptoms and wellbeing of participants in the control arm worsened from Time 1 to Time 2 but 
began to improve from Time 2 to Time 3. Comparatively, symptoms and wellbeing of participants in the 









Figure 29: POSITIVE OUTCOMES mean scores plotted for control and intervention arms 
 
6.3.4.1 Comparison of process measure mean scores for control and intervention arms 
Process measure mean scores recorded for the control and intervention arms have been 
compared and plotted in Figures 30 and 31 respectively, to note any change over time. 
  
Figure 30 compared mean scores for CAREM obtained from Baseline to final timepoint 3 for 
control and intervention arms. The CAREM measured the amount of empathy that participants 
felt they had experienced during care delivery. As observed, the control arm recorded a mean 
score of 5 at Baseline, which decreased slightly to 3 at Time 1, then steadily increased to 5 and 
7 at Times 2 and 3 respectively. On the other hand, participants in the intervention arm who 
recorded the same mean score of 5 at Baseline, drastically increased to 23 at Time 1 and steadily 
increased to 27 and 33 at Times 2 and 3 respectively. Since high CAREM scores indicate better 
outcomes, these scores meant that participants in the control arm experienced less amount of 
empathy compared to participants in the intervention arm who experienced good amount of 
empathy during care delivery, which increased steadily from T1 to Time 2 and significantly from 









Figure 30: CAREM mean scores plotted for control and intervention arms 
 
Figure 31 compared the PPE-15 mean scores obtained from Baseline to final timepoint 3 for 
control and intervention arms. The PPE-15 measured patient experience along the domains of 
communication, emotions, short-term outcomes, barriers and relationship with HCP.   Participants 
in the control arm recorded a mean score of 31 at Baseline, which increased to 32 and 33 at 
Times 1 and 2, then decreased to 32 at Time 3. Likewise, participants in the intervention arm 
recorded a mean score of 30 at Baseline, which decreased to 26 at Time 1, and further decreased 
to 24 at Time 2 and remained the same for Time 3.  Lower PPE-15 scores indicate better 
outcomes therefore, these scores implied that participants in the control arm did not have as good 
experience of care as compared to those in the intervention arm who had good experience with 









Figure 31: PPE-15 mean scores plotted for control and intervention arms 
 







6.4 Post-trial qualitative interview findings on CECI acceptability 
A qualitative exploration in the form of semi-structured exit interviews was used as part of the 
process evaluation to understand the CECI intervention outcomes from participants’ perspectives. 
The CECI participants (PLWHA and HCP) were invited to share their views, experiences and 
outcome with the intervention. 
 
6.4.1 Sample characteristics 
Participants were purposively recruited for the post-trial interview approximately 2 weeks after 
they had exited from the quantitative component of the feasibility cRCT. The sample 
characteristics are reported in Table 37 with reference to the sample for the entire feasibility cRCT 
dataset used in the quantitative data analysis so as to allow for comparability assessment. 
 




Feasibility cRCT  
n=60 
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As observed in Table 37, the sub-sample used for the post-trial interviews appeared similar to the 
sample used for the feasibility cRCT in terms of clinical and demographic characteristics. Table 
38 reports on the sample characteristics of HCP who delivered the intervention. The sampling 
frame for the post-trial interviews was achieved. 
 
Table 38: Sample characteristics for HCP who were interviewed in the CECI arm 
Participant ID Age Gender Role 
PTQIS HCP 1 38 M Doctor 
PTQIS HCP 2 38 F Counsellor 
PTQIS HCP 3 28 F Nurse 
PTQIS HCP 4 33 M Counsellor 
PTQIS HCP 5 25 M Nurse 
PTQIS HCP 6 27 F Social worker 
PTQIS HCP 7 26 F Nurse 
 
 
6.4.2 Coding framework  
Participants wellbeing prior to entering the feasibility cRCT, during the trial and their present 
wellbeing were explored during the post-trial interviews. Six major themes emerged from the 
thematic analysis of the post-trial interview data: (i) relevance of intervention training, (ii) 
intervention delivery, experience and acceptability, (iii) holistic care and quality of life, (iv) care 
communication and partnership, (v) time burden and service limitations, and (vi) therapeutic 
benefits of participating in the study. These themes mainly focused on participants experience 
during and immediately after exiting the trial, which are described in turn, and illustrative quotes 
with unique identifiers are provided to support the themes.  
 
6.4.2.1 Relevance of intervention training 
Conducting the CECI intervention training with the team of HCP helped to foster collective 
responsibility for implementation of PCC and strengthened peer support and mutual learning. This 




“The intervention training is good as it raised relevant areas of care that is so important 
to our clients, but these areas are not prioritised. So, I am very glad that all our staff 
were present at the training and we can all look at our service delivery.” (PTQIS HCP 
6, age 27, intervention). 
 
Moreover, the use of role-play during the intervention training has been highlighted as useful in 
explaining the concept of person-centred and holistic care to HCP: 
 
“What I found useful about the training session was the materials used during the 
training. For example, the use of role play was excellent as it helped explain the whole 
concept of holistic care and the person-centred approach. Every aspect of the training 
was useful.” (PTQIS HCP 4, age 33, intervention). 
 
Focusing the training on using the person-centred approach to care for PLWHA improved HCP’s 
understanding of the concept, which helped them to communicate effectively with patients when 
assessing their needs: 
 
“My view is that it was good the training focused on these aspects of care because it 
helped me to appreciate and understand the person-centred approach to care. In 
addition to how to communicate appropriately with my clients in order to understand 
them and assess their needs.” (PTQIS HCP 7, age 26, intervention). 
 
This has contributed to reflective practice among HCP who expressed fulfilment and satisfaction 
at the results of their collaborative care practice with PLWHA:  
 
“This training has helped me to take a second look at the way I practice and to see the 
difference the holistic approach makes in the care I deliver. Because looking back at 
the way I used to practice compared to now, I think that this holistic approach is very 
promising. This is because of the effect it had on our clients, the fulfilment I get being 
able to partner with my clients and coming up with a care decision that we both agree 
205 
 
on and seeing them for this past 3 months more enthusiastic about their care its really 
satisfying.” (PTQIS HCP 1, age 38, intervention). 
 
HCP wished the training had lasted for longer but acknowledged that the nature of the clinic could 
not allow that: 
 
“The duration of the training was okay although I would have wished that a whole day 
could have been dedicated for such important training to enable us to participate in 
some group work and discuss the domains of the training deeper. However, this was 
not possible considering the nature of the clinic.” (PTQIS HCP 5, age 25, intervention). 
 
6.4.2.2 Intervention experience and acceptability 
Participants in the intervention arm revealed acceptability and perceived benefits of the 
intervention with many participants reporting experiencing difference in the care they received. 
The difference in the care experienced included HCP approach to symptom assessment and 
involvement of PLWHA in planning their care: 
 
“The way staff assessed my problems step by step wanting to know all about me and 
my life outside HIV and more importantly, my involvement in care and staff planning 
my care with me was the main thing that helped me most.” (PTQI PLWHA 7, age 28, 
intervention). 
 
HCP had to encourage participants to contribute to their care plan as they initially thought it was 
not their responsibility to make decisions about their care, as has been the normal practice: 
 
“Generally, clients are very happy about being part of the decisions being made about 
their care. Initially, they were not sure if they should really be part of their care, so some 
kept saying ‘this is your job why are you asking me?’ But when I explain that I need 
their contribution in order to support them better, they gradually started making 




The importance of involving participants in their care decisions was highlighted by HCP who 
resolved that they would endeavour to involve participants in making decisions about their care:  
 
“I have come to see the real difference in involving my clients in care decisions 
compared to not involving them at all because they became very enthusiastic and were 
giving a lot of suggestions about how they want to be supported. Therefore, what I 
would do differently is to always ensure that I do not make any care decision without 
my client’s involvement. Also, I would modify the way I communicate with my clients in 
the sense that I will be more person-centred.” (PTQIS HCP 6, age 27, intervention)  
 
Participants also noted that they felt valued and respected by HCP who took their time to ask 
them of  their opinion about the care they receive: 
 
“Because all of a sudden, it felt that I was so important that my opinion about my care 
mattered to staff and they want me to contribute to how I should be supported. I can’t 
explain why but I think it is because staff were patient and they wanted me to be part 
of the care as I have never seen them like this before.” (PTQI PLWHA 9, age 39, 
intervention). 
 
This quote is supported by HCP who confirmed that participants’ self-worth had improved as a 
result of their involvement in their care: 
“Most of my client felt respected and important with the idea that they are invited to plan 
their care and were empowered by the decision. This opportunity also made my clients 
make meaningful contributions to their care.” (PTQIS HCP 7, age 26, intervention). 
 
HCP on the other hand, described the intervention as opening their eyes to the broader 
challenges faced by PLWH, which they felt unprepared to address: 
 
“Delivering this enhanced care is like an eye opener for me personally because it 
helped me to understand the daily challenges that our clients go through in the areas 
of taking their medication, spiritual issues and the enormous psychological issues that 
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we do not get to know about our clients because we don’t ask them about it.” (PTQIS 
HCP 4, age 33 intervention).  
 
Moreover, others described their initial experience of delivering the intervention, including 
challenges faced. However, they praised the weekly support received during the intervention 
delivery that helped to overcome some of the challenges: 
 
“The delivery of the enhanced care intervention was a bit challenging at the start as it 
was the first time, we have had to use this holistic approach, Some of these challenges 
were the amount of paper work that we needed to complete for one client and another 
was when the clients come in with complex issues. However, it became easy due to 
the continues supervision support received during the weekly meetings and we were 
able to adjust and get over the challenges we had.” (PTQIS HCP 2, age 38, 
intervention). 
 
6.4.2.3 Holistic care/ person-centred care and quality of life 
HCP described their understanding of person-centred/ holistic care as using the values and 
preferences of individuals to guide care delivery including addressing their physical, 
psychological, social and spiritual needs:  
 
“My understanding of person-centeredness or holistic care is that there are four types 
of need for all persons including our clients, these are the physical needs, psychological 
needs, social and spiritual needs. Apart from that, people may also have different 
preferences for how they want their care to be delivered and their beliefs and values, 
so when we consider all these aspects of individuals who come to seek care and allow 
it to guide the care delivery then we can say we are delivering a holistic care.” (PTQIS 
HCP 1, age 38, intervention). 
 
PLWHA described a novel experience of care that focused on them as individuals and considered 




“This new approach that staff are using at the clinic has really make me look forward to 
going to work and at work I am very much relaxed and I can’t explain it but it’s more 
like being satisfied with my life, it is as if a burden has been lifted of my head, I now 
smile more and am more chatty.” (PTQI PLWHA 2, age 40, intervention). 
 
This improvement in work-related quality of life was reiterated by another participant who felt able 
to work without having to think or worry about HIV:  
 
“I am now able to go to work and go about my daily activities without any guilt or worry 
about my HIV or what people think of me. Life is much much better now because I am 
able to talk to staff at the clinic about anything that worries me. Because staff are now 
interested in my problems and I am also happy to share it with staff each time I have a 
problem.” (PTQI PLWHA 8, age 26, intervention). 
 
Participants also remarked that they were able to live a normal life with reduced level of worry 
although unable to disclose HIV status to family: 
 
“I would not say I have stopped worrying completely but the rate at which I used to 
worry has reduced greatly. I tried to live a normal life among my family and community 
the only thing I have not been able to do is to disclose my status to my family or friends 
but even that I am much happier and relaxed now.” (PTQI PLWHA 1, age 41, 
intervention). 
 
The length of questionnaires was deemed to be acceptable and the similarity of questionnaires 
were also deemed to be appropriate. One participant had felt that there was some repetition 
between questions in outcome measures as some measures had asked about experiences over 
last 3 days (APCA POS) and others over last 30 days (MOS-HIV): 
 
“Most of the questions were easier to answer and short, one was quiet long. Also, some 
of the questions were similar to each other so I kept repeating myself. But the difference 
is that some of the questions were asking for 3 days experience and others were asking 




Participants described feeling good about being able to discuss the outcomes of care and felt 
positive about that: 
 
“It was as if I was giving an account of what has been happening in the clinic and about 
my life but it felt really good because after receiving care from clinic staff then I come 
and talk to the investigator who also takes time to ask me questions about my life and 
how am coping with living with HIV, that was great.” (PTQI PLWHA 10, age 31, 
intervention). 
 
6.4.2.4 Care communication and partnership 
The importance of communication was raised by participants who felt that their level of 
communication with HCP had improved to the point where they could speak their mind: 
 
“Staff are now more welcoming, politer and spending more time discussing my 
problems with me and allows me to also speak my mind and to share my opinion which 
was not the case before.” (PTQI PLWHA 7, age 40, intervention). 
 
HCP also acknowledged the importance of effective communication in order to know and 
understand what matters to participants. This was demonstrated by HCP’s interest in the 
problems experienced by PLWHA alongside their HIV disease, as well as involving them in 
planning their care:  
 
“Therefore, my understanding of the basis for this intervention is that it focuses on the 
‘person’ receiving the care and what matters to him/her most. And to know what matters 
to this person, I must communicate with the person well in order to know what is most 
important for that person.” (PTQIS HCP 1, age 38, intervention).  
 
Participants recognised the difference in the way HCP communicated with them and have 
related it to HCPs’ patience in wanting to know them better: 
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“Yes, so much change in the way staff talked with me, the way they asked me questions 
about my health and also asked me what matters to me about my care. It was like staff 
were not in a hurry to see the next patient, they were very patient and wanting to know 
all about me.” (PTQI PLWHA 8, age 26, intervention). 
 
Participants also praised the effect of good communication as it made them felt better and able 
to talk about their problems with HCP:  
 
“Now I feel much better because I don’t have to keep quiet about my symptoms of pain 
or any other physical problems because if I don’t talk about them staff will keep on 
asking me about my physical health. So now staff always ask me about pain and other 
problems which I always discuss them with staff and together we decide what will help 
me better.” (PTQI PLWHA 6, age 28, intervention). 
 
One HCP remarked that the training received on the intervention helped improved her 
communicative skills which has led to the discovery of her counselling abilities: 
 
“I didn’t know that I can be a good counsellor until this training on the intervention. Now 
I am able to communicate well with my clients, ask them question that will make them 
talk about themselves and the issues bordering them. This intervention has also 
empowered me to be able to assess and manage my clients using the available clinic 
resources, it is really exciting you know. And seeing my client have a lot to say about 
their care was to me the icing on the cake”. (PTQIS HCP 4, age 33, intervention). 
 
 
6.4.2.5 Time burden and service limitation 
The time taken to deliver the intervention and service limitation were among the challenges 
discussed. HCP were concerned that although they felt fulfilled to be able to deliver holistic care 
the intervention delivery process was time consuming: 
 
“My only concern is that the process of care delivery is time consuming and sometimes 
you get lost in your client’s concerns. However, I feel fulfilled that I am able to assess 
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and manage clients’ needs holistically which I could not do previously.” (PTQIS HCP 2, 
age 38, intervention). 
 
Both PLWHA and HCP express concerns about service limitations in terms of addressing complex 
psychosocial needs, as PLWHA would rather have all services delivered at the clinic where they 
usually receive care. HCP also wished the clinic could provide all services as PLWHA are 
reluctant to attend other clinics when referred for fear of discrimination: 
 
“Yes, when staff did the step by step assessment when planning my care they will say 
some of my problems unless they refer me to social welfare or a psychologist and I 
wish that this does not happen. This because I just want my care to be at this clinic and 
I don’t want to go anywhere for these extra care or assessment. I mean can the social 
welfare person or the psychologist come to the clinic instead of me going to them?” 
(PTQI PLWHA 10, age 39, intervention). 
 
“I wish we can be able to provide all other services that our clients will require so that 
we are sure they are really being supported. Because from past experience, if we refer 
them to access other services they hardly go for the fear of discrimination.” (PTQIS 
HCP 4, age 33, intervention). 
 
6.4.2.6 Therapeutic benefits of participating in the study 
The experience of participants in the control arm was explored to determine if there were other 
benefits of participating in the feasibility cRCT beyond the benefits derived from the intervention. 
PLWHA in the control arm described their experience of answering questions from the researcher 
as a source of motivation to attend the clinic: 
 
“My experience of care for the past 3 months has been good and a bit different from 
what am used to in the sense that someone is always following up on me asking me 
questions about my care and every aspect of my life which I think is quite nice because 
nobody has ever done that for me before. And I must say the thought of knowing that 
when I come someone will have time to ask me several questions all about my health 
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was my motivation to come because sometimes you only need someone to talk to and 
you feel better.” (PTQIC PLWHA 3, age 34, control). 
 
This assertion was reiterated by other participants who looked forward to coming to the clinic 
because they know that the researcher was expecting them: 
 
“The fact that someone is always sitting at the clinic waiting for me to come and all the 
person wants to know is how I have been over the past month was what really helped 
me. Because sometimes am coming to the clinic and I don’t really know what to expect 
but this time I actually look forward to coming because I know someone is actually 
expecting me.” (PTQIC PLWHA 3, age 29, control). 
 
Participants also expressed their thoughts on the completion of the outcome measures and 
shared similar feelings as participants in the intervention, that some of the questions were 
repetitive as some of the outcome measures asked about experience over 3 days (APCA POS) 
and others over 4 weeks (Positive Outcomes), and were pleased about the process measure 
question on their involvement in their care decisions (PPE-15): 
 
“Initially I felt it was too much because some of the questions were repeating but I 
needed to provide the answers even if am just repeating myself. But the difference is 
some questions asked about your experience for the past 3days whiles others asked 
for 4 weeks so I guess there is a balance. The questions about ‘do you want to be 
involved in your care’? and whether doctors or nurses discuss care decisions was very 
good questions.” (PTQIC PLWHA 7, age 47, control).  
 
Moreover, participants found answering the outcome measure questions easy although they 
required clarification to the APCA POS question on ‘peace’ and ‘life worthwhile’: 
 
“Most of the questions were easy to answer but there were some questions that I 
needed more explanation on for better understanding before I could answer, say 




6.4.3 Summary of post-trial interview findings 
Overall the intervention was acceptable across PLWHA and HCP who were extremely positive 
about the intervention and particularly the involvement of PLWHA in their care decisions, which 
they had found incredibly useful. PLWHA and HCP felt that the intervention improved their 
wellbeing and their ability to deliver person-centred care respectively. Moreover, PLWHA were 
pleased that the intervention delivery was more of a partnership between them and HCP where 
all their symptoms and concerns were collaboratively assessed, planned and delivered with their 
involvement. PLWHA felt respected and valued by the intervention delivery process as HCP 
included them in their care delivery, and most importantly that their concerns were addressed on 
their terms. HCP also revealed that the intervention opened their eyes to the distressing 
symptoms experienced by PLWHA that they lost sight of because they were not assessed, in 
addition to improving their communicative skills for holistic assessment. There were few reported 
challenges regarding the time required to deliver the intervention and service limitation for the 
management of psychosocial needs when assessed. These challenges have been noted at areas 
of improvement for the intervention in preparation towards a future definitive trial. 
Findings also indicate that none of the participants found the completion of the outcome measures 
burdensome although some participants required some assistance in the form of reading the 
questions and the responses out for them to provide their preferred response to each question. 
The APCA POS, MOS-HIV, PPE-15, CARE Measure and Positive Outcomes were observed as 
being feasible. The small sample size prevents a definitive conclusion regarding the most 
appropriate primary outcome measure. Although it is not advisable to assess for an effect in a 
feasibility study due to it being underpowered [394], our findings nonetheless provide some 
information to inform the selection of primary outcome measures and timing for a future definitive 
trial.  
As reported in the post-trial interview findings, participants found some of the questions repetitive 
although they at the same acknowledged that some of these measures asked for experiences 
over 3 days (APCA POS), 30 days (MOS-HIV) and 4 weeks (Positive Outcomes). This information 
is very crucial in making decisions about outcome measure selection and the possibility of opting 
for a trial index in a future definitive trial. Participants seemed to have no issues with the process 
measures (PPE-15 and CARE Measure), which will be an important consideration in a future 
definitive trial the process measures will remain unchanged. 
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In conclusion, the CECI intervention was implemented according to how the logic model intended 
it starting from HCP training through outcome data assessment, and all the recruitment and 




Chapter 7 Discussion 
7.1 Summary of main findings 
UNAIDS set an ambitious ‘90-90-90 targets’; aiming to diagnose 90% of all HIV positive people, 
provide ART for 90% of those diagnosed and achieve viral suppression for 90% of those treated, 
by 2020 [74]. Of these targets, it has been estimated that 79% knew their HIV status, 78% were 
accessing treatment and 86% of those accessing treatment were virally supressed as at 2018 
[49]. Although UNAIDS has emphasised the importance of person-centred are (PCC) for PLWHA 
in achieving the 90-90-90 targets [74], greater attention has been paid to HIV clinical management 
at the expense of broader psychological, social and spiritual concerns that persist despite 
treatment advances [5, 8, 106] and impact on their quality of life. HIV has become a chronic 
condition that requires persistent clinical and PCC [395] to improve retention in care in order to 
end the epidemic. Lazarus and colleagues also proposed adding a ‘fourth 90’ to the UNAIDS 
targets to ensure that 90% of people who achieve viral suppression also have good health-related 
quality of life [396]. The author argued that good health-related quality of life for PLWHA requires 
attention to be focused comorbidities and self-perceived quality of life. However, a systematic 
review conducted in Phase 1 of this thesis revealed that evidence for PCC in HIV management 
is weak despite global policy push. 
To address this evidence gap, this thesis conducted qualitative interviews with PLWHA and HCP 
in community HIV management in Ghana to understand what PCC means to them and what 
outcomes matter to PLWHA. The interview findings revealed that PLWHA wants to be involved 
in their care decisions and for care to address what mattered to them. HCP also express a lack 
of skills to undertake holistic assessment and to practice PCC. These findings were mapped onto 
a PCC theory in an expert intervention development workshop. An evidence-based theoretically 
driven PCC intervention was developed, which was tested in a feasibility cluster (2 clusters) 
randomised controlled trial (cRCT) with a post-trial qualitative exit interview. This intervention and 
the study design were found to be both feasible to deliver and acceptable to PLWHA and HCP. 
Training on the intervention was well received by HCP who felt equipped with skills to carry out 
holistic assessment and to practice PCC. Likewise, PLWHA felt satisfied about their involvement 
in making decisions about their own care and their symptoms and concerns being assessed and 
addressed holistically using PCC. This PCC intervention seems to have potential effectiveness 
and a priori feasibility criteria were met.  
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These findings are novel as this is the first time a person-centred intervention has been developed 
and tested in HIV population and adds important new evidence to understand the potential 
benefits of person-centred interventions in PLWHA and are worthy of further investigation in a 
future definitive trial.   
  
7.2 Study aim 
The aim of this thesis was to develop a community-based enhanced care intervention (CECI) to 
improve person-centred outcomes for people living with HIV/AIDS and to test the feasibility of a 
cluster randomised controlled trial in terms of participant recruitment and retention, and 
intervention delivery.  
The MRC guidance for developing and evaluating complex intervention was used to underpin the 
methodological approach. The CECI intervention was developed after conducting a systematic 
review to identify and appraise the evidence for person-centred models of community HIV care 
and qualitative interviews with stakeholders (PLWHA and HCP). This person-centred intervention 
consisted of the HCP training, holistic assessment of symptoms and concerns of PLWHA, 
collaborative care planning and delivery and twice weekly supervision meetings with HCP. This 
training was focused on person-centred care, communication, holistic approach to symptom and 
concerns assessment in the domains of physical, psychological, social and spiritual wellbeing and 
collaborative care delivery. This formed the Development stage of the MRC guidance. 
 
7.3 Summary of objectives 
7.3.1 Objective 1 (Systematic review of PCC models of community HIV management) 
Objective one aimed to identify and appraise the evidence for person-centred models of 
community HIV management delivered or led by HCP, and to assess their impact on outcomes 
for PLWHA. The PCC definition adopted for this systematic review and the entire study was one 
described as care ‘dedicated to the promotion of health as a state of physical, mental, 
sociocultural, and spiritual well-being, as well as to the reduction of disease, and founded on 
mutual respect for the dignity and responsibility of each individual person’ [146].  
A descriptive analysis of 5 PCC models of HIV management were conducted. PCC models of 
care delivered alongside HIV clinical management were found to be effective in improving PCC 
components such as physical, psychological, social and spiritual wellbeing of PLWHA. However, 
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of the PCC models identified in the studies retained, one study addressed only physical and 
psychological components of wellbeing [377]; two studies addressed social wellbeing in addition 
to physical and psychological wellbeing [375, 376]; and two studies addressed all 4 components 
of wellbeing [321]. Suggesting that less attention was paid to social wellbeing and more 
importantly spiritual wellbeing [155]. Notably, only one out of these five studies used validated 
tools to measure outcomes [320].  
Exploration of contextual meaning and practice of PCC, development of more PCC interventions 
focusing on the specific contextual needs within the domains of physical, psychological, social 
and spiritual wellbeing of PLWHA; measuring these outcomes with validated tools; and additional 
examination of the feasibility and acceptability of such interventions were identified as potential 
future research direction.   
The limitations of this review were the inclusion of only studies published in English resulting in 
publication bias and missing out on studies published in other languages. Furthermore, studies 
included had to say they were delivering PCC (albeit using a broad range of possible synonyms), 
implying that there is a possibility some studies may have delivered care in line with PCC but 
because they did not explicitly state that, those studies were excluded. Also, this review has a 
broad understanding of PCC which is Western in origin, and therefore findings cannot be 
generalised.  
 
7.3.2 Thesis objective 2 (Qualitative interviews to inform intervention development) 
Objective 2 aimed to explore the views of PLWHA and HCP regarding HIV care, what PCC means 
in the African (Ghanaian) context and what person-centred outcomes matter to PLWHA. Three 
interconnected themes emerged across PLWHA and HCP data: (i) care structures not built 
around the person, (ii) priority outcomes and components of PCC and (iii) re-engineering HIV 
care to be more person-centred. Many PLWHA and HCP participants reported symptoms and 
concerns in the domains of physical, psychological, social and spiritual wellbeing. This supports 
previous studies in the African context [102-104, 155], which found that  PLWHA frequently 
experience  distressing physical, psychological, social and spiritual symptoms and concerns, 
which negatively impact on their quality of life  and influence their engagement and treatment 
adherence.  
Both PLWHA and HCP held common and differing views on PCC which led to the development 
of a conceptual framework of PCC from the perspectives of stakeholders. Findings from this 
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qualitative study add to the previous evidence by revealing that the burden of person-centred 
symptoms and concerns is significant and impacts on every aspect of PLWHAs’ lives.  This 
research also showed pronounced sexual and intimate relationship concerns that required PCC. 
This may be because through interviewing PLWHA, the full impact of HIV on relationships and 
the family unit as a whole is revealed. Intriguingly, some of the HCPs had limited appreciation of 
the person-centred needs of PLWHA and the psychosocial effects on their wellbeing. This study 
provides novel insight into what constitutes PCC for PLWHA beyond the original western-oriented 
concept.                                                                                                                                                                                                                                                                                                                                                                                      
PLWHA understand PCC as care that involves them in their care decisions, which is concerned 
about the whole person and not only viral suppression and addresses what matters to them. 
PLWHA also view PCC as addressing broader social issues: living a normal life like anyone else, 
getting married and having children and being employed. In contrast, HCP described PCC as 
‘tailored care’ and ‘targeted care’, however, this was focused on their own perspectives as to what 
is important, rather than that of the PLWHA.  This was borne out in HCP data, which identified 
priority outcomes as biomedical (CD4, viral loads). This contrasts starkly with PLWHA data, which 
described social outcomes (living a normal life, getting married and having children). These 
differing priorities resulted in care that was not person-centred, as HCP expressed uncertainty 
about how PCC could be practiced, and a need for training. 
A major challenge faced by PLWHA in low- and middle-income countries is the stigma associated 
with HIV disease, which also impact on service utilisation and physical health [397, 398]. It has 
been argued that PLWHA are caught in a sequence where psychological problems are 
compounded by stigma [399]. These and other issues relating to diversity, ethnicity, gender, 
sexual orientation, religion and socio-economic status could be addressed using a person-centred 
approach [162] in ensuring that patients have equal access to vital care service [400]. A recent 
study demonstrate the potential to increase PLWHAs’ resistance to stigma using PCC delivery 
[382]. 
PCC is associated with improved clinical outcomes and cost effectiveness [401-403], as it allows 
services to target scarce resources at greatest need, which could also prevent further health 
service use due to unmet needs. ‘Person-centred care made simple’, a UK Health Foundation 
report presented evidence about cost savings and a decrease in healthcare services utilisation 
[404], which implies that when individuals are better informed, they could choose different 
treatments that are less expensive when supported to manage their own care more effectively 
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[405, 406]. Therefore, what is novel about this study that is different from other studies is that it 
explored the contextual meaning of PCC as applied to the symptoms and concerns of PLWHA in 
Ghana. This led to the development of a conceptual model and a framework to inform PCC 
delivery informed by the experiences and perspectives of PLWHA and their HCPs. This is clearly 
highly relevant to HIV care services in Africa. 
 
7.3.3 Thesis objective 3 (Mapping qualitative data onto components of PCC theory) 
Objective 3 aimed to map the qualitative data from objective 2 onto the components of the PCC 
theory adopted for this study, which is also the theory of change (ToC) to determine which 
components align with the theory and what additional components are required. The qualitative 
data aligned with the components of the PCC theory with the only overlap being the assessment 
and management of physical wellbeing, as the data reported care is primarily focused on physical 
wellbeing. The PCC described in HIV care within the West African context is one that should 
address broader aspects of wellbeing beyond physical needs including psychosocial and spiritual 
wellbeing. The existing approach to delivering HIV care in the community focused primarily on 
their physical wellbeing and did not involve them in decisions about their care. What stays the 
same is care focusing on physical wellbeing and what is different is care that will now address 
broader domains of need as described by PLWHA. Although these domains may be similar to the 
some of the models described in the Western context [152-154, 157, 159, 160], care addressing 
spiritual wellbeing seems absent except the one described by Mezzich [146]. 
However, HCP data revealed that the delivery of PCC could only be possible only if HCP were 
trained. This contrasts with a qualitative study conducted in South Africa which reported that HCP 
have a clear perceptions of PCC delivery however barriers such as resources, increased 
administrative work, HCP behaving unprofessionally hinder its implementation [407]. Making care 
more person-centred can lead to improvements in other areas of quality, particularly in safety and 
equity, leading to improved patient health status and satisfaction [408]. The past two decades 
have witnessed sizeable changes in health in sub-Saharan Africa and other low-income regions 
including the rapid rise of HIV/AIDS, to the encouraging declines in infectious diseases, and the 
growing burden of chronic diseases [409]. As health needs change and patient expectations rise, 
health systems in low-income countries will need to adopt a person-centred approach [410, 411] 
in order to improve health outcomes for patients. It has been argued that “all changes and new 
concepts that we initiate in order to make the healthcare sector more person-centred must include 
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all stakeholders. We must make sure that everybody is on board, or we are not likely to succeed” 
[412]. 
Implementing and achieving PCC delivery in healthcare systems requires relationship building 
between stakeholders through effective communication and acknowledgement of patients as 
experts in their own healthcare through partnerships that allow for sensitivity to patient’s values, 
needs and preferences for care. Furthermore, there should be ongoing education and training for 
providers on PCC delivery, with a specific focus on holistic patient assessment, management of 
symptoms and concerns, collaborative care planning and delivery. Also, there should be 
increased understanding of patient’s perspective for PCC to inform the content of PCC 
interventions and HCP training. 
 
Traditionally, PCC has not been integrated into healthcare quality improvement [413]. Recent 
policies emphasise the value of patient views, which not only complement HCP perspectives, but 
also provide unique information about healthcare effectiveness [30, 414-418]. Despite many 
efforts to practice PCC, most health systems are challenged by effective implementation of PCC 
across the continuum of care therefore, shifting to PCC requires services and roles to be re-
designed and re-structured to be more conducive to a PCC model [413]. Although the mapping 
of the qualitative data from thesis objective 2 resulted in the development of a framework to guide  
PCC implementation, there is still a need for health systems to be responsive to their specific 
contexts and to identify priority areas to encourage innovation for PCC. Policies and plans for 
strengthening health systems to better serve people with chronic conditions such as HIV/AIDS 
should be aligned with principles of PCC to strengthen patients’ knowledge and skills to participate 
in and benefit from their care.  
 
7.3.4 Thesis objective 4 
Objective 4 integrated findings from objectives 1-3, modelling the potential processes, outcomes, 
and mechanisms of action for the intervention. This intervention was developed in an intervention 
development workshop held with an expert panel who have diverse experience and knowledge 
in developing PCC interventions in HIV population. The community-based enhanced care 
intervention (CECI) was developed with a training content for HCP training on PCC, 
communication, holistic assessment of symptoms and concerns, collaborative care planning and 
delivery with a twice weekly mentorship and supervision meetings with HCP on the CECI 
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intervention. The training content for the intervention was developed dwelling on palliative care 
resources for training on holistic care delivery in addition to those used in one of the studies 
identified in the systematic review [380]. The components of the CECI intervention focused on 
the qualitative data and the components of the PCC theory.  
Appropriate outcomes and process measures for the CECI intervention were also chosen through 
information provided by the systematic review and qualitative study forming the ‘modelling 
process and outcomes’ step of the Development stage. The systematic review identified that there 
were symptom control and quality of life outcome measures that had previously been used in 
person-centred interventional study (TOPCare trial) [380]. This study used validated measures to 
measure person-centred outcomes in PLWHA, which included the APCA POS and MOS-HIV. 
These outcome measures identified from the systematic review were selected and used in the 
feasibility cluster trial evaluation of the CECI intervention, in addition to an additional person-
centred outcome measure (Positive Outcomes), which is an HIV-related outcome measure based 
on Lowther et al.’s [380] recommendation. Process measures were also selected based on issues 
related care processes as discussed in the qualitative data. The person-centred process 
measures chosen were the CARE Measure and Picker Patient Experience Questionnaire. These 
process and outcome measures appeared to be the appropriate measures as the qualitative study 
in objective 2, identified that PLWHA had holistic and PCC needs which did not just focus on 
symptom control or quality of life but included every aspect of PLWHAs’ life. 
 
7.3.5 Thesis objective 5 
Objectives 5 formed the Feasibility stage of the MRC guidance, which focussed on testing the 
CECI intervention in a parallel phase II mixed methods feasibility cluster randomised controlled 
trial (cRCT). The cRCT was conducted in two community clinics (randomised as intervention and 
control) and provided preliminary information related to the CECI intervention components and 
outcome measures chosen in objective 4. A total of 60 participants (30 participants per cluster) 
were recruited into the feasibility cRCT and HCP in the intervention in the intervention arm were 
trained on CECI delivery prior to the commencement of the first session of the intervention 
delivery to PLWHA. The quantitative results showed a positive and significant potential effect on 
all outcome and process measure scores from Timepoint 1 to final Timepoint 3.  This suggests 
that the CECI intervention may improve the person-centred outcomes for PLWHA in a clinically 
meaningful way. At the implementation of CECI intervention, evidence based guidelines were 
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used and a holistic symptoms and concerns assessment in the domains of physical, 
psychological, social and spiritual wellbeing, collaborative care planning and care delivery based 
on care plan agreements to meet care goals set were carried out. Ongoing management of 
PLWHAs’ holistic care needs were carried out by the HCP trained to deliver the CECI intervention 
at the community clinic.  
It is possible that the delivery of the CECI intervention using these evidence based guidelines, 
the twice weekly supervision meetings and the ongoing management of the holistic care needs 
identified during holistic symptom and concerns assessment resulted in the improvements in the 
scores seen in all the outcome and process measures used. It is difficult to know whether the 
benefit from the CECI intervention seen is due to the PCC delivery or the added time that HCPs 
spent in assessing and planning care together with PLWHA. However, the results are promising 
and warrant further investigation. Of note HCPs who provided the CECI intervention in the 
community setting also reported the positive effect and the difference the CECI intervention made 
on them as well as PLWHA. The actual process of the CECI delivery, having a clear individualised 
care plan and PLWHA being supported by HCPs to contribute to their care may have helped in 
the increased PLWHAs’ process measure scores seen in the quantitative results. 
A post-trial qualitative interview conducted with a purposeful sample (n=20 PLWHA and n=7 HCP) 
from participants who took part in the feasibility cRCT, revealed a general acceptability of the 
CECI intervention across PLWHA and HCP data. The quantitative and qualitative data collected 
during this feasibility cRCT proved the CECI intervention to be both feasible and acceptable. At 
the CECI delivery, not all PLWHA wanted to get involved in care planning decisions as they were 
not sure if it was their responsibility to do so. This finding indicates a need to train PLWHA on how 
to contribute to their care decisions in a future definitive trial.  For some PLWHA, the CECI delivery 
gave them the opportunity to have important conversations with HCP. However, many PLWHA 
who had not wanted to discuss or get involved in their care decisions and to plan their care later 
went on to have subsequent discussions with their HCPs in the weeks after the first CECI 
appointment. This in itself is an important influence of the CECI intervention.   
Feasibility criteria set for this cRCT were to recruit 60 participants across the two cluster sites 
within 8 weeks, to retain 80% of the sample after 3 months follow-up (final timepoint) and to 
determine CECI acceptability by both HCP and PLWHA. All these criteria were met. This was 
largely due to the successful delivery of the CECI intervention by HCP and making time to attend 
the twice weekly supervision meetings. The study design of a feasibility cRCT also seemed to 
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have worked well. All PLWHA participants interviewed were very grateful to have received the 
CECI intervention. Both PLWHA and HCPs praised the CECI intervention particularly its holistic 
approach to assessment of symptoms and concerns and the involvement of PLWHA in their care 
decisions. This is the first time a complex intervention looking at improving the person-centred 
outcomes for PLWHA has been developed using the MRC guidance. Compared to the TOPCare 
trial [320], which trained only a member of staff to deliver the PCC intervention, this study focused 
training on the multi-professional team which has greater potential system change and coverage.  
 
7.4 Methodological considerations 
7.4.1 Feasibility studies 
Feasibility studies are pieces of research done before a main study in order to answer the 
question “Can this study be done?” [419]. The primary outcome for this feasibility cRCT is 
recruitment and retention. Among some the uncertainties addressed by this feasibility cRCT in 
order to improve their precision for a successful definitive trial include (i) recruitment (willingness 
of clinicians to recruit; number of eligible participants; consent process; and willingness to 
participate); (ii) intervention (willingness of the two clinics to be randomised; acceptability of the 
intervention, impact of the intervention, and acceptability of process measures); and  (iii) outcome 
(characteristics of the proposed outcome measure, follow-up rates, response rates to 
questionnaires and adherence, time needed to collect and analyse data, and selection of right 
outcome measure [419, 420]. In order to reduce research waste, theoretically informed 
interventions developed are required to undergo feasibility testing [319]. 
 
7.4.2 Cluster randomised controlled trials 
Cluster RCT involves the allocation of  groups of subjects (PLWHA) to different treatments [355, 
356]. This thesis used a cluster RCT rather than individual randomisation in order to reduce/ 
minimise treatment ‘contamination’ [357] between the intervention and control arms. Cluster RCT 
is preferred because, while an individual RCT may be better suited to determining whether a novel 
therapy works in patients with a given disease or condition, a cluster RCT is better able to evaluate 
whether a new standard of care, guideline recommendation, or other community-wide, practice-
wide, hospital-wide, or system-wide change is affecting patient outcomes [421]. Therefore, the 
strength of using the cluster RCT has been that a team of HCP have been trained to deliver this 
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novel person-centred intervention which may translate into practice-wide change as well as 
change in health systems.  
 
7.4.3 Recruitment and retention 
A recruitment rate of 78% (n=39) and 87% (n=60) was achieved in Phase 2 and 3 respectively.  
The feasibility criteria set estimated a retention rate of 80% however at the final follow-up 
timepoint (3-months post intervention) retention was 97%. PLWHA demonstrated good 
participation in the CECI intervention which could be attributed to the person-centred and holistic 
approach used in delivering care in addition to PLWHA involvement in their care decisions and 
delivery as this was a novel experience for them. While this study did not provide any incentive 
for participation in the study, participants transportation fares (which was estimated using the 
longest distance travelled by participants to the study sites) were reimbursement. The post-trial 
interview data did not make any reference to this transportation reimbursement as influencing any 
outcome of care. However, the TOPCare trial [380] offered participants a flat rate regardless of 
the distance travelled. Although this is a recommendation by national research council [422], it 
has also been criticised in terms of it being mostly excessive, unaffordable for studies not funded 
by a research grant, inappropriate and most importantly unfair to participants who may incur 
additional cost as a result of travelling longer distances [423].  
The TOPCare trial offered participants almost the equivalent of a day and a half’s wages to 
reimburse their transport costs which impacted on the therapeutic effect of their intervention [380]. 
This appears excessive, although recommended by the local stakeholders and was ethically 
approved by ethics committees. Trial communities generally recognise that giving study 
participants money for transport reimbursement is a transfer of net value to the study participant 
[424, 425], which usually occurs in contexts where participants of the research are extremely poor 
[422] compared to the research institution.  A study conducted to support the development of 
guidelines for benefits and payments for research participants, revealed that although it is usually 
agreed that participants should be compensated for expenses, excessive payments distort the 
decision making processes, as individuals in poverty could participate against their better 
judgement [422]. The author therefore recommends that such payments be set based on distance 
between study sites and residential zone, in addition to a small amount for a drink or snack [422]. 
Whilst this approach, introduces a layer of complexity to transport reimbursements, it would 
lessen the therapeutic effect of this extra money and explain the actual effect of the intervention. 
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As participants in the study conducted by Lowther et al. described their ability to purchase certain 
items that they could not afford previously, resulting in the researchers’ difficulty in attributing the 
causal mechanism of the relief described by participants [380]. Therefore, a future definitive trial 
should consider the specific distance travelled by participants to the study site in order that such 
final reimbursements does not influence participants’ treatment outcomes. 
 
7.4.4 Intervention delivery and outcome 
The constraint of the PhD timeline meant that the intervention was delivered over a maximum of 
three months. A future trial may offer more flexibility in the length of time between each 
intervention session. The process of randomisation was successful as a result of the willingness 
of the two clinics to be randomised. The intervention was acceptable to both PLWHA and HCP, 
although HCP expressed that the intervention required longer time to deliver that the usual time 
spent on patients. Participants did not seem to have any issues with the process and outcome 
measures used, apart from few expressions of duplication of information/ outcomes being 
assessed by the measures. Refinement of the logic model and intervention content during 
dissemination of the thesis findings can facilitate delivery of an improved intervention. 
The follow-up rates, response rates to the measures and adherence were good however, 
uncertainties still remain relating to outcomes. Methods to improve the process evaluation should 
be developed taking into consideration the context of each study site, as this will enhance the 
interpretation of the role of mediators on study findings. This should include improved evaluation 
of intervention fidelity (intervention design, training of providers, intervention delivery, receipt of 
intervention, enactment of skills gained from the intervention), which could involve production of 
a feasibility protocol [389, 426]. 
 
7.4.5 Incidental benefits derived from completing measures 
Participating in this feasibility cRCT and responding to the questions in the outcome measures 
was meant to be just a data collection exercise.  However, in a socially isolated and stigmatised 
population such as PLWHA, interacting with a friendly, non-judgemental and accepting 
researcher had therapeutic effect. As demonstrated in the findings from the post-trial qualitative 
data for participants in the control arm, it was reported that the thought of meeting the researcher 
each time they visited the study site to respond to questions in the measures used motivated 
participants to attend their appointments. 
226 
 
7.5 Communication in healthcare 
One of the benefits of the CECI intervention as discussed by participants is the importance of 
openness in communication with HCP and researcher. They spoke of being able to express 
themselves with regards to what matters to them and being interacted with in a way which 
encouraged them to respond in an equally free and open manner.  It is likely that the researcher 
emphasised the importance of talking freely for data collection.  It is essential that the interviewee 
understands that information that they might wish to convey is acceptable and interesting to the 
researcher, who works to create an atmosphere of openness and acceptance where interviewees 
do not fear judgement when disclosing their personal, intimate experiences [427].  To reduce 
interviewer bias, researchers in qualitative research are advised to sustain “empathic neutrality 
whereby the researcher uses personal insight while taking a non-judgemental stance” [427].  To 
PLWHA, it is possible that this message could be read as, ‘my experience is acceptable and 
therefore I am acceptable’. This way, the research process contributes to the feelings of increased 
self-worth and acceptance reported in the qualitative data.    
Effective and sensitive communication could have implications for PCC; due to both the way in 
which information was given and the benefit of the information itself.  Participants in this study 
described the positive effects of being listened to and sharing their burdens with the researcher 
on their person-centred needs and wellbeing. The work of Payne et al, exploring communication 
and in primary care, found a positive approach such as that demonstrated by the study team, was 
associated with patient satisfaction [428]. Similarly, in a recent systematic review, high quality 
communication between physician and patient was found to positively influence emotional health, 
resolve symptoms, improve function and pain control [152].  When functionally and subjectively 
measured, skilful quality patient physician interaction which increases patient control and includes 
positive affect and health information has been found to be associated with better health status 
[429].    
Findings from the thesis Phase 2 qualitative interviews evidence that participants felt unsafe to 
discuss their problems amongst their community. Similar findings have been reported from a 
study of PLWHA in South Africa, which identified the need for a safe forum where PLWHA could 
exchange information about how they could apply health information to their lives, within the 
context of a stigmatising condition [430]. Participating in this study provided similar space and 
opportunity to reflect on the experience of living with HIV.  Campbell et al. suggest that reflection 
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and review, create the beginnings of critical thinking and facilitate the shift from victim to 
empowered actor, and help PLWHA to develop the confidence to engage with and positively 
influence their environment [430, 431]. Therefore the training HCP received on communication 
as part of the CECI intervention enabled them to demonstrate high quality communication skills 
which enabled participants to express themselves freely, which was therapeutic in itself, but also 
created a therapeutic relationship, in a similar way to unconditional positive regard, and positively 
influenced the delivery of PCC to PLWHA.  
 
7.6 Strength and limitations 
The success of this study is a major strength including achievement of recruitment and retention 
targets, response rates in addition to the acceptability of the intervention which was developed 
specifically for HIV population. The sampling frame was achieved, and the three Phases of the 
thesis were conducted within the planned time frame, with a robust randomisation process for the 
feasibility trial which also achieved the a priori feasibility criteria. The trial was registered and was 
reported according to CONSORT extensions for pilot and feasibility trials. 
A maximum variation sample was achieved for the qualitative study, and the study oversampled 
MSM (29%) in thesis objective 2, which is notable considering that same sex relationships are 
not legalised in Ghana. However, during the time period the researcher was unable to recruit 
heterosexual participants between the age group 20–29 years for the development interviews; 
hence, their specific views and experiences may not have been represented. Furthermore, it is 
possible that some subtleties derived from the data interpretations may have been lost due to 
translated transcripts from Twi to English, as there is not always a direct translation from Twi to 
English. In order to mitigate against this, at the end of each interview the researcher summarised 
what was discussed during the course of the interview to confirm with the interviewee whether 
that was the view they put across and if possible, provide further clarification. Also, the researcher 
sent the translated transcripts together with the corresponding audio recordings to an official Twi-
English translator to verify the transcriptions. 
The feasibility cRCT only recruited from two community clinics of which only one clinic received 
CECI to improve person-centred outcomes for PLWHA. Therefore, findings do not represent the 
wider PLWHA population. Also, the researcher was involved in all study stages including study 
design, implementation and subsequent analysis of data for which it was difficult for the 
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researcher to be blinded. As a result, this may have introduced bias specifically in the assessment 
of all participants at both study sites, the feasibility and acceptability of CECI training and delivery, 
and the analysis of study data. However, the strength of this study is the fact that CECI training 
and delivery were conducted at the cluster level where a whole team of HCP were trained to 
deliver the CECI. Therefore, the delivery of CECI is neither dependent on a single staff member 
who may be on sick leave nor the intervention is about their specific skill alone that may not be 
transferable. It is about change in culture and practice not an individual’s performance.  
Moreover, the same researcher recruited participants (PLWHA and HCP) from the sample that 
participated in the feasibility cRCT for the post-trial interviews, as well as carried out the 
interviews. Given the researcher’s relationship with the study participants may not have felt 
comfortable to share negative comments about the CECI intervention or the study. Also, due to 
cost and time limitation, a pre-determined set number of interviews (n=20 PLWHA and n=7 HCP) 
were carried out. It is possible that there were further views and experiences that may have 
emerged if further interviews had been carried out. In a future definitive trial, the researcher would 
sample and interview PLWHA and HCP with the intention of reaching thematic saturation. The 
CECI intervention is a complex intervention with several different active components. As a result, 
there will have been some variation in the care received by each PLWHA.  
As discussed, efforts were made to standardise CECI delivery as much as possible including 
training of HCP, use of holistic assessment tools and care plans, twice weekly supervision 
meeting on CECI delivery and to address other issues that may have arose during the intervention 
delivery.  This level of standardisation does seem reasonable considering the time and cost 
limitations. However, in a further evaluation trial of CECI intervention, it would be important to 
ensure further standardisation of the components delivered by including a component on PLWHA 
training to empower them to engage and contribute meaningfully towards planning and making 
decisions about their care.  
On reflection, the CECI intervention delivery session could have been digitally recorded to further 
assess fidelity with subsequent training to promote consistency. In addition, this would allow 
detailed information gathering on the content of the CECI intervention, which may provide insight 
on the mechanisms of action of the CECI intervention and allowed deeper consideration and 
understanding of which part of the complex intervention is effective. Recording this information is 
unlikely to have been too burdensome in terms of cost or time and would have been helpful in 
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considering the real-life implications of delivering the CECI intervention in both hospital and 
community settings of HIV care within the Ghana Health Service.    
The Feasibility cRCT was carried out at only two community clinics in Ghana therefore 
generalisability nationally and internationally may be limited and warrants further investigation. 
Within the constraints of cost and time, it was not possible to include more cluster sites to the 
cRCT. However, any future evaluation trial would ideally need to include more cluster sites, 
nationally and if possible, internationally within African context to assess outcomes across 
different cultures and to ensure generalisability of findings.    
Furthermore, the same researcher conducted the HCP training on the CECI intervention, 
facilitated the twice weekly supervision meetings with HCP as well as evaluated the training 
session after training. This is a source of bias as the HCP professionals may want to be loyal to 
the trainer and therefore give good feedback on the training. In a future evaluation trial, the 
facilitator of the CECI intervention training should be different from the person who evaluate the 
training. As this was feasibility cRCT, it was not powered to show effectiveness. Therefore, any 
positive results should be interpreted with caution and must be evaluated in an adequately 
powered trial. This may also have potentially diluted the effect size of the intervention. 
 
7.7 Implication for practice, policy and research 
7.7.1 Implication for clinical practice 
There is increasing advocacy for holistic and person-centred care delivery for PLWHA in order to 
achieve global treatment targets [48]. The CECI intervention supports the holistic and person-
centred approach to care delivery for PLWHA.  This study has shown that symptom and concerns 
of PLWHA may be improved with routine use of a holistic assessment tool in assessing the needs 
of patients. As both PLWHA and HCP acknowledged that psychological, social and spiritual needs 
are under-assessed and therefore, inadequately managed. This perhaps indicates a routine 
neglect of psychosocial and spiritual care in standard HIV management, but also a lack of training 
and confidence to manage these issues. In conjunction with the RN4CAST data [432], this is a 
demonstration of  a pattern of inadequate provision of  psychosocial care across international 
settings. The evidence hints that a lack of time to interact  with patients may be an important 
limitation [433]. It has been argued that when time is constrained, nurses prioritise medical tasks 
to process patients through the system for medical discharge [433], this is most clearly observed 
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when staffing  levels are low [434]. As the standard HIV management clinic is extremely busy (30 
to 40 patients per day, see Table 4), it is expected that the neglect of psychosocial and spiritual 
care is as a result of increased workload and subsequent time constraints.  
This neglect of psychosocial and spiritual care can be further attributed to the lack of importance 
placed on person-centred care or holistic wellbeing by HCP working in standard HIV management 
clinics. Evidence from the UK revealed that when patients in primary care presented with 
unexplained physical symptoms and suggested potential psychosocial causes, GPs were more 
likely to suggest physical investigations and interact with a low level of empathy [435]. These 
findings imply that even when patients present with physical symptoms recognised as 
expressions of unmet psychosocial need, they are not managed appropriately or referred to 
appropriate care, even in a well-resourced healthcare setting of a UK GP practice.  As mentioned 
in the background chapter 1 (section 1.3.4.3) of this thesis, nurses trained in Ghana receive a 
comprehensive training on human anatomy and physiology, pharmacology, nutrition and 
dietetics, community, psychiatric, paediatrics, obstetrics, medical and surgical nursing, in addition 
to psychology among others [98]. While the course is comprehensive in terms of the specialities 
covered, it appears to neglect communication skills, person-centred care and the importance of 
managing the holistic needs of patients, focusing instead on diagnosis and management of 
disease. This focus on medical management in nurse training does not seem to prepare nurses 
to care holistically for their patients. The lack of emphasis on PCC in medical education remains 
a barrier to its implementation [436], resulting in gaps in practice. Evidence for the effectiveness 
of psychosocial support in the management of physical outcomes in chronic conditions is 
established and psychosocial support is now mandated as part of supportive cancer and coronary 
care [437-439]. The findings of this study indicate that psychosocial needs are disappointingly 
under assessed and poorly addressed in HIV care. 
Strategies for improving HIV care should include relationship building among stakeholders 
(PLWHA and HCP) through effective communication and acknowledgement of PLWHA as 
experts in their own healthcare through partnerships that allow for sensitivity to patient’s values, 
needs and preferences for care. There should be ongoing education and training for providers on 
PCC delivery, with a specific focus on holistic patient assessment, management of symptoms and 
concerns, collaborative care planning and delivery. Increased understanding of patient’s 
perspective for PCC should inform the content of HCP training. 
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PLWHA should have access to specific social support networks as a forum to discuss their 
experience of HIV in a non-judgemental environment, free from the effects of stigma. Findings 
from the qualitative development interviews indicate the importance of social and emotional 
support and the potential to learn from others in the same situation. The stigmatising nature of 
HIV means that a safe and non-judgemental forum to discuss their experiences is rarely available, 
and evidence suggests that this could benefit patients in terms of health education and social and 
emotional support [430]. HCP should be supported by their clinic management to develop a more 
person-centred, holistic, respectful, caring and non-judgemental approach to care. This may 
involve continuous professional development through training, increasing HCP numbers to 
reduce workload, stress and burnout, role modelling person-centred approach to HIV care and 
improving teamwork in clinics.  Clinical supervision or peer debriefing would also recognise and 
mitigate any negative effects of the emotional labour of this approach to nursing. This would 
increase HCP and PLWHA quality of life and well-being. 
 
7.7.2 Implication for policy 
Findings from this study provide evidence that should be integrated into HIV care guidelines, for 
the promotion of person-centred care for PLWHA. Policies and plans for strengthening health 
systems to better serve people with chronic conditions such as HIV/AIDS should be aligned with 
principles of person-centred care. Also, multidimensional needs of PLWHA should be holistically 
assessed at regular intervals. This, with appropriate management and referrals, will reduce the 
distressing physical, psychological, social and spiritual symptoms and concerns experienced by 
PLWHA which also  impact on treatment adherence, wellbeing and quality of life [5, 102][430].  
 
Furthermore, more material support should be made available, consisting more than just financial 
reimbursement, and be more responsive to the local context and need.  This would mitigate the  
additional constraints placed upon families with members living with HIV/AIDS, especially if the  
affected member is the breadwinner and not could contribute towards the extra costs incurred 
through illness, such as CD4 and viral loads tests not covered by basic clinic care; this would also 
relieve psychological distress. Income generating avenues should be explored for this patient 
population, so as to lessen the effects of sickness due to HIV on family life.  This may involve 
collaborations with community-based organisations in the area, including working in areas such 
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as microfinance, mobile money operators, soft loans for petty trading or projects that increase 
skills and employment options for PLWHA.  
 
7.7.3 Future direction of research in this area 
Given that this feasibility cluster trial is both feasible and acceptable, in addition to meeting a priori 
feasibility criteria, there is a need for a definitive trial of this intervention, this is also the 
researcher’s next plans for postdoctoral research. The main research question for this definitive 
trial would be does the CECI intervention work?  
The post-trial interview data revealed that although the holistic assessment tool was able to 
capture more symptoms and concerns, it also lengthened the time allocated for clinical reviews 
as it took HCP at least 30 minutes to see one patient, and at most 60 minutes to see others, 
coupled with the completion of care plans. Therefore, a future definitive cluster trial, should 
carefully consider the cost implications of delivering this intervention. As this was a feasibility trial, 
it is not in the scope of feasibility trials to do a full cost analysis. Therefore, the researcher 
proposes a full health economic/costing component to be added to a future definitive trial to 
understand costs and savings on this intervention, as well as investigate the actual time spent on 
delivering the intervention. However, the researcher hypothesises that the CECI intervention is 
potentially cost saving due to prevention of problems and health service use, reducing admission 
and crisis management and retention in care.  
 
Further research is also needed to determine and understand the active ingredients of CECI by 
closely examining the process of CECI delivery. Aspects of CECI delivery which need to be 
considered should include content of each CECI component including the holistic assessment, 
collaborative care planning and delivery and how HCP involved PLWHA in making their care 
decision. This may be done through quantitative or qualitative measures. Further studies/ next 
intervention should target both HCP and patients’ outcomes to also evaluate both HCP and 
patients’ outcomes across different cluster sites. This may provide valuable information on how 
the CECI intervention works in community settings for PLWHA.  In planning a definitive trial, a 
decision on a primary outcome measure is crucial as this feasibility could not specify what primary 
outcome measure could be used. The results of the definitive trial could be used to inform change 
in clinical practice which might lead to a future policy on PCC delivery in HIV clinical care at the 
national level. Additionally, more empirical studies are required to evaluate the suitability of 
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introducing the CECI intervention not only to HIV population but also to other disease groups 
within the West African region.  
This emphasis on theoretically driven intervention development prior to testing in a feasibility trial 
contributes to reducing research waste in person-centred care research [319]. The methods and 
findings are currently undergoing peer review for publication, this will permit refinement prior to 
efficacy testing. However, this is a complex intervention delivered in complex system therefore 
knowledge gaps relating to contextual mediators and health economics at the level of the health 




7.8 Personal learning and reflection 
Undertaking this PhD has given me access to a patient group with whom I had limited prior 
experience. Through the experience of interacting with PLWHA, I have developed a more in depth 
understanding of the symptom burden they experience and the essential support they require to 
mitigate these symptoms. During data collection and the qualitative interviews, it became clear 
that for many of these patients, living with HIV is complex condition by which they feel 
overwhelmed. Undertaking this study has demonstrated to me the importance of providing 
person-centred and holistic support to PLWHA as they cope with an unpredictable condition which 
affects every aspect of their lives. My greatest achievement conducting research in HIV population 
has also been that I was successful in recruiting about 29% of MSM who contributed their care 
experiences and challenges being homosexuals. This is notable considering that same sex 
relationships are not legalised in Ghana and those who practice same sex relationships are at 
risk of disclosing their sexual orientation. Most importantly this has contributed to the data on how 
to improve care services to be more person-centred towards MSM in Ghana.  
As this feasibility cRCT collected data over 3 months, I had a number of interactions with each 
PLWHA. This experience has informed my clinical practice in a positive way as it has given me a 
much greater understanding of the burden which a chronic condition like HIV presents. The 
training received and the experience of undertaking the qualitative interviews, have helped me to 
further develop my clinical skills. This experience has enabled me to be better equipped to explore 
PLWHA illness experience with them. This PhD has made me deeply aware of the far-reaching 
impact of having unmet person-centred needs and how this impacts every aspect of PLWHAs’ 
lives. Throughout this PhD I have been touched by how PLWHA struggled in silence because 
they did not have the opportunity to share what mattered to them. They were unaware there could 
be an intervention that could assess and manage their needs holistically and suffered without 
complaint. During data collection and the post-trial qualitative interviews, it became clear that 
PLWHA were incredibly grateful for their involvement in their care and all the support they 
received as a result of the CECI intervention. This has made me aware that care services intended 





Lessons were learnt throughout the process of completing this PhD. The first lesson relates to 
gaining access to study sites and participants, which required the researcher to build good rapport 
with the clinic leads and HCP in respective clinics including helping to screen patients at the clinic. 
The clinic leads were also offered authorship of any publications that resulted from this PhD, 
which led to significant cooperation from the clinic leads of the two study sites. This cooperation 
also led to the successful negotiation with both study sites to schedule a monthly appointment for 
all participants during the intervention delivery in order to have an even time for outcome 
assessment for both the intervention and control arms. Secondly, the researcher had to transition 
from being a nurse to a qualitative researcher by acknowledging that while the researcher has 
clinical skills or experience that are related to the subject of enquiry, those experiences and skills 
could not be applied in the research interview in the same way as the insight sought would be 
used clinically. This reality reflected the researchers’ underlying shift from being someone whose 
expertise were being sought (nurse), to someone who was an inquirer (the researcher) seeking 
out the experience of PLWHA in order to better understand their experiences, symptoms and 
concerns. The researcher worked hard, with support from her supervisors, to manage this 
transition from clinician to qualitative researcher. Achieving this balance helped the researcher to 
identify the actual care needs of PLWHA to inform the development of a theory-driven and 
culturally appropriate person-centred intervention that could best address their needs. Thirdly, the 
full cooperation of HCP during interviews, the intervention training, mentorship and supervision 
was secured by the provision of daily refreshments for all HCP during and at the end of the study. 
Additionally, training certificates were awarded to all HCP who participated in the intervention 
training which some of the HCP were heard to say with pride “I have a training certificate from 
King’s College London”. Finally, closing and withdrawing from the study sites was quite difficult 
to manage, particularly at the control arm, where the continued presence of the researcher during 
the outcome data collection throughout the study was perceived by participants as an intervention 
itself. On reflection, experiencing the disappointment of these participants and not knowing how 
this disappointment would impact on their care as the researcher withdrew from the sites was 
disturbing. However, all participants were warned ahead before the final outcome data was 
collected that the study was coming to an end. 
I believe that governments and ministries of health have a duty to ensure that groups such as 
PLWHA receive an equitable share of national resources to foster the development of 
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interventions that address their holistic needs. I would hope that this PhD helps to highlight some 
of these issues and may facilitate development of person-centred interventions going forward.   
Although this PhD has been hard work and emotionally draining at times, I have experienced a 
great deal of personal enjoyment from the sustained contact over time with PLWHA and their 
HCP. I felt a genuine pleasure in learning of the disease experiences of PLWHA including feeling 
very privileged that participants felt able to open up and shared their intensely personal issues. It 
is my believe that this PhD has positively influenced my clinical practice through not only making 
me a better listener, as a result of skills acquired during qualitative interviewing, but also more 
considerate of PLWHA and the far reaching and devastating impact of HIV/AIDS on their lives. 
 
This PhD has also improved my academic and research skills as I learned from colleagues how 
to quickly adapt to good study habits, recording and annotating reading relevant to my thesis, 
writing regularly and attending relevant courses. It was difficult for me to discriminate between 
concepts or constructs requiring deeper understanding for my thesis, and those that were just 
interesting. My supervisors and the Thesis Progression Committee helped me to develop 
convergence, focus and research management skills. I learned to prioritise, to ensure that my 
learning, developing research skills and research activities were directed towards answering my 
thesis aim and objectives. I have developed pragmatic and organisational skills during 
management of two study sites and a feasibility trial, and my academic skills have developed 
during data analysis and academic writing. I have understood that the quality and usefulness of 
research is dependent on asking important, relevant questions, choosing the appropriate methods 
to answer them and acquiring the resources needed to do it. The research skills gained at each 





This study followed the Medical Research Council Guidelines and used sequential mixed 
methods design to develop and test the feasibility of delivering a person-centred theory informed 
community-based enhanced care intervention for PLWHA. This study has shown that it is possible 
to deliver person-centred intervention for PLWHA, and to recruit and retain participants into a 
cRCT. Findings also suggest that a person-centred model of care for PLWHA may improve their 
clinical and person-centred outcomes. Further research is needed to implement the learning 
gained from this feasibility cRCT and to evaluate these potential effects in a larger evaluation trial. 
This feasibility study provides a major contribution towards the understanding of the feasibility 
and acceptability of this person-centred intervention (CECI).  It also provides valuable insights 
into the potential mechanism of action of the CECI intervention in PLWHA, in addition to the 
potential challenges associated with undertaking research in this population.  Recruitment was 
successful with no significant challenges and the total sample (n=60) for the feasibility testing 
were recruited within 6 weeks of starting recruitment. Retention rate of recruited participants was 
also good (97%), particularly in the context of multiple follow-up assessments.  
 
This is the first study to develop and test the feasibility of a person-centred intervention for PLWHA 
in Ghana and possibly one of the few globally. Intervention adherence and PLWHA compliance 
with the intervention were excellent with minimal missing data. These findings demonstrate that 
the CECI intervention could be appropriate for use in HIV population. The study also 
demonstrated that a cluster RCT design is feasible and acceptable to be undertaken with PLWHA 
having met the recruitment and retention targets including our a priori feasibility criteria. These 
findings add to the evidence base and support further development and evaluation of these types 
of interventions, which this study demonstrates are feasible with potential effect sizes and justify 
a future definitive trial of CECI. 
 
Uncertainties relating to the development and feasibility of the person-centred intervention were 
explored during the development stage including data contributed by PLWHA and HCP to inform 
the selection of intervention components and corresponding outcome and process measures; 
mapping this onto the training content for HCP and the feasibility trial process. Integration of 
theory (theory of change) and evidence resulted in a person-centred intervention to optimise the 
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skills of HCP to assess and manage the symptoms and concerns of PLWHA holistically.  A 
conceptual model of person-centred care informed by the perspectives of PLWHA and HCP in 
community HIV management in Ghana, a framework for person-centred care delivery informed 
by the WHO’s framework on integrated people-centred health services and a logic model were 
produced for a cluster randomised controlled feasibility trial. This feasibility trial revealed that it is 
feasible to recruit and retain PLWHA diagnosed for at least six months in a trial of a community-
based enhanced care intervention. Participant satisfaction with trial procedures and the 
intervention, and intervention fidelity were high. 
These findings have implications for clinical practice, research and policy. This thesis presents a 
person-centred model of community-based enhance care intervention that can be integrated 
within existing community HIV management services. This may improve outcomes for PLWHA 
including wellbeing and quality of life. A definitive trial to examine the effectiveness of the 
community-based enhanced care intervention is feasible.  However, efforts should be made to 
train PLWHA to strengthen their knowledge and skills to participate in and benefit from their care; 
increase the duration of training for HCP and allow more time for practical demonstrations using 
role plays, and to examine the effects of this intervention over longer periods than studied in this 
thesis.   
This thesis has contributed to science in relation to understanding the contextual meaning and 
practice of PCC for PLWHA in Sub-Saharan Africa, which has informed the development of a 
culturally appropriate person-centred intervention for PLWHA. If proven to be effective and cost 
saving, this intervention may be applicable in HIV population within Africa.  
Prior to starting this PhD, it was clear that person-centred care is a Western concept that was 
used to underpin this thesis. However, this study demonstrates that the Western 
conceptualisation does not directly align to the cultural context of Ghana. This is because person-
centred care has been interpreted and applied differently in different contexts [39]. Also, in the 
context of Africa, it has been argued that the wishes of the patient are often a reflection of the 
wishes of their families [39], implying that the care is less individualised and more family-centred. 
Although this assertion may be true, it does not seem to apply to the context of HIV care due to 
the highly stigmatised nature of the disease leading to potential non-disclosure or disclosure 
resulting in loss of family and social support. Consequently, person-centred care for people living 
with HIV/AIDS in Ghana means individualised care that is focused on addressing specific social 
needs such as poverty (although there is not a charge to access healthcare, people regularly 
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incur travel and other costs in order to attend services), relationship support (being able to marry 
whoever they want irrespective of their HIV status); information needs (such as knowing what 
treatment options are available to them in addition to information on when to have unprotected 
sex for discordant couples); being given the opportunity to contribute to their care decisions; and 
in the case of MSM, being able to access any public health services without any fear of dual 
discrimination (being discriminated against for their sexual orientation and being HIV positive).   
The findings of this study represent a novel contribution to the evidence base for the development 
and evaluation of a person-centred model of care, which could help in meeting the 
multidimensional needs of PLWHA experiencing HIV infection as a chronic condition, particularly 
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Appendix EE. Gnatt chart showing PhD key milestones 
The Gantt Chart below show the key milestones of this PhD 
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